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QUILL ON SCALPEL
This section provides a medium through which Canadian surgeons can declare themselves, briefly 
and informally, on the day-to-day affairs of surgery.
Progress in Cardiovascular Surgery in Canada
Eleven of the papers appearing in this 
issue of the Journal were presented at 
the annual meeting of the Canadian 
Cardiovascular Society in October 1977. 
This editorial comments on three of 
the papers in an attempt to provide 
general background information for 
readers whose major interest lies out­
side the field of cardiovascular surgery; 
the three papers are concerned with 
myocardial preservation, valve replace­
ment and impending gangrene of the 
leg.
Some might ask why so much is cur­
rently being written about myocardial 
protection. The answer is that the prin­
ciples of intraoperative myocardial pro­
tection now have a sound scientific 
basis and considerable clinical applica­
tion. We have known for years that it 
is sometimes necessary and often de­
sirable to interrupt the coronary blood 
flow, thus jeopardizing the myocar­
dium. A number of options are avail­
able in this situation. The heart beat 
can be allowed gradually to peter out 
as the heart piles up an oxygen debt 
and metabolizes available nutrients, or 
it can be converted to fibrillation, or 
the myocardium can be cooled to re­
duce its metabolic requirements.
Many surgeons could not imagine a 
more physiologic solution than to can- 
nulate the coronary arteries directly 
through the root of the aorta and to 
supply the needed blood from a 
separate pumping system. In fact ex­
tremely good results have been ob­
tained with this technique, but occa­
sionally hearts were damaged by under- 
or overperfusion, and sometimes the 
coronary arteries were damaged so that 
late stenosis developed due to intimal 
hyperplasia at the point where the 
arterial endothelium was injured by the 
cannula. Furthermore, keeping the heart 
perfused and beating had its disad­
vantages; exposure, for example, was 
more difficult, and the coronary venous 
effluent not only inhibited exposure 
but led to unnecessary damage to blood 
cells, owing to their continuous aspira­
tion from the operative field. An opera­
tion done with coronary perfusion 
would therefore take longer than one 
with induction of ischemic arrest. Thus 
the surgeon had to weigh a lesser insult 
for a longer time against a greater 
insult for a shorter time.
Evidence accumulated that although 
the operative mortality might be ac­
ceptable, myocardial damage sometimes 
occurred. The hearts were not always 
as healthy after the operation as they 
had been before. The administration of 
inotropic drugs was often required 
after operation, balloon pumping was 
occasionally necessary and sometimes 
the heart size did not decrease despite 
an apparently successful operation. We 
learned that the inner one third of the 
myocardium was most vulnerable, par­
ticularly when a hypertrophied ventri­
cle fibrillated during operation.
Our new knowledge has led to in­
creasing acceptance of and growing 
enthusiasm for cardioplegic hypother­
mia to protect the heart. A cold (10°C) 
solution containing a high concentra­
tion of potassium is flushed into the 
aortic root, first to stop the heart 
promptly, thus avoiding the agonal 
beats of elective arrest and second, to 
achieve uniform myocardial cooling to 
the temperature of 15° to 20 °C for 
preservation. Hypothermia unquestion­
ably protects the heart. Witness the 
satisfactory results obtained when a 
heart is removed from the donor in one 
city, put in a cold bath and, with no 
other preservation, flown as far as 600 
miles for implantation into the reci­
pient.
The advent of cardioplegic hypother­
mia for myocardial protection has re­
duced the need for inotropic drugs in 
the recovery room and has led to the 
frequent administration of nitroprusside 
to reduce afterload. In other words, in­
stead of hypotension, we now have 
hypertension. The balloon pump is 
staying in the cupboard. The periopera­
tive infarction rate is decreasing sharp­
ly. The heart muscle truly seems to be 
in as good shape after the operation as 
it was before.
Not all these benefits are obvious in 
the report by Haraphongse and his as­
sociates from Edmonton (page 101), 
primarily because their “control” group 
of patients undergoing ischemic arrest 
at normothermia did so well. This un­
doubtedly reflects the expeditious man­
agement of aortic valve replacement by 
the Edmontonians so that the duration 
of myocardial ischemia was minimized. 
Still, support with inotropic agents was 
required in many patients of the nor- 
mothermic group and rarely in the cold 
cardioplegic group. Their careful docu­
mentation clearly supports cold cardio­
plegia.
With respect to valve replacement, 
the data provided by Jamieson and his 
associates (page 133) indicate that some 
patients receiving porcine valves re­
quire anticoagulation. All instances of 
embolism occurred in patients in atrial 
fibrillation and it is to be hoped that 
the frequency of embolism will be 
substantially reduced by the use of 
anticoagulant therapy, as they advise. 
The porcine bioprosthesis, one would 
expect, will prove less durable than 
manufactured, rigid valves, but the 
manner of failure will not be catas­
trophic, thus permitting semielective 
valve replacement. Such a prospect will 
not be pleasant for an informed patient 
but will be more attractive than a valve 
thrombosis or massive embolism. The
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decision whether to use a porcine or a 
rigid valve can be made on an individ­
ual basis. Influenced by the present 
series from Vancouver many surgeons 
will opt for rigid valves in fibrillating 
patients or in those with large dilated 
left atria or atrial thrombi. After all, 
the advantage of the porcine valve is 
that anticoagulation is not required. If 
anticoagulants are going to be used 
regardless of the valve type one may as 
well choose the more durable valve.
David and Key (page 107) re-em- 
phasize that patients with patent deep 
femoral arteries rarely lose their legs 
because of chronic occlusive disease. 
These authors direct their attack on the 
deep femoral artery itself in patients 
with rest pain or frank gangrene; they 
noted symptomatic or clinical improve­
ment when that artery could be canal­
ized by an endarterectomy with or with­
out a patch-graft arterioplasty. The 
operation was beneficial even when the
outflow below the knee was occluded. 
The authors caution that careful ra­
diologic techniques, including oblique 
and lateral views, are necessary to 
evaluate the patency of the deep fe­
moral artery. Experienced vascular sur­
geons will agree. Compared with femo- 
ropopliteal or femorotibial bypass, re­
construction of the deep femoral artery 
is a simpler, better-tolerated operation 
for patients with rest pain. Claudica­
tion may remain but limb viability will 
be restored. The authors intimate that 
they have recently quantitated flow and 
pressure in the legs of such patients 
and we hope that the clinical benefits of 
these operations will be documented by 
such techniques in the future.
A nthony R.C. D obell , m d , frcs[c] 
Director,
Division of cardiovascular and 
thoracic surgery,
Royal Victoria Hospital,
Montreal, PQ
Leg Amputation
Interest in the problems of amputees 
was stimulated during World War II 
and received further impetus in the 
United States from the wars in Korea 
and Vietnam. Prosthetic research labo­
ratories, rehabilitation units, amputee 
clinics and institutions devoted to the 
training of personnel in the care of the 
amputee were established and resulted 
in new concepts of pre-, intra- and post­
operative care. It became recognized 
that each distal joint that could be 
saved markedly improved the patient’s 
ultimate ability to function. There was 
a gradual waning of popularity for the 
above-knee amputation in patients with 
peripheral vascular disease despite the 
high probability of satisfactory healing, 
since in the case of amputation in 
geriatric patients or those with peri­
pheral vascular disease, the presence of 
a knee could well decide whether the 
patient would be able to walk with a 
prosthesis. Throughout the 1960s, sur­
geons began to take increasingly greater 
pains to save the knee so that by the 
end of that decade most clinics found 
that two thirds of their healed amputa­
tions performed for vascular disease 
were at the below-knee level.
Later, Burgess and Zettl1 demon­
strated that the use of long posterior 
flaps could make possible even more 
below-knee amputations, and improve­
ments in techniques resulted in an in­
creased salvage rate for Syme’s ankle 
disarticulations.
New prosthetic components, tech­
niques of immediate fitting of pros- 
theses in selected patients and early 
fitting of temporary prostheses in most 
geriatric subjects have substantially re­
duced the time between amputation and 
successful ambulation. This has led to 
a marked increase in the number of 
patients using prostheses.
All this progress has been due to the 
direct interaction between surgeons, 
prosthetists, therapists, engineers and 
other medical and nonmedical person­
nel. It also required the organization of 
interdisciplinary clinics and teams in­
volving all of these persons in the con­
tinuing care of individual patients. It is 
no longer sufficient for the surgeon to 
amputate a gangrenous limb and then 
send the patient off in due course to a 
rehabilitation unit. Other health pro­
fessionals must be involved before 
operation in the decision as to the level
Hepalean®
INDICATION:
Low-dose anticoagulant. There is 
now good evidence1.2,3 that low-dose 
heparin is effective in preventing serious 
venous thromboembolic complications in 
high risk surgical patients.
CONTRAINDICATIONS:
Haemophilia and severe clotting disorders; 
shock; hypersensitivity to heparin; severe 
liver damage. Active bleeding from a local 
lesion such as an acute ulcer or ulcerating 
carcinoma. Recent neurosurgery or spinal 
surgery.
WARNING:
1. Administration of large doses of HEPA­
LEAN should be delayed four hours post-
operatively.
2. When any of the conditions mentioned 
under precautions are present the advant­
ages of HEPALEAN therapy must be care­
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deleterious results.
PRECAUTIONS:
HEPALEAN should be used with caution in 
pregnancy although it does not cross the 
placental barrier and is the safest and most 
useful form of therapy in thromboembolic 
disorders of pregnancy.
Care must be taken where large doses of 
antibiotics and/or drugs containing amino 
groups are administered along with or prior to 
HEPALEAN administration.
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Low-Dose Subcutaneous Heparin.
The usually recommended dose is 5,000 units 
subcutaneously 2 hours before surgery 
and then 5,000 units given either 12 hourly 
or 8 hourly after surgery with the first dose 
given at approximately 12 hours after surgery. 
It is not necessary to monitor low-dose 
prophylactic heparin.
SUPPLY:
For low-dose therapy HEPALEAN 25,000 
units/ml 2 ml Vial is recommended. It pro­
vides 5,000 U.S.P. units in a dose of only
0. 2.ml.
HEPALEAN is supplied in the following con­
centrations and package sizes: Please note 
that all Harris injectables are colour-coded.
Strength:
1,000 units/ml 1 ml ampul, 10 ml vial,
30 ml vial
10.000 units/ml 1 ml ampul, 5 ml vial
25.000 units/ml 2 ml vial
1. Reference: Kakkar V. V., Corrigan, T. P. and 
Fossard D. P. 'Prevention of Fatal Post-operative 
Pulmonary Embolism by Low Doses of Heparin',
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July 1975.
2. Reference: Gallus, A. S., Hirsh J„ O'ESrienS. E„ 
McBride J. A., Tuttle R. J., Gent M. 'Prevention of 
Venous Thrombosis with Small, Subcutaneous 
Doses of Heparin’, (JAMA 235:1980-1982, 1976).
3. Reference: Genton £., 'Low-Dose Heparin in the 
Prophylaxis of Venous Thromboembolism’, The 
Canadian Journal of Hospital Pharmacy — July, 
August, 1977.
Complete prescribing information is available 
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Brampton Street, Hamilton, Ontario L8H 7K1
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M. MacKay, B.Sc., Art as Applied to Medicine, (Faculty of Medicine) University of Toronto.
New “ Low-Dose” Hepalean® (25,000 u/ml) .. .  
provides 5,000 U.S.P. units in a dose of only 
0.2 m l ... to reduce haematoma and pain at 
the site of injection.
In a multi-centre study of 4121 
K patients . . .  “ Pulmonary emboli 
were considered fatal if fresh em-
* boli were present in the pulmonary 
trunk, the main pulmonary arteries, 
and if no other cause of death was
*• found.
<-* Using these criteria, 16 patients
(0.7%) in the control group died 
due to embolism-, while only 2 fatal 
•m emboli (0.09%) occurred in the
heparin-treated patients 
(FK0.005).”
“ The frequency of D.V.T. was 
reduced from 24.6% in the con­
trol group to 7.7% in those receiv- 
ing heparin. These findings are 
v similar to those reported pre­
viously.”  (D.V.T. — Deep Vein
* Thrombosis)1
“ The effect of low-dose heparin 
prophylaxis on venous thrombosis 
and bleeding after major elective 
surgery was studied in a prospect­
ive controlled study of 820 pa­
tients. The total incidence of 
venous thrombosis detected with 
leg-scanning using fibrinogen 
labeled with radioactive Iodine 
(125l)was reduced from 16.0% in 
the control group to 4.2% in treat­
ed patients. More important, the 
incidence of popliteal or femoral 
vein thrombosis was reduced from 
2.9% to 1.0%. Prophylaxis 
resulted in a slight increase in 
bleeding — minor wound haema­
toma, mean volume of blood trans­
fused, and a post-operative 
hematocrit fall in treated patients. 
However, increased bleeding was 
clinically minor, and prophylaxis 
was well tolerated.” 2
“ It would appear that low-dose 
heparin fulfills most of the criteria 
for an optimal prophylactic agent.
It is effective in patients exposed 
to moderate provocation to throm­
bosis, it is safe as regards major 
complications, and is acceptably 
convenient for patients and health 
professionals. It can be recom­
mended in patients at moderate 
risk of developing venous throm­
bosis, and especially in those 
considered at high risk, including 
the elderly, obese, those with 
malignant disease or congestive 
heart failure, and those who have 
had prior episodes of venous 
thrombosis. The drug should be 
started prior to the development of 
thrombosis and continued until 
the risk of thrombosis has 
passed.” 3
Harris Laboratories PAABCCPP
and type o f amputation and, likewise, 
the surgeon must be concerned in the 
subsequent care.
The benefits of this multidisciplinary 
activity are reflected in the paper by 
Hunter and Holliday (page 176) in this 
issue o f the Journal. A  physician and 
therapist, after reviewing the results of 
several clinics, have furthered our 
awareness that saving the knee is a 
tremendous aid to the patient, especially 
in cases o f bilateral amputation. They 
have shown that significant numbers of 
patients with bilateral above-knee am­
putation can be successfully fitted with 
prostheses. Although almost half of 
such patients used a wheelchair as a 
primary aid to mobility even some of 
these, we must presume, have benefited 
from occasional use o f their prostheses 
for transfer. In confirmation of the re­
sults o f Hunter’s study, we have man­
aged 40 patients with bilateral leg am­
putation in the past 7 years; 18 have 
been able to  walk with the use of 
prostheses.
More information on the manage­
ment of complicated amputee problems 
is sure to become available. New hori­
zons in amputation surgery will pro­
bably be concerned with better methods 
o f predicting the likelihood of success 
in a given operation. At present, the 
Doppler technique appears to hold con­
siderable promise in this regard.
N elson S. M itchell, m d , frcs[c] 
Department of surgery,
Royal Victoria Hospital,
Montreal, PQ
Reference
1. Burgess EM, Zettl JH: Amputations 
below the knee. Artif Limbs 13: 1, 
1969
Glimpses of Surgical History: 
T  for Transplantation
David A .E . Shephard
The concept of transplantation is an­
cient: Greek myths refer to transplants 
of animal tissue into man, and the 
fabled chimera (part lion, part goat, 
part serpent) symbolizes the potential 
of transplantation of genetically for­
eign tissue. But old legends and folk 
tales describe transplantation of tissue 
from human donor to human recipient 
too. Among such legends are the heart 
transplants performed by Pien Ch’iao 
and Hua T o  in China two centuries 
BC, and the leg transplant by medical 
saints Cosmos and Damian in Italy 
five centuries later. In fact the first 
transplant is credited to Susruta, the 
Indian, who was familiar with auto­
genous pedicled grafts for wounds or 
disease of the facial area; in his coun­
try, by the way, rhinoplasty had been 
performed by members of the Koomas 
caste of potters and tile and brick mak­
ers. The first free skin graft is attri­
buted to Astley Cooper who, much 
later, grafted a healthy piece of skin 
from an amputated thumb to its stump.
Organ transplantation is relatively 
modern. Surgeons may rightly be proud 
o f their successes, but few will forget 
the contributions to history of their 
own patients and fellow scientists. 
What lessons, for example, were learned 
from the case of a 5-year-old child 
whose shredded leg took hundreds of 
pinch grafts from the maternal donor 
under the hands of Emile Holman some 
50 years ago; and what impressions 
the successful temporary kidney trans­
plant in a pregnant uremic woman 
made on surgeons Charles Hufnagel 
and David Hume two decades later! 
How huge were the basic contributions 
of Victorian natural scientists Charles 
Darwin and Gregor Mendel, and of 
modern immunologists like Peter Meda- 
war and Macfarlane Burnet! Such 
comment forcefully illustrates the 
theme of this series of personal glimp­
ses: the cross-fertilization from other 
disciplines needed for the surgical 
discipline to advance, and the human 
stories behind the initial failures and 
later triumphs that make surgery so 
personal and yet so great a physical 
transgression.
One meaning of the word chimera 
is “mere wild fancy; an unfounded 
conception” . The history of transplanta­
tion belies this definition, to the im­
mortal glory of those, often unremem­
bered, who have helped surgeons shape 
its progress.
SESAP II Question
418. Disorders associated with Raynaud’s phenomenon include
(1 ) thromboangiitis obliterans (Buerger’s disease)
(2 ) progressive systemic sclerosis (scleroderma)
(3 ) cervical rib
(4 ) atherosclerosis
For the incomplete statement one or more of the completions given above 
is correct. Your answer should be:
A  if only 1, 2 and 3 are correct,
B if only 1 and 3 are correct,
C if only 2 and 4 are correct,
D  if only 4 is correct,
E if all are correct.
For the critique of Item 418 see page 183 of this issue.
(Reproduced by permission o f the American College o f Surgeons from 
SESAP II Syllabus: Surgical Education and Self-assessment Program No. 2. 
For enrolment in the Surgical Education and Self-assessment Program 
N o. 2 please apply to the American College of Surgeons, 55 East Erie St., 
Chicago, IL 60611.)
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CARDIOVASCULAR SOCIETY PAPERS
Myocardial Protection During Aortic Valve Replacement: 
Normothermia Versus Hypothermia*
M ant H a ra ph o n g se , m d , F R C P [ c ] , f  R o b er t  S. F raser, m d , f r c p [c ] ,$  R ic h a rd  E. R o ssa ll , m d , f r c p [ c ],§  
R . L eig h to n  F isk , m d , f r c s [c],^| C arlos A.E. B asualdo, m d , f r c p [c ] ,* *  E l l io t t  T. G e l f a n d , m d , f r c s [c ]^]
and John C. Callaghan, md, FRCs[c]ff
The operative results in 32 patients 
who underwent aortic valve replace­
ment with aortic occlusion and normo- 
thermic myocardium (group 1) were 
compared with 54 similar patients in 
whom the myocardium was protected 
by hypothermic coronary perfusion 
through the aortic root (group 2). The 
operative mortality and the incidence 
of heart failure, subendocardial 
ischemia and myocardial infarction 
were the same in the two groups.
The maximal concentrations of 
cardiac enzymes after operation in 
group 2 patients were significantly 
lower than those in group 1. The 
postoperative cardiac performance
*From the departments of medicine and 
surgery, University of Alberta Hospital, 
Edmonton, Alta.
Presented at the annual meeting of the 
Canadian Cardiovascular Society, Toronto, 
Ont., Oct. 19-22, 1977
t Assistant professor of medicine and 
director, hemodynamic laboratory, 
University of Alberta Hospital
XProfessor of medicine, University of 
Alberta
§Professor of medicine and director, 
division of cardiology, University of 
Alberta Hospital
flAssistant professor of surgery, Univer­
sity of Alberta
* * Associate professor of medicine, 
University of Alberta
t t  Professor of surgery and director, 
division of thoracic and cardiovascular 
surgery, University of Alberta Hospital
Reprint requests to: Dr. M.
Haraphongse, Director, Hemodynamic 
laboratory, University of Alberta 
Hospital, Edmonton, Alta. T6G 2B7
was significantly different in that only 
5.6% of group 2 patients required ino­
tropic agents after operation compared 
with 25% of group 1 patients. The 
patients in group 2 were easier to 
defibrillate after cardiopulmonary 
bypass.
On a compare les resultats operatoires 
de 32 patients qui ont eu un rempiace- 
ment de la valvule aortique, par 
occlusion aortique, en conservant 
le myocarde a temperature normale 
(groupe 1), a ceux de 54 patients 
semblables chez qui le myocarde a ete 
protege par perfusion hypothermique 
coronarienne par le tronc aortique 
(groupe 2). La mortalite peroperatoire 
et la frequence de I’insuffisance 
cardiaque, I’ischemie sous-endocardique 
et I'infarctus du myocarde ont ete 
comparables pour les deux groupes.
Les concentrations maximales des 
enzymes cardiaques apres I'operation 
pour les patients du groupe 2 ont ete 
significativement plus basses que 
cedes du groupe 1. La performance 
cardiaque postoperatoire a ete signifi­
cativement differente, puisque seule- 
ment 5.6% des patients du groupe 2 
ont necessity des medicaments inotropes 
apres I’operation, en comparaison de 
25% des patients du groupe 1. II etait 
aussi plus facile de defebriller les 
patients du groupe 2 apres derivation 
cardiopulmonaire.
The myocardium must be protected 
from the injurious effects of ischemia 
during cardiopulmonary bypass. Meth­
ods used to protect the myocardium 
during aortic valve replacement (AV R ) 
have included direct coronary arterial 
perfusion and ischemic arrest at d if­
ferent myocardial temperatures. Coro­
nary perfusion with cold lactated 
Ringer’s solution through the aortic 
root has recently been used at the 
University of Alberta Hospital, Ed­
monton, as a method of myocardial 
protection during coronary bypass sur­
gery and during valve replacement. 
The morbidity, mortality and cardiac 
performance improved after the intro­
duction of this technique.
This report compares the results of 
A V R  under normothermic anoxic ar­
rest with the results obtained under 
cardiac hypothermia and cardioplegia 
induced by coronary perfusion.
Patients and M ethods
A ll patients who underwent isolated 
A V R  between Jan. 1, 1970 and Feb. 
29, 1976 were included in this study. 
Group 1 consisted o f 32 patients who 
had A V R  between Jan. 1, 1970 and 
Dec. 31, 1973 with aortic occlusion and 
normothermic myocardium. Group 2 
consisted of 54 patients who had similar 
operative procedures between Jan. 1, 
1974 and Feb. 29, 1976 but with aortic 
occlusion and hypothermic myocardium.
In group 1, the mean age o f patients 
was 52 years (±12  years); 20 (62.5%) 
patients were men. In group 2, the 
mean age was 51 years (± 1 4  years); 
43 (79.6%) patients were men. Pre­
operative investigations (Table I) were 
the same for both groups and included 
complete studies by cardiac catheteriza­
tion and coronary angiography.
In group 2 hypothermia was induced 
by perfusion with 5% glucose and cold 
lactated Ringer’s solution to which 
were added potassium chloride (40 
mmol/L) and sodium bicarbonate
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T a b le  1— P re o p e ra t iv e  C h a ra c te r is t ic s  in  P a t ie n ts  w h o  had  A o rtic  V a lv e  R e p la c e m e n t w ith  E ith e r  
N o rm o th e rm ic  (n  =  3 2 )  o r  H y p o th e rm ic  (n  =  5 4 )  M yo ca rd iu m
C h a ra c te r is t ic
P a t ie n ts  w ith  
n o rm o th e rm ic  
m y o c a rd iu m , %
P a t ie n ts  w ith  
h y p o th e rm ic  
m y o c a rd iu m , %
D ia g n o s is
A o r t ic  s te n o s is  (p re d o m in a n t) 59.4 53.7
A o r t ic  in c o m p e te n c e  (p re d o m in a n t) 40.6 46.3
S u b a c u te  b a c te r ia l  e n d o c a rd itis 6.3 12.9
A n g in a  p e c to r is 31.3 18 .5
S yn co p e 28.1 25 .9
H e a r t  fa i lu r e 15.6 22 2
M y o c a rd ia l in fa rc t io n 0 0
E le v a te d  le f t  v e n tr ic u la r  e n d -d ia s to lic  p re s s u re * 46.9 61.1
N Y H A  fu n c t io n a l  class
i
i i
0 5.5
15.6 24.1
in 71.9 62.9
IV 12.5 7.4
E le c tro c a rd io g ra m
N o rm a l 15.6 18.5
L e f t  v e n tr ic u la r  h y p e rtro p h y
(v o lta g e  c r i t e r ia ) 15.6 9 .3
L e f t  v e n tr ic u la r  h y p e rtro p h y  w ith  s tra in 68.8 72.2
♦M ean  ±  SD w a s  17 ±  9 mm Hg in  g ro u p  1 an d  21 ±  12 m m  Hg in  g ro u p  2.
(44.6 mmol/L). After the patient was 
placed on total cardiopulmonary by­pass a cross-clamp was placed on the aorta and 500 to 700 mL of 
solution was introduced into the aorta proximal to the clamp, through a small catheter introduced through a 
purse-string suture in the aortic wall. When the aortic valve was incompe­tent, the left ventricle was manually 
compressed during the period of aortic infusion. This maneuver aided in op­posing aortic regurgitation and prevent­ing distension of the left ventricle. Car­diac arrest occurred rapidly, after about 200 mL of the cold solution had been injected. Additional solution was placed 
in the pericardial well around the heart. If the period of aortic cross-clamping 
needed to be prolonged beyond the time expected for completion of a pro­cedure, additional cold solution was introduced into the aortic root and 
pericardial well. Upon release of the cross-clamp and re-establishment of 
coronary arterial flow, rewarming of the heart took place within, minutes. Direct-current defibrillation was applied if necessary.
T a b le  I I — D e v ic e s  used  to  
V a lv e
R e p la c e  A o r t ic
P a t ie n ts  w ith P a t ie n ts  w ith
n o rm o th e rm ic h y p o th e rm ic
m yo card iu m , m y o c a rd iu m ,
% %
P ro s th e s is (n  =  3 2 ) (n  =  5 4 )
S m e lo f f -
C u tte r
L i l le h e i
72 18.5
K a s te r 22 81 .5
B jo rk 6 0
Both groups were analysed with re­spect to mortality, number of complica­
tions and postoperative changes in the electrocardiogram. Electrocardiograms were obtained immediately after sur­gery, then daily for 1 week and again 
just before discharge from hospital. Myocardial infarction was diagnosed if new Q waves appeared; subendocardial
ischemia was diagnosed if symmetrical T-wave inversion was noted within the first 24 hours after surgery. Supraven­tricular and ventricular arrhythmias were recorded. Die use of inotropic agents to maintain circulation, and the number of defibrillations necessary to restore sinus rhythm following comple­tion of the procedure were also noted. The differences in the above factors in the two groups were compared by X2 analysis. Serum creatine phos- phokinase (CPK) and serum glutamic oxaloacetic transaminase (SGOT) values were measured daily for 3 days after operation. Statistical significance of the differences between these mean values was calculated by using Student’s f-test.
Results
Both groups of patients were similar with respect to age, sex, preoperative 
symptoms, and previous history of bac­terial endocarditis, heart failure, or 
myocardial infarction. The number of patients who had elevated left ventri­
cular end-diastolic pressure, their pre­operative functional classification and 
electrocardiographic findings were com­parable in both groups (Table I). The allocation of devices used to replace the aortic valve is set forth in Table II.The overall operative mortality was
T a b le  I I I — C a rd ia c  C o m p lic a tio n s
P a t ie n ts  w ith P a t ie n ts  w ith
n o rm o th e rm ic h y p o th e rm ic
m y o c a rd iu m , % m y o c a rd iu m , %
C o m p lic a tio n (n  =  3 2 ) (n  =  54 )
S u b e n d o c a rd ia l isch em ia 6.3 11.1
M y o c a rd ia l in fa rc t io n 9.4 7.4
A rrh y th m ia s
S u p ra v e n tr ic u la r 46 .9 42 .6
V e n tr ic u la r 12.5 3 .7
H e a r t  fa i lu re 6.3 1.8
M o r ta lity 3.1 1.8
T a b le IV — S u rg ic a l E ven ts
P a t ie n ts  w ith P a t ie n ts  w ith
n o rm o th e rm ic h y p o th e rm ic
m y o c a rd iu m m y o card iu m
(n  =  3 2 ) (n  =  54 ) P v a lu e
A o r t ic  c ro ss -c la m p  tim e ,
m ean ±  S D , m in  
C a rd io p u lm o n a ry  bypass t im e ,
46 .5  ±  8.8 52.6 ±  11.8 < 0 .0 2 5
m ean ±  S D , m in 66.1 ±  16.3 74.3 ±  16.9 < 0 .0 5
In o tro p ic  s u p p o rt p o s to p e ra tiv e ly , % 
N u m b e r of d e f ib r i l la t io n s  n e c e s s a ry  to
25 5 .6 < 0 .0 1
res to re  s in u s  rh y th m , %
S pontaneous 16 30 NS
1 22 48 < 0 .0 0 2 5
2 28 11 < 0 .0 5
> 2 34 11 < 0 .0 1
N S  =  not s ig n if ic a n t .
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similar in both groups (Table III). One 
patient in group 1 died of subdural 
hemorrhage. One patient in group 2 
died of myocardial infarction. The 
differences between the two groups in 
the incidence of subendocardial is­
chemia, myocardial infarction, post­
operative cardiac arrhythmias and 
heart failure were not statistically 
significant.
The cardiopulmonary bypass time 
(Table IV) in group 1 averaged 66.1 
minutes, which was substantially short­
er than the average of 74.3 minutes in 
group 2. The average time of aortic 
cross-clamping was also shorter in 
group 1 (46.5 minutes) than in group 
2 (52.6 minutes).
Inotropic drugs were given when 
cardiac performance was depressed as 
evidenced by an arterial systolic blood 
pressure below 90 mm Hg or urine 
output of less than 20 mL/h. In group 
1 eight (25%) patients required an ino­
tropic agent to maintain circulation, but 
this was necessary in only three (5.6%) 
patients in group 2.
The number of defibrillations neces­
sary to restore sinus rhythm following 
completion of the procedure was sig­
nificantly higher in group 1 than in 
group 2 (Table IV).
Postoperative concentrations of se­
rum enzymes (CPK and SGOT) were 
analysed (Fig. 1) in patients with a 
normal postoperative course. Maximal 
concentrations of enzymes in the pa-
CPK(IU/L)
0 I . 1______ I----------1----- —L
P r e o p  1 2 3  
P o s t o p  D a y s
FIG. 1—Serum enzyme values for 
glutamic oxaloacetic transaminase (SGOT) 
one standard error in patients with normal 
thermia, solid square =  hypothermia).
tients with hypothermia were signifi­
cantly lower than in normothermic pa­
tients.
Discussion
The 30-day mortality rate and the 
incidence of myocardial injury follow­
ing AVR are variables that should 
reflect the adequacy of intraoperative 
myocardial protection. Because of the 
present low operative risk for isolated 
AVR, large numbers of patients would 
need to be compared in order to estab­
lish the superiority of one method of 
myocardial protection over another. 
Nevertheless, the readier restoration of 
heart beat, the reduced requirement for 
myocardial support after the operation 
and the smaller rise in serum enzyme 
values following AVR in group 2 to­
gether suggest that there has been a 
beneficial and protective effect on the 
myocardium in these patients who had 
hypothermic cardioplegia.
Ischemic cardiac arrest under nor­
mothermic conditions is a safe method 
for open intracardiac operation1 and is 
moderately well tolerated for 30 min­
utes.2 Beyond that time biochemical 
changes,3 subendocardial hemorrhage4 
and generalized myocardial damage are 
progressive and probably irreversible.2 
Furthermore, normothermic ischemic 
arrest leads to a substantial reduction 
in high-energy phosphates and results 
in poor functional recovery.5
SGOT(IU/L)
300
250
200
150
100
50
0
P r e o p  1 2 3  
P o s t o p  D a y s
creatine phsophokinase (CPK) and serum 
following operation are shown as means and 
postoperative course (solid circle =  normo-
Hypothermia affords considerable 
myocardial protection by reducing the 
metabolic rate6 and extends the safe 
period of ischemic arrest.7 The func­
tional recovery of the heart following 
the termination of arrest is directly 
related to the concentration of ATP 
and of creatine phosphate in the myo­
cardium at the end of the period of 
arrest.5 Hypothermic coronary perfu­
sion for intraoperative cardioplegia 
provides rapid arrest and uniform cool­
ing of the heart with minimal hypoxia. 
Cellular levels of high-energy phos­
phates are maintained and complete 
recovery is possible.5’8
Cardiac performance, as estimated 
by the need for support with inotropic 
agents and ease of defibrillation after 
operation was better in group 2 than 
in group 1 even though the periods of 
cardiopulmonary bypass and aortic 
cross-clamping were longer in group 2 
patients.
In this study, we compared two 
methods of anoxic arrest during AVR. 
Both groups of patients were similar 
in all aspects preoperatively. Hypo­
thermic coronary perfusion for intra­
operative cardioplegia as a method of 
myocardial protection was superior to 
normothermic anoxic arrest.
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Noninvasive Assessment of Patients Following 
Aortocoronary Bypass Surgery*
W J. Kostuk, md, frcp[c], facc, D. Deatrich, rt and M.J. Chamberlain, mb, ch b, frcp[c]
A simple, accurate, noninvasive method 
is required for the objective evaluation 
of aortocoronary bypass surgery.
Stress myocardial imaging with intra­
venous injection of potassium-43 or 
thallium-201 was used an average 
of 4.4 months after direct myocardial 
revascularization in 77 patients to 
assess the accuracy of stress myo­
cardial imaging in predicting complete­
ness of revascularization. The results 
were correlated with maximal treadmill 
exercise tests, extent of revasculariza­
tion and status of bypass grafts 
(occlusion, stenosis and distal disease). 
We found stress myocardial imaging 
to be a more sensitive method than 
the stress electrocardiogram for the 
detection of incomplete revasculariza­
tion. The method appears to be a 
sensitive noninvasive means of evaluat­
ing the results of aortocoronary bypass 
surgery.
II existe un besoin pour une methode 
simple, precise et non envahissante, 
capable de realiser une evaluation 
objective du pontage aortocoronarien.
La mise en evidence du myocarde a 
I’effort, par injection intraveineuse de 
potassium-43 ou de thallium-201 a ete 
employee, en moyenne 4.4 mois apres 
une revascularisation myocardique 
directe, chez 77 patients, afin d'evaluer 
la precision de cette technique pour 
predire la reussite de la revasculari­
sation. Les resultats ont ete mis en 
correlation avec les tests d'effort 
maximum sur tapis roulant, I’etendue 
de la revascularisation et I'etat des 
greffons de pontage (occlusion, stenose 
ou atteinte distale). Nous avons trouve 
que la mise en evidence du myocarde 
a I’effort est une methode plus sensible 
que I’electrocardiogramme a I'effort 
pour deceler une revascularisation
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incomplete. Cette methode semble 
etre un moyen non envahissant sensible 
pour evaluer les resultats du pontage 
aortocoronarien.
Aortocoronary venous bypass has 
emerged as the procedure of choice 
for the surgical treatment o f refractory 
angina pectoris.1’6 Although it is asso­
ciated with considerable symptomatic 
improvement in most patients, this im­
provement is not always the result of 
increased myocardial perfusion. Un­
fortunately, the only definitive method 
available for objective evaluation of the 
results of aortocoronary venous bypass 
surgery is that o f cardiac catheteriza­
tion with selective graft visualization. 
This method cannot be used for long­
term sequential evaluation. Recently, 
the noninvasive method o f myocardial 
perfusion imaging after the injection of 
potassium-43, rubidium-81 or thallium- 
201, at rest and during treadmill exer­
cise, has been shown to be a sensitive 
technique for detecting regional myo­
cardial ischemia.7'11 The present study 
describes our experience with stress 
myocardial scintigraphy in assessing the 
results of aortocoronary bypass surgery. 
The results o f imaging are compared 
with those obtained by electrocardio­
graphy and cardiac catheterization.
Methods
Patient Selection
The study group comprised 77 pa­
tients in whom aortocoronary bypass 
procedures were undertaken for the 
treatment o f angina pectoris refractory 
to antianginal therapy. The patients 
were selected at random mainly on the 
basis of their willingness to undergo 
postoperative cardiac catheterization 
and angiographic evaluation together 
with exercise testing and myocardial 
imaging.
Studies Performed
Stress testing by means o f maximal 
treadmill exercises was carried out an 
average o f 4.4 months (range, 3 to 39 
months) following aortocoronary bypass 
surgery. After undergoing standard 
electrocardiography, the patients were 
exercised using a graded multistage
treadmill test. A  modified Bruce pro­
tocol, in which a complete 12-lead 
electrocardiogram (ECG) was obtained 
at 2-minute intervals both during and 
after stress testing, was used.12 Exercise 
was continued to an end point of chest 
pain, severe fatigue, dyspnea, depres­
sion o f the ST segment or maximal 
heart rate.
Stress myocardial imaging was per­
formed in association with the tread­
mill exercise test. At the end point of 
exercise, the radionuclide (0.5 mCi of 
43K or 1.5 mCi o f 201T1) was injected 
intravenously and exercise continued 
for an additional 45 to 60 seconds to 
ensure adequate myocardial uptake. 
Electrocardiographic monitoring was 
carried out throughout the test and 
continued for 10 minutes after exercise. 
Scanning with a rectilinear scanner 
(43K) or a mobile scintillation camera 
(201T1) was started immediately after 
electrocardiographic monitoring ceased.
Postoperative angiography was per­
formed within 6 weeks o f the stress 
testing in 70 o f the patients. Selective 
bypass and coronary angiograms in 
multiple projections using Judkins’ tech­
nique were obtained. Myocardial scans 
at rest were obtained at the time of 
cardiac catheterization, by selective 
injection o f labelled particles of macro- 
aggregated albumin (M AA) into the 
coronary arteries and the venous bypass 
grafts. M A A  labelled with technetium- 
99m was introduced into the coronary 
arteries and M A A  labelled with 
iodine-131 was inserted into the bypass 
grafts.13 Previously, we showed that such 
scans are comparable to those obtained 
at rest following intravenous injection 
of 43K .14
Criteria for Positive Results
All data were interpreted without 
knowledge o f the patient’s clinical con­
dition, or operative or angiographic 
status. Chest pain was not included in 
the definition o f a positive or negative 
test.
Stress electrocardiograms were con­
sidered positive for myocardial ischemia 
if a flat or downsloping ST-segment 
depression o f 1 mm or greater was 
recorded in any o f the 12 leads for at 
least 80 milliseconds with an isoelectric
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ST segment in the control tracing. A 
clinical diagnosis of postoperative myo­
cardial infarction was made only if 
there was development of Q waves of 
greater duration than 0.04 seconds in 
at least two leads.
Myocardial scans demonstrating a 
homogeneous distribution of radioac­
tivity were interpreted as normal. A 
focal defect on the stress study with 
a similar defect on a rest study was 
considered compatible with infarction. 
Myocardial ischemia was diagnosed 
only if a focal defect appeared or in­
creased in size in the stress scan as 
compared with the rest scan.
Severe stenosis was defined as 70% 
or greater obstruction of an artery or 
vein on selective angiography. Complete 
revascularization was defined as the 
presence of a patent graft supplying all 
the major arteries that had severe 
stenosis.
Clinical Improvement
In our analysis, clinical improvement 
was considered excellent if there was 
complete freedom from pain, ^good if 
there was a lessening of pain, usually 
associated with improvement by two 
functional classes (New York Heart 
Association classification), or unchanged 
or worse when compared with the pre­
operative state.
Results
The results of postoperative electro­
cardiography and myocardial scanning 
are correlated with the postoperative 
angiographic findings in Table I. In­
traoperative myocardial infarction was 
diagnosed in seven patients. In all, the 
rest scan detected the infarction, while 
in only four did Q waves develop on 
the resting ECG.
Of 35 patients without evidence of 
myocardial ischemia on the stress ECG 
and myocardial scan, 31 had complete 
revascularization. In four patients both 
noninvasive tests gave false-negative 
results.
In only three patients in whom the 
exercise ECG was positive for myo­
cardial ischemia was the condition not 
detected on the myocardial scans. In 
one patient, however, there was com­
plete revascularization; thus the exer­
cise ECG represented a false-positive 
result. In two patients “ungrafted” dis­
ease or an occluded graft was evident, 
making the results of myocardial scan­
ning falsely negative.
In 18 patients, both the stress scan 
and the exercise ECG suggested myo­
cardial ischemia. In one patient there 
was complete revascularization and thus 
the noninvasive studies were falsely 
positive. However, in the remainder, 
these studies correctly identified con­
tinuing myocardial ischemia.
In the remaining 21 patients the 
myocardial scan was positive for myo­
cardial ischemia, while the ECG was 
negative. In 16 instances this was 
related to “ungrafted” disease, in 3 to 
occlusion of the bypass graft and in 1 
to stenosis of the graft, while in 3 
there was evidence of distal disease. 
Thus, the exercise ECGs gave false­
negative results.
In Table II the results of the non­
invasive studies are related to the 
symptomatic improvement that each 
patient noted.
All 35 patients in whom the nonin­
vasive investigations suggested no myo­
cardial ischemia had an excellent to 
good result in terms of symptomatic 
improvement, with the majority enjoy­
ing an excellent result.
Combination of the three groups in 
which one or both of the noninvasive 
studies were positive, showed that only 
two (4.8%) patients had complete re­
vascularization and restoration of nor­
mal myocardial perfusion to account 
for the excellent to good results. In a 
further seven patients (circled numbers 
in Table II), a perioperative infarction 
occurred that might, by elimination of 
the ischemic focus, account for the 
symptomatic improvement in these pa­
tients.
Overall, we found that 64% of the 
patients had an excellent result, 26% 
a good result, while 10% were un­
changed or worse.
In Fig. 1 the heart rate-blood pres­
sure product of maximal stress testing 
preoperatively is related to the post­
operative stress myocardial scan. In 
the 39 patients with a positive scan, 
the double product increased signifi­
cantly from a preoperative value of 189 
to a postoperative value of 260. Like­
wise, for the group in whom the myo­
cardial scan showed no evidence of 
myocardial ischemia, a significant im­
provement from 207 to 309 occurred.
Table II—Correlation of Noninvasive Tests with Symptomatic Results
Test
result
No. of 
patients
Complete 
revascularization 
( and % ) Excellent Good
Unchanged 
or worse
Negative scan 
Negative electrocardiogram 35 31 (88.6) 33 2 0
Negative scan 
Positive electrocardiogram 3 1 2 1 0
Positive scan
Positive electrocardiogram 18 1 (4.8) 6® 6 6
Positive scan
Negative electrocardiogram 21 0 8® U ® 2
Total (and % ) 77 33 (42.9) 49 (63.6) 20 (26.0) 8 (10.4)
Table 1—Correlation of Noninvasive Tests with Postoperative Studies in 77 Patients
Test
result
No. of 
patients
Complete
revascularization
New
infarct
Aortocoronary 
bypass graft
Distal
diseasedisease Closed Stenosis
Negative scan 
Negative electrocardiogram 35 31 0 2 1 2 1
Negative scan 
Positive electrocardiogram 3 1 0 1 1 0 0
Positive scan
Positive electrocardiogram 18 1 4 10 4 4 2
Positive scan
Negative electrocardiogram 21 0 3 16 3 1 3
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This would imply that, in both groups, 
myocardial perfusion improved post- 
operatively.
Although the preoperative double 
product is similar in both groups, a 
difference between the postoperative 
results was found. Patients in whom 
myocardial stress scintigraphy showed 
no myocardial ischemia, had a signifi­
cantly higher increase in the double 
product, which suggests that complete 
revascularization resulted in a notably 
improved myocardial blood flow com­
pared with partial revascularization.
The sensitivity, specificity and pre­
dictive value of exercise electrocardio­
graphy and exercise myocardial scinti­
graphy in evaluating patients after 
aortocoronary bypass surgery are shown 
in Fig. 2. We found a significant dif­
ference in the sensitivity of these two 
noninvasive tests (43% and 84%, re­
spectively). The specificity and pre­
dictive values are similar.
Discussion
The striking symptomatic improve­
ment noted in the majority of patients
P<0.001
FIG. 1—Heart rate (HR)—blood pres­
sure (BP) product of maximal stress test­
ing preoperatively and postoperatively is 
related to result of stress myocardial scan 
postoperatively. Postive ( +  ) result in­
dicates myocardial ischemia (or new in­
farction), negative (—) result implies no 
myocardial ischemia. Numbers indicate 
patients in each group. Height of bar rep­
resents mean and standard error of mean.
□  ECO 
H  SCAN
sf: p <o.ooi
FIG. 2— Sensitivity, specificity and pre­
dictive value of exercise electrocardio­
graphy and exercise myocardial scinti­
graphy in evaluating patients after aorto­
coronary bypass surgery.
in this study is similar to that reported 
from other series.15'18 Clinical evalua­
tion of symptomatology, however, is 
inadequate.19 Objective evaluation of 
the results of coronary artery bypass 
surgery is essential as the enthusiasm 
for this procedure continues to grow. 
The results of noninvasive testing with 
maximal stress testing, however, may 
be equivocal.4,20 To date, postoperative 
cardiac catheterization by selective 
coronary and graft angiography and 
ventriculography has been the best ob­
jective method for evaluating the re­
sults of myocardial revascularization. 
Unfortunately, the invasive nature of 
this procedure necessitates hospitaliza­
tion and is associated with a substantial 
expense. This restricts its use for se­
quential study.
We found that an abnormal myocar­
dial stress scan was indicative of incom­
plete revascularization, attributable to 
ungrafted vessels (which can be deter­
mined by considering the operative 
procedure and the preoperative angi­
ogram) or a specific problem related 
to the bypass graft itself (occlusion, 
stenosis or distal artery disease). The 
exact nature of the latter can only be 
appreciated by postoperative angiog­
raphy.
Our results show that noninvasive 
testing with myocardial stress imaging 
is a sensitive method for objective evalu­
ation of regional myocardial perfusion 
following aortocoronary bypass surgery. 
Moreover, myocardial imaging is a 
more sensitive test than stress electro­
cardiography for such evaluation.
Of considerable interest was the 
finding that patients with no evidence 
of myocardial ischemia by noninvasive 
testing postoperatively, exhibited a sig­
nificant improvement in their double 
product (heart rate-blood pressure) 
compared with patients in whom the 
noninvasive studies were abnormal. 
Nevertheless, in both groups substantial 
symptomatic improvement occurred. 
The long-term implications of the dif­
ference in patients with complete and 
incomplete revascularization is un­
known. Myocardial stress imaging with 
201T1 is a safe, simple, noninvasive 
procedure that will permit long-term 
evaluation of myocardial revasculariza­
tion.
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Profundoplasty for Limb Salvage*
T irone E. David, md, frcs[c] and James A. Key, mb, ch b, frcs, frcs[c]
Profundoplasty was performed in 26 
legs because of rest pain or gangrene; 
previous arterial reconstruction had 
been done in 12 of them. In 16 limbs 
the popliteotibial segment was patent; 
profundoplasty was successful in each 
case. In 10 limbs the popliteotibial 
segment was occluded, and profundo­
plasty failed in one instance. One patient 
died.
The authors believe that re-establish­
ing blood flow and pressure to the 
deep femoral artery, especially to the 
descending branch of the lateral 
circumflex artery and the distal part 
of the deep femoral artery can 
effectively improve the condition of 
ischemic legs.
Une plastie de I’artere femorale 
profonde a ete pratiquee sur 26 jambes, 
a cause de douleurs au repos ou de 
gangrene; une reconstruction arterielle 
avait deja ete effectuee dans 12 cas. 
Pour 16 membres, le segment popli­
teotibial etait inobstruee; la plastie de 
I’artere femorale profonde a reussi 
dans tous ces cas. Pour 10 membres, 
le segment popliteotibial etait obstrue 
et cette intervention a echoue dans 
un cas. Un patient est decede.
Les auteurs croient qu'en 
retablissant la circulation sanguine et 
la pression dans I'artere femorale 
profonde, specialement dans la branche 
descendante de I’artere circonflexe 
externe de la cuisse et la partie distale 
de I'artere femorale profonde, on peut 
effectivement ameliorer I'etat d’une 
jambe ischemiee.
The importance of the deep femoral 
artery in the revascularization of the 
lower leg has been recognized for many years.1,2 Most patients with aortoiliac 
occlusive disease and an occluded superficial femoral artery have a re­markable improvement of the ischemic
*From the department of cardiovascular surgery, Toronto General Hospital and University of Toronto, Toronto, Ont.
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symptoms following revascularization 
procedures that increase pressure and flow to the deep femoral artery.3Many patients with an occluded su­
perficial femoral artery also have 
stenosis or occlusion of the deep femoral 
artery4 and they usually have severe ischemia of the leg. A femoropopliteal 
or femorotibial bypass is generally rec­
ommended for such patients;5’6 an al­
ternative to these procedures is femoral artery profundoplasty.7'9
We believe that patients with occlu­
sion of the superficial femoral artery and stenosis or occlusion of the deep 
femoral artery should have profundo­
plasty instead of a bypass procedure. Although our experience is modest, the 
results of this operation for limb salvage 
have been consistently good.
Material
Twenty-six femoral artery profundo- 
plasties were performed on 22 patients during the period July 1, 1975 to June 30, 1976. There were 15 men and 7 
women whose ages ranged from 44 to 
82 years (mean, 66 years). Four 
patients were diabetic, 16 were hyper­tensive, 18 had atherosclerotic heart dis­
ease and 20 were smokers.All legs were operated upon because 
of severe ischemia: 19 for rest pain, 4 
for digital gangrene and 3 for an 
ischemic ulcer on the foot.Previous arterial reconstruction had 
been done in 12 legs: femoropopliteal 
bypass in 5 and aortofemoral bypass in 7. Lumbar sympathectomy had been 
done in nine instances; in four it had 
been combined with the previous 
arterial reconstruction.Arteriography revealed that the aor­toiliac segment was mildly diseased (17 patients) or had been replaced by Dacron grafts (5 patients). The super­
ficial femoral artery was occluded and the deep femoral artery was either 
stenotic or occluded in all limbs. Based on the arteriographic findings in the 
distal arterial tree, it was possible to divide the limbs into two groups: those with a patent popliteotibial segment (16 legs) and those with occluded popli­
teal and proximal tibial arteries (10 
legs).Preoperative ankle pressure was ob­
tained in only five limbs.
The Operation
Under general anesthesia, the com­mon femoral, the superficial femoral 
and the deep femoral arteries were ex­posed through a long vertical incision. 
The lateral circumflex vein was ligated 
and divided as it crossed the deep 
femoral artery. The branches of the deep femoral artery (lateral and medial 
circumflex and first, second and third 
perforating branches) were carefully 
dissected and preserved. Care was taken not to injure the femoral nerve or its 
branches. In all our patients, the atherosclerotic process extended to, or 
beyond, the second perforating branch. With systemic heparinization, the com­
mon femoral and the deep femoral arteries were opened longitudinally (Fig. 1). This arteriotomy was carried 
down to the level of the second or third perforating branch, or beyond, if necessary. Endarterectomy was then 
done (Fig. 2) and each branch was carefully explored for patency and size 
with Hegar’s dilators. Patency of the lateral circumflex artery with its 
descending branch and the distal deep 
femoral artery is the key to a success­ful operation. If the lateral circumflex 
artery arose from the common femoral 
artery, it was dissected and endarterec- 
tomized to restore adequate blood flow through it. “Vessel-loops” were used to 
control retrograde bleeding from the 
branches of the deep femoral artery. A 
vein patch was used to close the arte­
riotomy (Fig. 3). When a vein was not 
readily available, the superficial femoral 
artery was opened longitudinally, endar- 
terectomized and used as an onlay patch to close the arteriotomy (Fig. 4). A Hemovac suction apparatus was left in 
the wound for the first day or two. No agent was given to counteract the effect 
of heparin.Lumbar sympathectomy was per­formed on the same occasion in three patients with an ischemic ulcer on the 
foot.
Results
Patients with a Patent Popliteotibial
Segm ent
Profundoplasty to the level of the 
second or third perforating branch was 
carried out in every case. All patients
107THE CANADIAN JOURNAL OF SURGERY
obtained immediate relief from rest 
pain. In three patients with digital 
gangrene, the digits were left to mum­
mify and the stumps were healed within 
3 to 6 months after the operation. One 
heel ulcer healed in 3 weeks.
Follow-up ranged from 12 to 24 
months. One patient died from myo­
cardial infarction. One man returned 
to the hospital because of sudden cold­
ness and numbness of his revascularized 
limb. He was treated with heparin and 
his condition improved rapidly. Femoral 
arteriography revealed a thrombosed 
deep femoral artery, but the lateral 
circumflex artery was widely patent and 
supplied the distal leg through collateral 
vessels with genicular branches. He can 
now walk 100 to 150 yards before 
claudication occurs, but it does not in­
terfere with his life-style.
The remaining 10 patients (13 oper­
ated limbs) continue to do well, al­
though 4 of them have intermittent
claudication after walking more than 
200 yards; in none does it affect their 
life-style.
Patients with Occluded Popliteal and
Proximal Tibial Arteries
We were unable to revascularize the 
deep femoral artery completely in two 
patients because of advanced athero­
sclerotic disease; the arteries were 
totally blocked and the intima and me­
dia were entirely replaced by athero­
ma; the adventitia was fibrotic. In one 
patient, we were able to revascularize 
the lateral circumflex artery and the 
first perforating branch and this was 
enough to relieve rest pain (Fig. 5). 
The other patient eventually required 
an above-knee amputation.
One diabetic patient died from myo­
cardial infarction on the 5th postoper­
ative day. The operation had relieved 
his rest pain.
Eight patients have been followed up
FIG. 4—Superficial femoral artery may 
be used to close arteriotomy as an onlay 
patch.
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from 12 to 24 months. None have rest 
pain. Three patients feel incapacitated 
by their intermittent claudication, which 
occurs after walking less than 100 
yards. The other five are not troubled 
at all, although they all experience 
claudication if required to walk longer 
distances than usual.
Pre- and postoperative measurements 
of blood pressure at the ankle were 
available in three patients. There was a 
remarkable increase in the tibial arte­
rial/systemic pressure ratio in two pa­
tients and no change in the third patient 
(who obtained relief from rest pain and 
at present does not complain of inter­
mittent claudication).
Discussion
One frequently overlooks the deep 
femoral artery when examining an 
arteriogram, unless this vessel is severe­
ly diseased. Moreover, even when the 
surgeon is aware of its importance he 
may not be able to assess the extent of 
the occlusive disease process from 
anteroposterior views of the vessel. 
Lateral or oblique views give more 
valuable information.4
Profundoplasty can be done as an 
alternative to femoropopliteal or femo- 
rotibial bypass when the superficial 
femoral artery is occluded and the
FIG. 5—Postoperative arteriogram
showing patent lateral circumflex artery 
and first perforating branch following in­
complete profundoplasty.
deep femoral artery is stenotic or oc­
cluded. Some authors believe that pro­
fundoplasty is a better operation,8 while 
others prefer bypass procedures.5
Both femoropopliteal bypass and pro­
fundoplasty give similarly good results 
when the distal arterial tree is patent. 
However, when a femorotibial bypass 
has to be done to relieve ischemia, the 
success of the operation may be jeo­
pardized by an inadequate vein or a 
diseased and small tibial artery. In 
our experience, profundoplasty has 
been the best operation in these cases. 
We reserve femorotibial bypass for pa­
tients in whom profundoplasty has 
failed.
If the deep femoral artery is com­
promised, we prefer profundoplasty 
to femoropopliteal bypass.
We believe that proximal arterial 
reconstruction should always be done 
first. A carefully performed extended 
profundoplasty gives uniformly good 
results when the popliteal artery is 
patent. Physiologic studies reveal a 
remarkable improvement of the blood 
supply to the leg.3,8 More importantly, 
ischemic symptoms are relieved and 
the intermittent claudication is either 
completely relieved or improved.
Some authors reported poor results 
when profundoplasty was carried out on 
patients with an occluded popliteotibial 
segment.7,10 However, our experience 
was different. Eight of 10 patients 
had a notable improvement following 
profundoplasty. It is possible that by 
increasing pressure and flow through 
the branches of the deep femoral artery, 
new collateral vessels open up and may 
enlarge with time. When operating on 
these severely ischemic limbs, one must 
remember that each tiny arterial branch 
is carrying a vital amount of blood. 
The importance of the descending 
branch of the lateral circumflex artery 
cannot be stressed enough (Fig. 5). We 
have measured blood flow through 
this vessel after endarterectomy and 
patching of the deep femoral artery 
and have found that it often carries 
more blood than all perforating 
branches together.
Profundoplasty can be performed un­
der local anesthesia.11 However, when 
an extensive dissection has to be done— 
sometimes beyond the third perforating 
branch—the procedure can be difficult 
for both surgeon and patient.
Although the role of sympathectomy 
in patients undergoing profundoplasty 
has not been established, we think it 
may be a useful adjunct to the arterial 
reconstruction.
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Femorofemoral Bypass: A Valuable Procedure*
T o m a s  A . Salern o , m d , FRC s[c],f O. R ufus A y e n i, m d , P eter E. B l u n d e l l , m d , fr cs[c ], facs and
R ay  C . J. C h iu , m d , ph  d, frcs[c], facs
Twenty-seven femorofemoral bypasses 
were performed in 25 patients with 
severe arteriosclerosis obliterans 
affecting the iliofemoral arteries. The 
series comprised 16 men and 9 women, 
aged 51 to 80 years. Nineteen patients 
were poor-risk cases with severe 
cardiorespiratory disease. Twenty-one 
patients had undergone vascular 
procedures previously without success. 
The operation was carried out: (a) as 
the primary procedure for very poor-risk 
patients in an attempt to salvage a 
limb, (b) to deal with unilateral limb 
occlusion of an aortoiliac-femoral 
prosthesis, or (c) as management of 
infected prosthetic grafts. Fourteen 
Dacron grafts and 13 saphenous veins 
were used for the bypasses. There 
were no operative deaths. Twenty-two 
patients were clinically improved, two 
required amputation later and one 
patient was lost to follow-up. Four 
patients, including three with pre­
existing graft infection, had wound 
infections that cleared with drainage 
and antibiotics. No other major com­
plications occurred in this group of 
poor-risk patients. Femorofemoral 
bypass is safe and provides the surgeon 
with a useful method of revascularizing 
the limbs of selected patients.
Vingt-sept derivations femorofemorales 
ont ete effectuees chez 25 patients 
souffrant d’arteriosclerose avancee 
affectant les arteres iliofemorales.
Cette serie comporte 16 hommes et 9 
femmes, ages de 51 a 80 ans. Dix- 
neuf patients souffraient de maladies 
cardiorespiratoires severes et etaient 
consideres comme de “mauvais ris- 
ques”. Vingt-et-un patients avaient 
deja subit une intervention vasculaire,
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sans succes. L'operation a ete entre- 
prise: (a) comme intervention primaire 
chez des patients a risque eleve, pour 
tenter de sauver un membre, (b) pour 
corriger I’occlusion unilateral d’une 
prothese de I’artere iliofemorale, ou 
(c) pour traiter un greffon prosthetique 
infecte. Quatorze greffons de Dacron 
et 13 veines saphenes ont ete utilises 
pour les pontages. II n'y a eu aucun 
deces peroperatoire. Vingt-deux pa­
tients ont ete ameliores cliniquement, 
deux ont du subir une amputation par 
la suite et un patient ne s'est pas repre­
sente. Quatre patients, dont trois qui 
avaient une infection pre-existante du 
greffon, ont eu une infection de la plaie, 
qui a gueri avec un drainage et des 
antibiotiques. Aucune autre complica­
tion serieuse n'est survenue chez 
ce groupe de patients a risque eleve. 
La derivation femorofemorale est sure 
et offre au chirurgien une methode 
utile de revascularisation des membres 
chez des patients choisis.
The major indications for femorofemo­
ral bypass in patients with severe arteri­
osclerosis obliterans involving the 
peripheral arteries are: cardiorespiratory 
disease in a poor-risk patient, previous 
abdominal surgery or irradiation, peri­
toneal sepsis and occlusion of a limb 
after an aortoiliac-femoral bypass.1"1 
This list may be enlarged to include 
infection of an aortoiliac-femoral pros­
thesis.5 The present series was reviewed 
to evaluate the usefulness o f this proce­
dure in reducing operative mortality 
and morbidity and in salvaging limbs 
o f poor-risk patients, and to determine 
the conduit o f choice for this opera­
tion.
Patients and Methods
From 1970 to 1977, 27 femorofemo­
ral bypasses were performed in 25 
patients at the Montreal General Hos­
pital. The series comprised 16 men and 
9 women, aged 51 to 80 years (mean, 
64.8 years). Nineteen patients were 
classified as poor operative risks be­
cause o f severe cardiopulmonary dis­
ease. Twenty-three patients complained 
o f severe intermittent claudication, 12 
suffered rest pain and 1 had impend­
ing gangrene, indicating an imminent 
threat to limb viability. Four very poor-
risk patients with unilateral occlusive 
disease o f the iliac artery underwent 
femorofemoral bypass as the primary 
procedure for limb salvage; 21 patients 
had already had one or more vascular 
procedures that had proved unsuccess­
ful, including aortoiliac-femoral and 
iliofemoral bypasses, iliac endarterec­
tomy, abdominal aneurysmectomy and 
others (Table I). The interval between 
the first operation and the fem oro­
femoral bypass varied from 2 months 
to 6 years (mean, 2.5 years). In one 
patient a sympathectomy was performed 
concomitantly with a femorofemoral 
bypass.
In all patients the procedure was 
carried out under light general anesthe­
sia. Fourteen bypasses were performed 
using Dacron or Dacron-velour grafts 
(diameter, 5 to 8 mm). The remaining 
13 grafts were reversed autogenous sa­
phenous vein.
In two patients with a previous aor- 
tofemoral bypass, one limb o f the graft 
was infected at the groin. In one o f 
the two a false aneurysm also developed 
at the site o f infection. At the time of 
operation on these patients, draping 
w7as done in such a way as to isolate 
and seal o ff the infected groin before 
the abdomen was entered to allow in­
spection o f the aortofemoral Dacron 
graft. In both cases infection had not 
extended to the bifurcation of the 
graft. This was later confirmed when 
bacteriologic cultures produced no 
growth o f organisms. The infected limb 
o f the graft was then ligated and tran­
sected near the level o f the bifurcation. 
The peritoneum and graft tract were 
closed with chromic catgut sutures to
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prevent further contamination. The 
abdominal wound was closed and 
draped so as to seal it from the groin. 
A segment of saphenous vein was then 
removed from the noninfected thigh 
and anastomosed to the noninfected 
donor femoral artery. Finally, the op­
posite groin was opened, the infected 
limb of the prosthetic graft was removed 
and the crossover femorofemoral by­
pass was completed. The subcutaneous 
tissue was approximated over the graft 
and the skin was left open. Both pa­
tients made an uneventful recovery.
In a third patient an aortoduodenal 
fistula developed following the resec­
tion of an abdominal aortic aneurysm 
and insertion of a graft. The infected 
graft was removed, and axillofemoral 
and crossover femorofemoral bypass 
grafts were introduced using 8-mm 
Dacron prostheses. This patient also 
recovered without complication.
Two patients had occlusion of one 
limb of an aortobifemoral Dacron 
graft. One and 3 years later, both re­
ceived femorofemoral bypasses using 
Dacron grafts. These grafts also throm­
bosed, so that a second saphenous vein 
femorofemoral bypass was required 6 
months and 1 year later, respectively.
Results
No death occurred within 30 days of 
the operation. In two patients limb 
salvage was attempted despite poor 
run-off, as indicated by severe rest pain 
and imminent gangrene, using a Da­
cron graft for one and a saphenous 
vein femorofemoral bypass for the 
other. Both bypasses failed, with the 
result that above-knee amputations were 
necessary after 14 and 20 days, respec­
tively. Superficial infections caused by 
Staphylococcus aureus developed in 
four patients, including the three with 
pre-existing infected grafts. All these 
infections cleared after drainage and 
administration of antibiotics without 
removal or failure of the grafts. For up 
to 14 months there was no evidence of 
recurrent infection.
The femorofemoral grafts were found 
pulsating in 14 patients for up to 5 
years; the average duration of follow­
up was 22 months. In 10 patients, 6 
with Dacron and 4 with venous grafts, 
pulsation could not be felt but the legs 
were viable at an average follow-up 
of 3 months. Pulsation in the graft was
not documented in three patients who 
had viable extremities (Table II). The 
patency of Dacron grafts therefore ap­
pears to be not appreciably different 
from that of vein grafts, although vein 
grafts were used as the conduit of 
choice when a Dacron prosthesis had 
failed.
Twenty-two patients who had femo­
rofemoral bypass showed immediate 
clinical improvement after the opera­
tion and had viable legs. In two of 
these a second femorofemoral bypass 
was performed. Two patients required 
early amputation and the clinical status 
of one patient is unknown.
Discussion
Whenever feasible an aortoiliac-fe- 
moral bypass is the procedure of choice 
for aortoiliac occlusive disease, since 
Theologically it is superior and does not 
rely on the continued patency of the 
donor iliofemoral artery. However, since 
McCaughan and Kahn3 first performed 
femorofemoral bypass in 1960, the in­
dications for this procedure have 
broadened. Our own experience with 
27 grafts in 25 patients, many of them 
for limb salvage in very poor-risk pa­
tients, confirmed the advantages of this 
procedure in selected cases.4 All our 
patients tolerated the light anesthesia 
well and there was no mortality or 
serious cardiorespiratory complication. 
Patients are ambulant almost imme­
diately and, since the abdominal cavity 
is not entered, can be fed soon after 
recovery from anesthesia.
The lack of pulsation in the graft dur­
ing follow-up may not indicate graft 
occlusion in all cases, as it does not 
necessarily lead to gangrene of the leg 
or aggravation of symptoms. Moreover, 
if occlusion is delayed, there may be 
time for collateral vessels to develop.
Dissection of the saphenous vein for 
a femorofemoral bypass is more time- 
consuming than insertion of a prosthe­
sis, but we tend to use the vein as the 
conduit of choice in patients with a 
poor run-off, because of its superiority 
in the femoropopliteal area. This may 
have produced a bias in our estimation 
of the patency of vein grafts. No “cir­
culatory steal” from the donor limb, 
as reported by some authors,6 was noted 
in these patients.
Femorofemoral bypass can also be 
used in the treatment of certain infected
aortofemoral bypass grafts. An axillo­
femoral bypass with the removal of the 
entire infected graft is usually the 
operation of choice.7 However, the 
axillofemoral bypass is associated with 
a high occlusion rate, a high mortality 
rate and a high incidence of bilateral 
amputations.5 Our experience indicates 
that when the infection is localized to 
the groin area with no evidence of 
spread to the bifurcation of the aortic 
graft, the infected graft limb can be 
removed and the lower extremity re­
vascularized with a femorofemoral 
crossover vein graft. If upon explora­
tion the intra-abdominal graft is found 
to be infected, or is proved to be so by 
the subsequent clinical course and re­
sults of bacteriologic cultures, the en­
tire graft can be removed and, in the 
presence of functioning femorofemoral 
bypass, a unilateral axillofemoral by­
pass performed.
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Table II—Patency of 27 Femorofemoral Bypass Grafts
Loss of graft Patency
Type of conduit No. of grafts pulsation unknown
Dacron graft 14 6/12 2
Vein graft 13 4/12 1
Total 27 10/24 3
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Acute Cardiac Failure: The Relation Between Coronary 
Flow and Oxygen Consumption*
W.J. K eon , md, frcs[c], Y. A kyurekli, md, frcs[c], G.c. Taichman, ph d and B. Korecky, MD, PH D
In an initial study with dog hearts 
functioning in situ on total coronary 
bypass, we demonstrated that prede­
termined levels of reduced cardiac pump 
function could be achieved by reducing 
total coronary flow through changes in 
the perfusing pressure. In subsequent 
experiments, oxygen values were 
measured so that changes in myo­
cardial aerobic consumption in response 
to brief (3 minute) alterations in 
coronary perfusing pressure could be 
determined as well. As a result significant 
linear correlations were found between 
coronary flow and myocardial oxygen 
availability (r =  0.98), oxygen extraction 
(r =  0.49) and oxygen consumption 
(r =  0.92). These changes in oxygen 
values paralleled those in cardiac func­
tion (stroke work, r =  0.84).
Au cours d’une etude initiale sur le 
coeur de chien in situ en derivation 
coronarienne complete, nous avons 
demontre que des niveaux predetermines 
de fonction cardiaque diminuee 
pouvaient etre obtenus en reduisant le 
debit coronarien total par des change- 
ments de la pression de perfusion. 
Dans des experiences subsequentes, 
les concentrations d’oxygene ont ete 
mesurees de facon a ce que les 
changements de la consomption 
aerobique du myocarde en reponse a 
de breves (3 minutes) alterations de la 
pression coronaire de perfusion puissent 
egalement etre decrits. Comme resultat, 
des correlations lineaires significatives 
ont ete trouvees entre le debit 
coronarien et la disponibilite d’oxygene 
myocardique (r =  0.98), I’extraction 
d’oxygene (r =  0.49) et la consommation 
d’oxygene (r =  0.92). Ces changements 
dans les concentrations d'oxygene 
ont ete paralleles a ceux de la fonction 
cardiaque (travail systolique, r =  0.84).
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In reviewing the literature on the 
regulation of coronary blood flow 
(CBF), Rubio and Berne1 stated that 
several factors can influence the quan­
tity of blood passing through the heart. 
A primary determinant, they noted, 
was myocardial oxygen consumption. 
Although it is generally accepted that 
coronary flow is highly responsive 
to conditions of myocardial oxygen 
demand under physiologic conditions, 
certain pathologic states may diminish 
this autoregulatory process so that CBF 
may become a critical determinant of 
cardiac pump function. Within the 
physiologic range of flow there is a 
lack of agreement on the determinant 
effects of coronary flow on cardiac 
pump function and myocardial oxygen 
consumption. In thoracotomized ani­
mals2,3 and isolated hearts4 decreases 
in coronary flow produced similar 
changes in cardiac work and oxygen 
consumption. However, both Ross and 
colleagues,5 using perfused hearts at 
a constant level of work, and Sarnoff 
and associates,6 using isolated supported 
hearts at controlled levels of activity, 
observed that alterations in flow did 
not alter myocardial oxygen consump­
tion. In a previous report7 we demon­
strated with dog hearts working in situ 
that there was a significant linear rela­
tion between changes in coronary flow 
and various hemodynamic indices of 
cardiac pump function. The present 
study was undertaken to define the 
changes in aerobic consumption asso­
ciated with these induced hypodynamic 
states.
Methods
Short-term experiments were per­
formed on male mongrel dogs (body 
weight, 23 to 47 kg). As previously 
described7 animals received premedica­
tion of atropine (0.4 mg, intramuscu­
larly) and were anesthetized with so­
dium thiopental (20 mg/kg, intravenous­
ly). Tracheal intubation was performed 
and positive-pressure ventilation with 
a Harvard pump (Harvard Apparatus, 
Millis, MA) initiated. Animals were 
maintained at a surgical plane of anes­
thesia with a mixture of 30% nitrous 
oxide and 70% oxygen plus 0.25% to 
0.75% halothane. Animal core tem­
perature was maintained between 35° 
and 37°C with a thermoregulating 
water blanket. As a precautionary 
measure against ventricular arrhyth­
mias, all animals received a priming 
dose of lidocaine hydrochloride (70 
mg) followed by continuous infusion 
(2 mg/min) throughout the experiment. 
The heart was exposed through the left 
fifth intercostal space and1 the peri­
cardial sac opened and sutured to the 
walls of the thoracic wound in order 
to cradle the heart.
The major components of the coro­
nary arterial circulation were isolated, 
after blunt dissection, with 2-0 silk ties. 
In our initial study,7 the left coronary 
system was perfused through cannulas 
introduced into the circumflex (CX) 
and left anterior descending (LAD) 
arteries at the distal end of the left 
main stem (Fig. la); in the present 
experiment the technique was modified 
to perfuse the initial branches of the 
left main coronary artery as well.8 The 
CX artery was cannulated proximally 
and distally at a point 3 to 5 cm from 
its origin, and the left main coronary 
artery was isolated at its aortic origin 
with 3-0 silk. By occluding the left 
main stem and perfusing the proximal 
CX artery, we perfused all initial 
branches of the left main stem (septal 
artery) plus the LAD artery; through 
the distal cannula on the CX branch 
we were able to perfuse the remaining 
portion of the CX artery (Fig. lb). The 
right coronary (RC) artery was per­
fused from a catheter introduced at 
its aortic origin.
During these experiments various 
hemodynamic variables were monitored. 
Heart rate was computed from the 
electrocardiographic (lead II) signal. 
Arterial (systolic, diastolic and mean) 
and left ventricular (systolic and 
diastolic) pressures were measured from 
fluid-filled catheters (Cordis, no. 521- 
742, Cordis Corporation, Miami, FL) 
in conjunction with Statham P23Db 
transducers (Statham Instruments, Ox­
nard, CA) and Electronics for Medicine 
SGM-2 amplifiers (Electronics for 
Medicine, White Plains, NY). Right 
and left mean atrial pressures were 
determined by direct cannulation and 
water manometry. All pressures were 
referenced to the level of the right
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atrium. Flow through the pulmonary 
artery (cardiac output) was measured 
periodically by means of a thermodilu­
tion technique using a Swan-Ganz 
catheter (no. 93-118-7F, Edwards Labo­
ratory, Santa Ana, CA) in conjunction 
with an Edwards computer (model 
9510). Coronary flows were measured 
by three extracorporeal electromag­
netic flow probes (Biotronex BLC-2032, 
Biotronex Laboratories, Silver Spring, 
MD) in series with perfusing 
Travenol 5M0287 cannulas (Travenol 
Laboratories, Deerfield, IL). At the end 
of each experiment, flow probes were 
calibrated by means of timed samples. 
In deriving total CBF, blood flows to 
all three vessels (LAD, CX and RC) 
were added together and normalized 
per 100 g of ventricular weight meas-
FIG. 1— (a) Initial method of can- 
nulating and perfusing coronary vascula­
ture.7 (b) Current method, left main 
coronary stem ligated. LAD =  left an­
terior descending, CX =  circumflex, RC 
=  right coronary.
ured at the completion of the experi­
ment. In analysing these hemodynamic 
data, electronic signals were either 
recorded directly on a Beckman S-l 1 
dynograph (Beckman Instruments Inc., 
Schiller Park, IL), or stored on Bell and 
Howell VR-3200 magnetic tape (Bell 
and Howell, Pasadena, CA) for later 
processing. Myocardial aerobic data 
were obtained by measuring the up­
take of oxygen across the coronary cir­
culation. Accordingly, arterial (extra­
corporeal) and coronary sinus blood 
samples were drawn and analysed for 
their oxygen content ([0]A and [Ojc«, 
respectively) with a Lexington analyser 
(LEX-O2-CON-TL, Lexington Instru­
ments, Waltham, MA). These data, in 
combination with CBF values, were 
then used to compute
1. myocardial oxygen availability
(mL/min-100 g) = (CBF)([O]A)/(100);
2. myocardial oxygen extraction (%)
= «0 ]A -  [0]CS)(100)/([0]A);
3. myocardial oxygen consumption 
(mL/min-100 g)-(CBF)([O]A-[OW /(100).
The extracorporeal circuit was primed 
with heparinized (3 mg/kg) citrated 
whole blood from donor dogs and Hart­
mann’s solution in a 1:1 ratio. During 
coronary bypass, venous blood was col­
lected from both femoral veins into a 
reservoir whose height regulated the 
venous pressure (9 to 16 cm H 2O). This 
blood was then oxygenated and heated 
to body temperature (37°C) by a Har­
vey H-200 oxygenator (W. Harvey 
Research Corp., Santa Ana, CA). Ar- 
terialized blood was then pumped to a 
second reservoir, which subsequently 
drained into the three coronary per­
fusing catheters. Flows to the coronary 
arteries were established on the basis 
of the height of this reservoir above the 
left atrium. To minimize the systemic 
hypotensive states encountered during 
coronary artery cannulation, the extra­
corporeal system was equipped with a 
partial bypass. This circuit was used 
only during the initial phases of coro­
nary bypass and was discontinued early 
during the stabilization period. In addi­
tion, excessive left ventricular pressures 
were avoided by cannulating the left 
atrium with a wide-bore catheter in 
conjunction with the pressure reservoir. 
Adjustments were made in the reservoir 
height so that the left intra-atrial pres­
sure would not exceed 30 cm H 2O.
Once coronary perfusion was estab­
lished, animals were allowed to stabilize 
for at least 60 minutes at a coronary 
perfusing pressure (CPP) of 120 mm 
Hg. During this period the plateau of 
the Frank-Starling curve (myocardial 
heterometric relation) was established 
by adjusting the venous pressure until 
arterial pressure and cardiac output 
were maximal. Once the desired level
was achieved, no further alterations 
were made throughout the experiment. 
Towards the end of the stabilization 
period, two sets of biochemical and 
hemodynamic values were obtained, 15 
minutes apart. If values were con­
sistent, both sets of data were averaged 
and used as control values for all sub­
sequent maneuvers; if not, additional 
time was allocated for stabilization.
Arterial blood-gas samples were 
analysed periodically for pH and oxy­
gen and carbon dioxide pressures (Po2 
and Pco2) by means of a Radiometer 
BMS-3 analyser (Radiometer, Copen­
hagen, Denmark) and appropriate ad­
justments were made to the animal or 
to the extracorporeal circuit by altering 
the inspiratory content of carbon diox­
ide or by the administration of 10% 
sodium bicarbonate. Arterial blood val­
ues from animal sources ranged from 
7.33 to 7.47 for pH, 93 to 146 mm Hg 
for P0 2 and 28 to 36 mm Hg for Pco2, 
while arterialized blood from extracor­
poreal sources ranged from 7.37 to 
7.43 for pH, 83 to 136 mm Hg for 
Po2 and 32 to 48 mm Hg for Pco2.
In these experiments nine dogs were 
used to investigate myocardial oxygen 
consumption at various rates of re­
duced CBF. Accordingly, brief (3 min­
ute) reductions in CPP were used to 
reduce CBF. At the end of this period 
hemodynamic and oxygen values were 
ascertained, after which the CPP was 
returned to 120 mm Hg. In all, eight 
different hypotensive pressures were 
examined from 110 mm Hg to 40 mm 
Hg in a randomized fashion. Between 
these hypotensive periods the animals 
were allowed to recover for 10 min­
utes; if at the end of this period control 
hemodynamics (±10% ) were not re­
established, the data from these animals 
were excluded from further analysis.
Results
Since the dogs in this experiment 
were cannulated in a different manner 
from that previously described,7 two 
were monitored for a 5-hour period 
(starting 10 minutes after cannulation) 
at a constant CPP of 120 mm Hg (Fig. 
2). During the stabilization period flows 
to all coronary vessels slowly declined 
until a steady state was reached, with the 
exception of RC flow which continued 
to decrease throughout the observation 
period. However, RC flow represented 
the smallest component of the total 
CBF. The reduction and developing 
steady state conditions seen in the 
coronary flows paralleled changes in 
myocardial oxygen consumption, while 
systemic hemodynamic values quickly 
recovered after cannulation and re­
mained relatively unchanged (range, 
-17% to +8% ). Hemodynamic values 
obtained towards the end of the stabi-
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FIG. 2— Coronary flows and hemodynamic data from one dog in control study. 
Records were started 10 minutes after coronary perfusion was established.
lization period (control) are presented 
in Table I for the 11 animals in this 
study. The results are in agreement with 
those previously reported. Brief (3 min­
ute) reductions in CPP evoked similar 
reductions in CBF (Fig. 3), of approxi­
mately equal magnitude (a 71% ± 3 %  
reduction in CBF resulted from a 67% 
decrease in CPP). Fig. 4 demonstrates 
that the decrease in total CBF was
sustained equally by all three com­
ponents of the coronary circulation 
(based on our current method of cannu- 
lation and perfusing the heart). Fig. 4 
also demonstrates that most coronary 
flows at all levels of CPP were pre­
dominantly left coronary (LAD and 
CX) in origin. As a result of sharp re­
ductions in CBF, myocardial oxygen 
availability decreased (Fig. 5) with a
significant degree of linear correlation 
(r =  0.98). The decrease in CBF caused 
the heart to extract more oxygen from 
its limited supply (Fig. 6). Although 
the correlation coefficient for CBF 
versus oxygen extraction was low 
(r =  0.49), the value was significant 
and can be attributed to a large varia­
tion between different animals, since 
individual trends for each animal (Fig. 
7) demonstrated similar inverse rela­
tions. In addition, the magnitude of the 
change in oxygen extraction was con­
siderable: at the lowest CPP (40 mm 
Hg) the value had increased to 79% ±  
3% from 59% ±  6% at a CPP of 120 
mm Hg. In spite of this compensatory 
change in the ability of the heart to 
extract more oxygen, myocardial oxy­
gen consumption decreased in a linear 
fashion (r =  0.92) with blood flow 
(Fig. 8); however, the magnitude of the 
decrease (-71% ±  3%) was greater 
than the reduction in oxygen consumed 
(-60% ± 3 % ) .  The net result of these 
changes, whereby a significant linear 
correlation (r =  0.84) was established 
between CBF and myocardial pump 
function (expressed as cardiac work), 
is shown in Fig. 9.
D iscussion
In these studies, the major problem 
of electrical instability, which was 
evident in our initial report,7 was over­
come by modifying three aspects of the 
animal model: first, an alternative meth­
od of cannulating the left coronary 
artery was used; second, left atrial 
pressure was partially regulated; and 
third, lidocaine hydrochloride was in­
fused continuously. Previously, the left 
coronary circulation was perfused from 
extracorporeal sources distal to the 
main stem. In an effort to assess the 
effectiveness of this type of cannula- 
tion (Fig. la), radioactive-labelled 
(ytterbium-169) microspheres, 15fi ±  
5/a in diameter, were introduced into 
the coronary reservoir and the distribu­
tion was measured.9 In three animals 
cannulated as in Fig. la  and perfused at 
a CPP of 120 mm Hg, 78% ± 9 %  
of the nutritive flow originated from 
extracorporeal sources (unpublished
T a b le  1— H e m o d y n a m ic  D a ta  in  11 D o g s *
V a r ia b le M e a s u re m e n t
H e a r t  r a te ,  b e a ts /m in 127 ±  15
P re s s u re s
A r t e r ia l  —  m ean, m m  Hg 119 ±  8
s y s to lic , m m  Hg 131 ±  10
d ia s to lic , mm Hg 97 ±  9
R ig h t  a t r i a l ,  cm H 20 13 ±  3
L e f t  a t r ia l ,  cm H 20 23 ±  6
L e f t  v e n tr ic u la r  e n d -d ia s to lic , mm Hg 19 ±  4
M a x im u m  r a te  o f  le ft  v e n tr ic u la r  p re ss u re  (m a x  d P /d t ) ,  mm H g /s 2204 ±  184
F lo w s
C a rd ia c  in d e x , m L /m in -k g 140 ±  29
C o ro n a ry  f lo w , m L /m in -1 0 0  g 94 ±  13
%  le f t  a n te r io r  d e s c e n d in g  a r te ry 44 ±  3
%  c irc u m fle x  a r te ry 38 ±  3
%  r ig h t  c o ro n a ry  a r te ry 18 ±  2
L e f t / r ig h t  ra t io 4 .51  ±  0 .49
S tro k e  w o rk , k g -m /m in 5.1 ±  0 .4
H e m o g lo b in , g /d L 10 .9  ±  0 .3
O x y g e n  v a lu e s
A r t e r ia l  c o n te n t , m L /d L 14.4 ±  1 .6
C o ro n a ry  s in u s  c o n te n t, m L /d L 6 .3  ±  0 .4
M y o c a rd ia l a v a ila b i l i ty ,  m L /m in -1 0 0  g 14 .8  ±  2 .0
M y o c a rd ia l e x tra c t io n , % 59 ±  6
M y o c a rd ia l c o n su m p tio n , m L /m in -1 0 0  g 8 .7  ±  0 .9
• A l l  v a lu e s  (m e a n  ±  S E M ) w e re  ta k e n  a t  en d  o f s ta b il iz a t io n  p e r io d  (c o n tro l v a lu e s ) .
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FIG. 6—Relation between myocardial 
oxygen extraction and total CBF.
FIG. 7—Relation between myocardial 
oxygen extraction and total CBF. Each 
line is a linear regression line for each 
animal.
FIG. 8—Relation between myocardial 
oxygen consumption and total CBF.
FIG. 9—Relation between cardiac work 
and total CBF.
data), while the remaining parts of the 
heart presumably either were not per­
fused at all or were perfused from the 
aortic root. In the dog, the left coro­
nary artery carries the largest portion 
of the total supply10 and usually arises 
from the aortic root as a single vessel, 
although double openings are occasion­
ally present (12%). The main stem of 
the left coronary artery is usually short 
and soon divides into LAD and CX 
branches. In 83% of the animals 
studied, the septal artery arose from 
the posterior wall of the main stem to 
supply the basal portions of the inter­
ventricular septum and part of the
free wall of the right ventricle.10 In 
our initial study,7 the septal artery was 
not perfused by the extracorporeal cir­
cuit; thus, during hypotensive episodes 
associated with coronary cannulation 
and the induction of bypass, myocardial 
areas perfused by the septal artery may 
have sustained longer periods of re­
duced flow. As a result, our initial 
model was susceptible to ventricular 
arrhythmias during either stabilization 
or the subsequent experimental period.
In the present study changes in coro­
nary flow were induced by 3-minute 
alterations in CPP. Over the perfusing 
pressure range of 70 to 130 mm Hg 
Mosher and associates11 have shown 
that coronary flow remains constant 
(autoregulates), while below and above 
this range coronary flow becomes pres­
sure-dependent. Our results (Fig. 3) 
indicate that such a response could not 
be elicited; however, our earlier study7 
demonstrated that longer periods (10 
minutes) of reduced CPP were asso­
ciated with a mild autoregulatory re­
sponse. Part of the defect may be a 
result of the hemodilution imposed by 
the extracorporeal circuit, since changes 
in arterial oxygen by dilution12 or de- 
saturation13 may modify the response.
Our observations provide evidence 
that cardiac pump function as well as 
myocardial oxygen consumption can be 
greatly influenced by reductions in 
coronary flow. These observations on 
dog hearts working in situ agree with 
those of earlier studies2"4’13 and em­
phasize the range and linearity of the 
correlation. In the experiments reported 
by Opie14 and Bacaner, Lioy and 
Visscher13 the rate of oxygen delivery 
rather than changes in CBF were con­
sidered primarily responsible for the 
alterations in myocardial performance 
by eventually limiting myocardial aero­
bic consumption.4’5 In addition, other 
authors have shown that perfusing pres­
sure15 and coronary flow16 can inde­
pendently affect the inotropic state as 
well. On the other hand, Sarnoff and 
associates6 and Ross and colleagues5 
have reported that CBF and myocardial 
oxygen consumption were not interre­
lated when external work was held 
constant; however, both studies have 
been criticized not only in terms of 
methodology3 but also interpretation of 
data.13 In the present study the primary 
mechanism responsible for decreases in 
cardiac pump function appears to be a 
reduction in myocardial oxygen con­
sumption caused by a decrease in oxy­
gen availability.
Myocardial ischemia is said to exist 
when coronary arterial flow proves in­
sufficient to accommodate functional 
demands. Since over 90% of the energy 
normally produced by the consumption 
of substrates and oxygen is utilized to 
support mechanical activity,17 a substan-
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tial reduction in oxygen consum ption is 
prim arily expressed as a decrease in 
m echanical activity. Although our re­
sults are in agreement with this hypo­
thesis, current experiments18 indicate 
tha t the correlations between coronary 
flow and myocardial oxygen consum p­
tion, and pum p function may be signi­
ficantly altered during the period of 
recovery following prolonged ischemia.
We thank K. Sheldrick and the person­nel of the department of research, Ottawa Civic Hospital, for their technical as­sistance.
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Patency of Aortocoronary Saphenous Vein Bypass Grafts
5 to 7 Years After Surgery*
L u c ie n  C a m p e a u , m d , f r c p [c ], J ac q u es  L e sper a n c e , m d , F r ed er ic o  C orbara , m d , J acques H e r m a n n , m d ,
C laude  G r o n d in , m d , f r c s [c] and  M artial  G . B ourassa , m d
Sequential studies have been carried 
out on two series of patients who 
underwent aortocoronary saphenous 
vein bypass grafting. The first series 
was studied at the onset of our surgical 
experience and the second series 
2 years later after surgical techniques 
had been modified. Angiographic studies 
were performed at 2 to 3 weeks and 
at 6 to 18 months after surgery. The
*From the Montreal Heart Institute and the University of Montreal, Montreal, PQ
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present study, which evaluates the 
results 54 to 88 months after operation, is 
based on 100 unselected patients who 
were known to have at least one 
patent graft 6 to 18 months after 
operation. Only 17 of the 159 grafts 
became occluded during a mean interval 
of 5 years, giving an average yearly 
attrition rate of 2.2% after the first 
year. The mean yearly attrition rate was 
2.4% in the first series (group 1) and 
0.7% in the second series (group 2) 
of patients. The cumulative graft 
patency rate was 57.7% at a mean 
postoperative time of 6.7 years in 
group 1 and 83.2% at 5 years in group 2. 
Late graft failure was more frequent in 
grafts which, at the 6- to 18-months 
evaluation, had localized stenoses at 
anastomoses or on the graft trunk; such 
stenoses are believed to be associated
with unsatisfactory surgical techniques. 
Localized narrowing appearing after 
the first year was observed in 14 
grafts (8.8%) and was believed to be 
of atherosclerotic origin. Such narrowing 
may also lead to graft failure.
L’etude porte sur I'exploration angio- 
graphique 54 a 88 mois apres pontage 
aortocoronarien par veine saphene. II 
s’agit de I’etude la plus tardive parmi 
les explorations postoperatoires 
sequentielles effectuees d'une fapon 
prospective chez des patients faisant 
partie de deux series distinctes. La 
premiere serie a ete composee de 
patients parmi nos premiers operes, 
et la deuxieme serie faite de patients 
operes 2 ans plus tard apres modifi­
cations des techniques chirurgicales. 
Ces explorations ont ete pratiquees
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2 a 3 semaines et 6 a 18 mois apres 
la chirurgie. Des patients ayant au moins 
une greffe permeable a revaluation 
de 6 a 18 mois, 100 patients ont pu 
etre explores tardivement. Des 159 
greffes etudiees, 17 se sont obstruees 
durant un intervalle moyen de 5 ans, 
pour un taux moyen annuel d'occlusion 
de 2.2% apres la premiere annee. Le 
taux moyen d'occlusion est de 2.4% 
pour les patients de la premiere serie 
et de 0.7% chez les patients de la 
deuxieme serie. La permeabilite cumulee 
dans la premiere serie est de 57.7% 
a un temps moyen postoperatoire de 
6.7 annees, et elle est de 83.2% a 
5 ans dans la deuxieme serie. Les 
occlusions tardives sont plus frequentes 
parmi les greffes qui presentaient des 
retrecissements localises 6 a 18 mois 
apres la chirurgie, retrecissements 
probablement reliees a des techniques 
chirurgicales inadequates. Les retre­
cissements localises d’apparition plus 
tardive, observes sur 14 greffes 
(8.8%), et probablement d'origine 
atherosclerotique, peuvent egalement 
produire ces occlusions tardives.
This progress report concerning the 
patency of aortocoronary saphenous 
vein bypass grafts forms part of a 
prospective sequential evaluation of 
graft changes after operation in a series 
of near-consecutive patients. To date, 
follow-up angiographic studies have 
been carried out at 2 to 3 weeks, 6 
to 18 months, 30 to 42 months,1'7 and 
at 54 to 88 months after surgery. In 
this the latest study, the graft failure 
rate was low, and a new type of graft 
alteration was observed, which appears 
to be of atherosclerotic origin.
Patients and Methods
The 100 patients composing this 
study group were operated upon between 
Sept. 24, 1969 and Aug. 2, 1972 and 
evaluated 6 to 18 months after surgery, 
either as part of a research survey or 
because of an unsatisfactory clinical 
course. Most survivors among the first 
138 patients to have bypass surgery 
(research series, group 1) and among 
patients 379 to 478 who were operated 
upon after 2 years of experience (re­
search series, group 2) underwent con­
trol angiographic evaluation at 2 to 3 
weeks and at 6 to 18 months after 
surgery.4 In addition, other patients 
were investigated between 6 and 18 
months because of an unfavourable 
course (symptom-motivated group, 
group 3).7 Out of 198 patients who had 
at least one patent graft at the 6- to 
18-months evaluation, 100 were re­
studied 54 to 88 months after operation 
(mean, 70 ±  10 months). It was not 
possible to re-evaluate the other 98 
patients of whom 32 had died.
In these 100 patients 159 grafts were 
restudied (Table I). It should be noted 
that 27 patients (36 grafts) had also 
been restudied between 30 and 42 
months after operation.6 Selective coro­
nary arteriography and graft opacifica­
tion were performed in most cases with 
preshaped catheters introduced percu-
Table I— Material
Group No. of patients
No. of patent grafts 
at 6 to 18 months
1 45 59
2 37 75
3 18 25
Total 100 159
Table II— Graft Status at 6 to 18 Months after 
Operation
No. of grafts
Status, %  (and%)
No narrowing >  15 31 (21)
Diffuse narrowing 20-80 80 (54)
20-45 72
50-80 8
Localized narrowing 20-80* 37 (25)
20-45 27
50-80 10
Total 148 (100)t
‘With or without diffuse narrowing.
f l l  grafts not evaluated at 2 to 3 weeks have
been excluded.
taneously in the femoral artery by tech­
niques previously described.8
Graft changes observed at 6 to 18 
months have been described elsewhere3,6 
and their distribution in these 159 
grafts is shown in Table II. Graft occlu­
sion was studied separately in the pa­
tients of groups 1, 2 and 3. The dif­
ferences between the results were tested 
by the Yate’s corrected x2 analysis and 
by Student’s f-test.
Results
Complete graft obstruction was ob­
served in 17 (10.7%) of the 159 grafts 
during a mean 5-year interval, giving 
an average annual attrition rate of 
2.2%. The average yearly attrition rate 
was 2.4% for grafts of group 1 pa­
tients, 0.7% for group 2 and 6.5% 
for group 3 (Table III). No late 
occlusion was observed in grafts without 
localized or diffuse narrowing at 6 to 
18 months (Table IV). Of grafts with 
diffuse narrowing 12.7% were oc­
cluded and of grafts with localized 
narrowing, 21.6%. These differences 
are not statistically significant. A high­
er late attrition rate was found, how­
ever, in grafts without localized nar­
rowing as compared with grafts with 
localized stenosis (P <  0.02).
The cumulative patency rate was 
66% for the entire series 5.8 years 
after operation (Fig. 1). It was 57.7% 
at 6.7 years for grafts of group 1 and 
83.2% at 5.1 years for grafts of group 
2 (Fig. 2). Patency rates at 2 to 3 weeks
Table I I I - Graft Attrition Between 6- to 18-Months and 54- to 88-Months Evaluations
Group Patent
Grafts
Occluded
Attrition 
rate, %
Mean interval 
between evaluations,
yr
Mean attrition 
rate/yr, P 
%  value
1 51 8 13.6 5.7 2.4 -I
2 73 2 2.7 4.1 „ , ]
<  0.05
Research series
1.6 1total 124 10 7.5 4.8
<  0.01
3 18 7 28.0 5.3 5.3 .
Total series 142~ lT 10.7 4.8 2.2
Table IV— Graft Attrition Related to Graft Status at 6- to 18-Months Evaluation
At 6 to 18 months At 54 to 88 months
Status, % Patent Patent Occluded (and % ) P value
No narrowing >  15 31 31 0
NS "I
Diffuse narrowing 20-80 80 71 9(12.7) ^
NS J
Localized narrowing 20-80 37 29 8(21.6) J
NS =  not significant.
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and at 6 to 18 months after operation 
were obtained from previous studies.5'7
Discussion
Patency of saphenous vein grafts is 
related to the degree of distal run-off 
of the grafted coronary artery as well 
as to the quality of the surgery; occlu­
sion within 1 month of operation in 
most cases occurred when the grafted 
segment of the distal coronary artery 
had a small capacity.2 Graft patency 
at 6 to 18 months also appeared related 
to the distal run-off, graft attrition be­
ing two to four times greater for grafts 
to arteries with poor run-off than to 
arteries with good run-off as assessed 
by cinecoronary angiography, by 
measurement of the artery diameter at
operation or by graft flow.7 Improved 
surgical techniques also modify graft 
patency favourably.4,5'7 In fact, the 
patency during the first month was 
improved in grafts to arteries with poor 
run-off, and the 6- to 18-months patency 
rate was higher in grafts to arteries with 
a borderline or a good run-off. Graft 
failure after the first year was seldom 
observed, particularly for grafts in 
group 2 patients operated upon after 
surgical techniques were modified. Late 
graft failure appears to be related 
primarily to localized stenoses on the 
graft trunk or at the sites of graft 
anastomoses, which were believed to 
have been caused by unsatisfactory 
surgical techniques; such localized 
stenoses were rare in grafts of group 2.5
Years after surgery
FIG. 1— Graft patency rates at 2 to 3 weeks, 6 to 18 months and at 54 to 88 
months (5.8 years) for all grafts studied. Numbers in parentheses indicate number 
of patent grafts at beginning and end of each interval. Cumulative patency rate at 5.8 
years is 66%.
FIG. 2— Patency rates observed in groups 1 and 2. Cumulative patency rate is 
57.7% at 6.7 years in group 1, and 83.2% at 5.1 years in group 2.
The higher late attrition rate in groups 
1 and 3 grafts correlates well with the 
greater incidence of such localized 
stenoses found at the 6- to 18-months 
angiographic evaluation.
Diffuse graft narrowing owing to 
medial hypertrophy and to fibrous in- 
timal proliferation does not appear to 
progress further after the first year,6 
or to lead to late graft occlusion. The 
influence of atherosclerosis on late 
graft failure is unknown, but it does 
not appear to be significant, at least 
during the first 5 years after operation. 
Nevertheless, 14 (8.8%) of 159 grafts 
had localized stenoses after the first- 
year evaluation. In two patients who 
underwent a second operation the le­
sions were found to be due to athero­
sclerosis. This phenomenon may be­
come an important factor in late graft 
failure.
Graft patency of 83.2%, 5 years 
after surgery, in patients operated upon 
with improved surgical techniques, ap­
pears satisfactory. It is rewarding to 
observe the very low graft failure rate 
of 0.7% per year after the first year 
and the complete absence of graft oc­
clusion in grafts that appeared normal 
at 1 year.
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Changing Patterns of Intra-aortic 
Balloon Pump Assistance*
R.D. Weisel, md, B.S. G oldman, md, frcs[c], S. T easdale, md, frcp[c] and R.S. Baigrie, md, frcp[c]
Intra-aortic balloon pump assistance 
(IABPA) for cardiogenic shock is well 
established. The response to balloon 
pumping and patient survival are better 
after low output from cardiotomy than 
after myocardial infarction. Elective use 
of IABPA preoperatively allows an extra 
margin of safety for patients with 
acute coronary insufficiency, significant 
left main coronary artery stenosis, or 
depressed left ventricular function. 
However, advances in monitoring 
techniques during the induction of 
anesthesia and weaning from cardio­
pulmonary bypass support, as well as 
improved methods for myocardial 
preservation, have reduced the 
requirements for elective IABPA. Current 
indications for preoperative IABPA 
include: patients with acute coronary 
insufficiency who are totally unre­
sponsive to full medical management 
and who continue to have pain and 
electrocardiographic changes at rest, 
and patients with serious left main 
coronary artery stenosis who also have 
acute coronary insufficiency or depressed 
left ventricular function. The survival 
of patients with valvular heart disease 
and left ventricular dysfunction is not 
improved with preoperative IABPA, 
while most patients with depressed left 
ventricular function from coronary 
artery disease may now undergo 
revascularization uneventfully, although 
inevitably some will still require 
postoperative IABPA.
Dans le choc cardiogene, (’assistance 
intra-aortique par pompe a ballonnet 
(AIAPB) est bien etabli. Une meilleure 
reponse a Taction de la pompe a
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ballonnet et une meilleure survie sont 
associes a un faible debit suivant 
cardiotomie qu'apres infarctus. 
L’utilisation non urgente de I’AIAPB 
avant I'operation offre une marge 
de securite supplementaire pour 
les patients ayant une insuffisance 
coronarienne aigue, une stenose 
importante de la principaie artere 
coronaire gauche, ou une fonction 
ventriculaire gauche deprimee. Toutefois, 
['amelioration des techniques de 
surveillance pendant I'induction de 
I’anesthesie et le sevrage de la 
derivation cardiopulmonaire, de meme 
que de meilleures methodes de 
protection du myocarde, ont reduit les 
besoins de recourir a I’AIAPB non 
urgente. Les indications presentes de 
I'AIAPB dans la periode preoperatoire 
comprennent: les patients souffrant 
d’insuffisance coronarienne aigue et qui 
sont totalement resistants a un 
traitement medical complet et qui 
continuent d'avoir de la douleur et a 
presenter des changements electro- 
cardiographiques au repos, et les 
patients ayant une stenose grave 
de la principaie artere coronaire et 
une insuffisance coronarienne aigue 
ou une fonction ventriculaire gauche 
deprimee. La survie des patients atteints 
de maladie valvulaire et de dysfonc- 
tionnement ventriculaire gauche n’est 
pas beaucoup amelioree par I'AIAPB 
preoperatoire, alors que la plupart des 
patients ayant une fonction ventriculaire 
gauche deprimee des suites d’une 
maladie coronarienne peuvent maintenant 
subir sans incident une intervention 
de revascularisation, bien que inevita- 
blement certains patients continueront 
de necessiter une AIAPB postoperatoire.
Intra-aortic balloon pump assistance 
(IABPA) is a valuable aid for the 
treatment of cardiogenic shock com­
plicating acute myocardial infarction 
or following cardiopulmonary bypass.1"34 
It has also been used successfully for 
the management of medically refrac­
tory ischemic pain in pre- or postinfarc­
tion states.5,6,8-13,15’16'23'26,34"40 Revascu­
larization is then performed urgently 
rather then emergently.
Indications for elective IABPA have
evolved to avoid intraoperative and 
postoperative ischemic complications in 
patients with either left ventricular (LV) 
dysfunction or stenosis of the left main 
coronary artery.5"7,13,41,42 However, in­
tensive pharmacologic treatment of 
acute myocardial ischemia, improved 
techniques for inducing anesthesia, bet­
ter intraoperative myocardial protec­
tion and improved postoperative hemo­
dynamic monitoring, have all greatly 
reduced the elective use of IABPA. This 
report describes the changing patterns 
of IABPA at the Toronto General 
Hospital.
Patients
Between Nov. 1, 1974 and Oct. 31, 
1977, 315 patients received IABPA  
(AVCO-Roche, Cranbury, MA) at the 
Toronto General Hospital: they repre­
sented 14% of the total number of 
patients undergoing open-heart surgery. 
Each patient had central venous and 
arterial catheters in place during 
IABPA, and many had pulmonary 
artery thermodilution catheters as well. 
The patients were classified in three 
groups.
Group 1 comprised 42 patients with 
cardiogenic shock after myocardial in­
farction in whom IABPA was instituted 
as soon as the shock became medically 
refractory. After stabilization of the 
hemodynamic state, cardiac catheteriza­
tion was performed without complica­
tion. Surgery was performed either 
when an anatomic lesion was present, 
or when hemodynamic stability could 
not be maintained by IABPA. All pa­
tients underwent an attempt at wean­
ing after 5 to 7 days of assistance. Sur­
gery was delayed in those with ana­
tomic lesions until 6 weeks after infarc­
tion, when possible. Most of these pa­
tients, however, had hemodynamic in­
stability and underwent surgery earlier. 
Patients without anatomic lesions who 
were candidates for aortocoronary by­
pass or infarctectomy were operated 
upon electively if they could become 
balloon-independent, or urgently dur­
ing their second week of support if they 
were balloon-dependent.
One hundred patients who required 
IABPA in the postcardiotomy period
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constituted group 2. They were reviewed 
retrospectively to identify preoperative 
and intraoperative factors contributing 
to their low cardiac output after cardio­
pulmonary bypass.
Preoperative IABPA was used to 
stabilize patients with acute coro­
nary insufficiency, either before ca­
theterization or before induction of 
anesthesia. The balloon was also 
inserted electively for patients with 
left main coronary artery stenosis or 
severe left ventricular dysfunction to 
maintain hemodynamic stability during 
induction and cannulation for cardio­
pulmonary bypass. These 173 patients 
constituted group 3.
Weaning from balloon support was 
accomplished over a 6- to 12-hour 
period by decreasing the pumping in­
terval from 1:1 to 1:8. This was facili­
tated by repeated evaluation of the 
hemodynamic response to the reduced 
pumping interval.
Results
Table I outlines the indications for 
IABPA, the hospital survival and the 
definitions of the clinical states en­
countered for the 315 patients who had 
IABPA between 1974 and 1977. Figs. 
1 to 3 depict the patterns of balloon
utilization and patient survival during 
this period. Use of IABPA increased 
from 1974 to 1976 (Fig. 1) from 14% 
to 17% of all cardiac operations, but 
decreased to 11% in 1977. Fig. 2 re­
veals that use of IABPA for cardiogenic 
shock, following either acute myocar­
dial infarction or cardiotomy, has re­
mained relatively constant over the en­
tire period, and that the change was 
due to a decrease in elective use of 
IABPA preoperatively.
Group 1
IABPA for shock after infarction 
has allowed a 48% overall survival (20 
of 42 patients). In 25 patients who un­
derwent operation the survival rate was 
68% compared with 12% in 17 
shocked patients treated with IABPA 
alone. Of the patients who were oper­
ated upon, 21 had anatomically cor­
rectable lesions, which included acute 
ventricular septal defect (4 patients), 
acute mitral regurgitation (5 patients), 
ventricular aneurysm (8 patients), and 
recurrent persistent ventricular tachy­
cardia (4 patients). Seventeen (81%) of 
these 21 patients survived.
Group 2
Of the 100 patients in this group,
68% survived. Of these 100 patients, 
58 had undergone coronary artery by­
pass operations, with an ultimate sur­
vival rate of 77%. A review of the 
preoperative status of these 58 patients 
revealed three constant factors: 13 had 
acute coronary insufficiency (survival 
rate, 62%), 37 had depressed left ven­
tricular function (survival rate, 78%) 
and 8 had left main coronary artery 
stenosis (survival rate, 88%).
Of 42 patients who required IABPA 
after prosthetic valve replacement only 
57% survived. Of these, 29 had de­
pressed left ventricular function pre­
operatively, and 52% survived. Six re­
quired urgent valvular surgery for acute 
decompensation and only three sur­
vived. Seven patients required IABPA 
postoperatively because of intraopera­
tive myocardial damage and our 
inability to wean them from cardio­
pulmonary bypass.
Group 3
Elective IABPA was instituted in 
1973 for the same three factors, which 
had produced a high operative mor­
bidity and mortality (Fig. 3). Of 161 
patients who subsequently underwent 
coronary artery bypass procedures, 93 % 
survived. This group included 67 pa-
Patients
FIG. 1—Number of patients and hos­
pital survival rate for 315 patients who 
underwent intra-aortic balloon pump assist­
ance (IABPA) at Toronto General Hospital 
from Nov. 1, 1974 to Oct. 31, 1977.
Patients
FIG. 2— Indications for IABPA and 
survival rates for the years 1974 through 
1977. AMI — acute myocardial infarction.
T a b le  1— In d ic a t io n s  fo r  In t r a -a o r t ic  B a llo o n  Pum p A s s is ta n c e  ( IA B P A ) ,  
T o ro n to  G e n e ra l H o s p ita l, 1974 to  1977
N o . o f
p a t ie n ts  S u rv iv a l,  %
G ro u p  1— c a rd io g e n ic  sh o c k  fo llo w in g  in fa rc t io n 42 48
T re a te d  m e d ic a lly 17 12
T re a te d  s u rg ic a lly 25 68
G ro u p  2— c a rd io g e n ic  sh o ck  fo llo w in g  c a rd io to m y 100 68
C o ro n a ry  a r t e r y  bypass  
P re o p e ra t iv e  c o n d itio n s
58 77
1. ac u te  c o ro n a ry  in s u ff ic ie n c y * 13 62
2. le f t  v e n t r ic u la r  d y s fu n c tio n ) 37 78
3. le f t  m a in  c o ro n a ry  s te n o s is ) 8 88
V a lv e  re p la c e m e n ts  
P re o p e ra t iv e  c o n d it io n s !
42 57
1. le f t  v e n t r ic u la r  d y s fu n c tio n 29 52
2. u rg e n t s u rg e ry 6 50
G ro u p  3— E le c tiv e  p re o p e ra t iv e  in s e rt io n 173 90
C o ro n a ry  a r te r y  d is e a s e 161 93
1. ac u te  c o ro n a ry  in s u ff ic ie n c y 67 87
2. le f t  v e n t r ic u la r  d y s fu n c tio n 40 95
3. le f t  m a in  s te n o s is 41 83
a . c o m p lic a te d ^ 11 54
b. u n c o m p lic a te d 30 100
4 . S tab le  a n g in a  ( t r ip le  c o ro n a ry  
a r te r y  d is e a s e )
13 100
V a lv u la r  h e a r t  d is e a s e 12 42
T o ta l 315 77
‘ W h e n  p a t ie n ts  w ith  u n s ta b le  a n g in a  had  p e rio d s  o f c h e s t pain e x c e e d in g  20 m in , a s s o c ia ted  w ith  
r e v e r s ib le  S T -T  w ave  c h a n g e s , d e s p ite  a p p ro p r ia te  m e d ic a l th e ra p y .
(W h e n  e je c t io n  fra c tio n  w a s  less  th a n  4 0 %  o r  w h e n  v e n tr ic u lo g ra m  w as  g ra d e d  4 on s c a le  o f 1 
to  4 .
)W h e n  a r te r io g ra p h y  re v e a le d  o b s tru c tio n  o f le f t  m a in  co ro n ary  a r te ry  g r e a te r  th a n  7 0 % . 
§7 p a t ie n ts  had  n e ith e r  le f t  v e n t r ic u la r  d y s fu n c tio n  n o r  u rg e n t s u rg e ry .
I fW h e n  a c u te  c o ro n a ry  in s u ff ic ie n c y  o r  le f t  v e n t r ic u la r  d y s fu n c tio n  w a s  a ls o  p re s e n t.
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Patients
1974 1975 1976 1977
FIG. 3—Indications for elective preoperative IABPA are noted for patients who 
subsequently underwent coronary artery bypass graft surgery. ACI =  acute coronary 
insufficiency, LVF =  left ventricular function, LMS =  left main stenosis.
tients with acute coronary insufficiency 
unresponsive to medical management 
(survival rate, 87%), 40 patients with 
depressed left ventricular function 
(survival rate, 95%) and 41 patients 
with left main coronary artery stenosis 
(survival rate, 83%). Of 11 patients 
in whom left main coronary artery 
stenosis was complicated by either 
acute coronary insufficiency or de­
pressed left ventricular function, only 
6 (54%) survived, despite elective
IABPA. However, the 30 patients with 
uncomplicated left main coronary artery 
stenosis all survived. Thirteen patients 
with severe triple-vessel coronary artery 
stenosis (“left main equivalent”) had 
preoperative IABPA during the early 
years of our experience; all survived.
Table II notes the incidence of elec­
tive IABPA for acute coronary insuf­
ficiency, left ventricular dysfunction 
and left main coronary artery stenosis, 
as a percentage of total cardiac proce­
dures performed in the past 4 years. 
There has been a decrease in the pre­
operative use of IABPA for these three 
conditions in 1977.
Twelve patients with valvular heart
disease had undergone preoperative 
IABPA because of poor left ventricular 
function; only 42% survived despite 
corrective surgery. These patients were 
operated upon early in our experience 
and we now believe that IABPA does 
not improve surgical survival.
Discussion
IABPA remains a valuable modality 
in the treatment of cardiogenic shock 
following acute myocardial infarction 
in those patients who continue to have 
a depressed cardiac index, oliguria or 
elevated pulmonary wedge pressure 
despite optimal colume loading or 
afterload reduction by pharmacologic 
means.1-3'5-644'16-18'24-26'30 Nine of the 17 
medically treated patients with shock 
due to myocardial infarction were 
transferred to our hospital with long­
standing hypotension (more than 6 
hours), despite treatment with pressor 
agents elsewhere. These patients had 
a poor response to IABPA and 
died despite its use. Presumably 
the extent of damage, lack of correct­
able lesion and prolonged shock prior 
to IABPA militated against a successful
result. Of the remaining patients, 21 
were found to have anatomically cor­
rectable lesions. These patients have 
the best prognosis from surgical therapy 
after IABPA.1'3'5'6'1446'27-28'35'40 An at­
tempt was made to delay surgery be­
cause of apparently better survival in 
patients operated upon longer than 6 
weeks after acute infarction. In patients 
who did not have anatomically cor­
rectable lesions after infarction wean­
ing was attempted between 5 and 
7 days after IABPA. Patients who 
could not be weaned from balloon sup­
port because of hemodynamic instabi­
lity, recurrent ischemia, or extending 
infarction were considered candidates 
for urgent surgery. They were operated 
upon early and the mortality was high. 
Infarctectomy alone was not usually 
successful. Coronary bypass grafting to 
stenotic vessels in the noninfarcted area 
resulted in better survival (contralateral 
revascularization).
Cardiogenic shock after cardiopul­
monary bypass had a substantially better 
prognosis than shock following infarc­
tion, presumably because of a reversible 
ischemic insult.5’6'10'lz'14'1!i'19'20'22 Early in­
sertion of the balloon was favoured over 
prolonged inotropic support because of 
the unique advantages IABPA offers to 
ischemic myocardium.
An attempt was made, by retrospec­
tive analysis, to identify patients at 
great risk for a low output state post- 
operatively and to avoid this situation 
by preoperative elective IABPA.5"8'13'15 
Initially, patients with valvular heart 
disease and severely depressed left 
ventricular function underwent elective 
IABPA, but were found to respond 
poorly and their survival after surgery 
was not enhanced. These patients are 
no longer considered candidates for 
elective IABPA. Improved methods of 
myocardial preservation, however, ap­
pear to have reduced the number of 
patients requiring postoperative IABPA 
after valve replacement (12% of pa­
tients receiving valve replacements re­
quired IABPA in 1976, but only 6% 
in 1977).
For patients with substantial left 
main coronary artery stenosis or re­
fractory acute coronary insufficiency, 
the critical period for ischemia, ar­
rhythmia or infarction is during the 
induction of anesthesia, cannulation and 
manipulation for cardiopulmonary by­
pass, and the subsequent weaning from 
bypass.5-8'34'37'39'41-55 Fig. 4 illustrates 
hemodynamic events that may result in 
subendocardial ischemia during induc­
tion of anesthesia and sternotomy. 
IABPA is an ideal means of preventing 
these changes. Diastolic augmentation 
will maintain endocardial perfusion de­
spite systolic hypotension; hypertension 
and tachycardia, however, may limit 
ultimate usefulness of IABPA. Pre-
Table II— Elective Preoperative IABPA. Presented as a Percentage of the Open-Heart Operations 
Performed Between 1974 and 1977
Year
Indication 1974 1975 1976 1977 1974-77
Acute coronary insufficiency 2.9 3.7 3.3 2.3 3.0
Left ventricular dysfunction 2.0 1.6 3.2 0.5 1.8
Left main coronary artery stenosis 1.8 2.3 1.8 1.3 1.8
Valvular heart disease 1.1 6.9 0.3 0 0.5
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Pre operative Induction In tub ation  Vasodilatation Sternotom y
EVR 1.2 0.8 0.6 0.7 0.6
FIG. 4— Hemodynamic, electrocardiographic and endocardial viability ratio 
(EVR) (diastolic pressure time index/tension time index, DPTI/TTI) changes for typical 
patient undergoing coronary artery bypass.
operative IABPA was utilized in 
67 patients with acute coronary in­
sufficiency and in 41 patients with left 
main coronary artery stenosis; not only 
was the survival rate acceptable, but 
the necessity for urgent postoperative 
insertion was avoided. Careful evalua­
tion of different techniques for induc­
tion of anesthesia has allowed us to 
identify many potential intraoperative 
problems. Table III reports the effects
on the endocardial viability ratio (Bell 
D, Teasdale S: Personal communica­
tion, 1977). It is evident that the com­
bination of droperidol and fentanyl 
citrate maintained a favourable endo­
cardial viability ratio, suggesting the 
least impairment of subendocardial 
coronary flow. Monitoring of both 
endocardial viability ratio and hemo­
dynamic events, and the use of vaso­
dilator and propranolol therapy during
of different agents used for induction induction, have reduced the incidence
Table Ill-Endocardial Viability Ratio (EVR) During Anesthesia
Relaxed, awake in 5 min after
operating room induction
No. of Mean change
Agents used patients EVR EVR in EVR
Thiopentone, 3 mg/kg 8 0.97 0.52 -0 .8 2 *
Morphine sulfate, 1 mg/kg 
Droperidol, 100 mg/kg -f fentanyl
7 1.21 0.69 -0 .2 6 *
citrate, 10 mg/kg 8 1.49 1.11 -0 .3 3
*P <  0.01.
of ischemia and infarction in patients 
with left main coronary artery stenosis 
or acute coronary insufficiency. Elec­
tive IABPA is now indicated only when 
severe left main coronary artery stenosis 
is complicated by either acute myocar­
dial ischemia or left ventricular dys­
function, and in those patients with 
acute coronary insufficiency only when 
the pain is not relieved by good medi­
cal management.
Patients with poor left ventricular 
function run increased risks from coro­
nary artery bypass surgery.15,56,57 Bo- 
looki and colleagues13 have reported that 
preoperative IABPA allows smoother 
induction and more physiologic pulsa­
tile cardiopulmonary bypass to preserve 
myocardial function better. Similarly 
we have used elective IABPA in 40 pa­
tients with poor left ventricular func­
tion and 95% survived. This is con­
trasted to a 78% survival rate for 37 
other patients with equally poor left 
ventricular function who required 
IABPA for low cardiac output after 
surgery. Two factors have led to 
decreased preoperative use of and post­
operative need for IABPA in patients 
with poor left ventricular function. The 
first is intensive hemodynamic monitor­
ing. Myocardial performance curves of 
20 patients, constructed during weaning 
from cardiopulmonary bypass, are il­
lustrated in Fig. 5. These curves al­
lowed early identification of patients 
with poor postoperative left ventricu­
lar function. The second factor is im­
proved techniques for intraoperative 
myocardial protection, which have 
allowed better preservation of myocar­
dial performance in the immediate 
postcardiopulmonary bypass period.58 
These two factors have permitted a de­
crease in the elective use of IABPA 
from 3.2% of all open-heart operations 
in 1976 to 0.5% in 1977.
FIG. 5—Myocardial performance curves 
before and after institution of IABPA are 
illustrated for 20 patients who had hypo­
tension following coronary artery bypass 
surgery. Depressed performance is ap­
parent from low stroke work, which did 
not improve despite elevation of left atrial 
pressure by volume loading from bypass 
circuit. IABPA resulted in increase in 
stroke work to acceptable levels with 
similar volume loading.
□  T T I
Prior to  IA B P A  F o llo w ing  IA B P A
FIG. 6— Illustrative hemodynamic, electrocardiographic and EVR changes in pa­
tient with postcardiotomy cardiogenic shock reveals systolic hypotension, narrow pulse 
pressure, elevated end-diastolic pressure, decreased diastolic coronary filling time interval 
and low EVR despite use of inotropic drugs. IABPA caused reduction in peak systolic 
pressure, diastolic augmentation, reduced left ventricular end-diastolic pressure and 
more prolonged diastolic filling period, resulting in more normal electrocardiogram and 
more favourable subendocardial perfusion, as noted by EVR =  1.95.
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None the less, there are patients with 
apparently adequate preoperative myo­
cardial performance who continue to 
require inotropic support for hypoten­
sion, and who do not respond to an 
additional period of vented cardiopul­
monary bypass. They remain potential 
candidates for IABPA. The monitoring 
of hemodynamic variables and the endo­
cardial viability ratio in the postoper­
ative period may allow identification of 
those patients at greatest risk. Although 
they may survive the perioperative 
period, subendocardial necrosis may 
produce late changes in left ventricular 
function. Fig. 6 illustrates that IABPA 
is preferable to prolonged inotropic 
support in the perioperative period for 
these patients.
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Drainage of peritoneal abscess occurring /,, 
as a complication of abdominal stab wound 
prior to initiation of antibiotic therapy.
V /M /M t
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Clinical Evaluation of Porcine Heterograft Cardiac Valves
in 200 Patients*
W.R.E. Jamieson, md, frcs[c], A.I. Munro, md, frcs, frcs[c], R.T. M iyagishima, md, frcs[c]
and Peter Allen, md, frcs[c]
Of 200 patients who received porcine 
heterograft cardiac valves, the first 
100 did not receive postoperative 
anticoagulant therapy. In the second 
100 patients anticoagulant measures 
were used when thrombogenic factors 
not related to the prosthesis were 
evident. Anticoagulation should be 
employed following mitral valve 
replacement while factors contributing 
to thromboembolism prevail. The 
conditions that tend to induce vascular 
stasis in the left atrium followed by 
embolism are chronic atrial fibrillation, 
a large dilated left atrium and a calcified 
left atrial wall. The results of our 
study provide assurance of the continued 
use of the porcine bioprosthesis.
De 200 patients qui ont recu une 
heterogreffe de valvules cardiaques 
porcines, les 100 premiers n'ont pas 
re$u d'anticoagulotherapie apres 
I’operation. Dans la deuxieme serie de 
100 patients des anticoagulants ont 
ete utilises quand il y avait evidence 
de facteurs thrombogenes non relies 
a la prothese meme. Des anticoagulants 
devraient etre employes apres rempla- 
cement de la valvule mitrale alors que 
des facteurs favorisant les thrombo- 
embolies sont presents. Les conditions 
qui tendent a provoquer une stase 
vasculaire dans I'atrium gauche suivie 
d'une embolisation, sont la fibrillation 
auriculaire chronique, une importante 
dilatation de I'atrium gauche et une 
calcification de la paroi auriculaire 
gauche. Les resultats de notre etude 
rassure sur le maintien de I’emploi 
de la bioprothese porcine.
*From the division of cardiothoracic surgery, department of surgery, University of British Columbia, Vancouver General Hospital, Vancouver, BC
Presented at the annual meeting of the Canadian Cardiovascular Society, Toronto, Ont., Oct. 19-22, 1977
Supported by the British Columbia Heart Foundation
Reprint requests to: Dr. Peter Allen,Ste. 600, 750 West Broadway, Vancouver, BC V5Z 1H5
The ideal prosthetic cardiac valve 
should be functionally durable, non- thrombogenic and hemodynamically satisfactory.1'3 The porcine hetero­
graft, in our opinion, satisfies these 
requirements. The prosthesis is func­tionally durable as demonstrated by 8 
years of clinical experience since the initial implantations were done.3,4 From January 1975 the porcine bioprosthesis has been utilized in the majority of 
valve replacements at the Vancouver General Hospital. Either the Hancock or the Carpentier-Edwards bioprosthesis was introduced in all valvular positions. A clinical evaluation of the first 200 patients in whom 227 such valves were 
introduced has provided evidence that assures continued use of the porcine heterograft.
The rate of thromboembolism was low. The first 100 patients were man­aged without anticoagulant therapy.5 As a result of this experience it was 
recommended that anticoagulation be given after mitral valve replacement when any of the following factors con­
tributing to thromboembolism existed: chronic atrial fibrillation, intraoperative 
atrial thrombus, calcified left atrial 
wall, or large dilated left atrium.This recommendation was followed 
in the management of the second 100 patients. The majority of patients in whom factors contributing to thrombo­
embolism were present received oral 
anticoagulants in the postoperative period.
Patients
The series comprised 105 females and 95 males. Their average age was 51.8 years (range, 12 to 85 years).The average duration of follow-up was 14 months. The total number of valves implanted in the various posi­tions and the duration of follow-up of 
the surviving patients are shown in Ta­ble I. More valves were placed in the mitral than in the aortic position be­cause, initially, the smaller prostheses 
were not available to our institution. Approximately 25% of our patients had multiple procedures such as double or
triple valve replacement, or valve re­placement accompanied by aortocoro­nary bypass grafting for arteriosclerotic 
coronary artery disease. The series in­cludes five cases of valve replacement in the pediatric age group, one for 
pulmonary insufficiency following defi­
nitive correction of tetralogy of Fallot and four for rheumatic heart disease.6,7The indications for surgery repre­sented a multiplicity of diseases affect­
ing the cardiac valves. The aortic valve was replaced because of pathologic changes related to rheumatic heart disease, calcific bicuspid aortic stenosis, subacute bacterial endocarditis, or Mar­
fan’s syndrome. Functional tricuspid in­sufficiency and rheumatic heart disease were the indications for tricuspid re­placement. Replacement of the mitral valve was necessary because of a variety of conditions, namely, rheumatic heart disease, papillary muscle dys­
function, Marfan’s syndrome, ruptured chordae tendineae, myxomatous de­generation and Barlow’s disease. The pulmonary valve required replacement 
because of post-tetralogy pulmonary in­
sufficiency.
In this series 47 (25%) patients had had previous operative intervention or 
further definitive surgery during the observation period, or both (Table II). The majority had had mitral commis­
surotomy and mitral or aortic valve 
replacement. Four patients required re­operation during the observation period, one for technical error in placement of 
the mitral prosthesis and three for peri- prosthetic leaks.
Table I—Number of Valves Implanted in 
Various Positions and Duration of Follow-up
Duration,
Position Number mo
Aortic valve 90 13
Mitral valve 125 15
Pulmonary valve 1 22
Tricuspid valve 4 18
Double valve 24 13
Triple valve 2 13
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T a b le  II— Summary o f 47 P a t ie n ts  who had 
U n dergone  a P re v io u s  O pera tion
No. of
P re v io u s  ope ra tion pa t ie n ts
M it r a l com m issuro tom y 18
V a lv e  rep lacem en t 16
P e r ip ro s th e t ic  leaks 7*
P lic a t io n — m itra l va lve 1
H om og ra ft 1
Id io p a th ic  hype rtroph ic  sub-
a o r t ic  s te n o s is 1
T e ch n ic a l e r ro r 1
T r ic u s p id  com m issuro tom y 1
T r ic u s p id  p lic a t io n  (E b s te in ’ s 1
an om a ly )
*3 p a t ie n ts  w ith  a po rc ine  va lve , 4 w ith  o th e r
typ e s  o f v a lv e  p re v iou s ly  in se rted .
Results
There were 30 deaths (Table III). 
Twenty-one occurred in those receiving 
mitral valve replacement with or with­
out aortocoronary bypass grafts.
The various causes of death, classi­
fied as early or late, are set forth in 
Table IV. The early or hospital mor­
tality was 8% and the late mortality 
was 7.6%. The two deaths related to 
a pseudoaneurysm of the left ventricle 
were attributed to the “sawing” action 
of the strut of the mitral prosthesis 
(Allen P: Personal communication,
1977). Death in these two patients was 
due to severe congestive heart failure 
uncontrollable by medical therapy.
The later death from hemopericar-
Table III— Types o f O pera tion  Perfo rm ed  and T o ta l M o r ta lity
O pe ra t io n No. o f patien ts A liv e Dead
S in g le  va lve*
A o r t ic 71 69 2
M it ra l 99 79 20
P u lm o n a ry 1 1 0
T r ic u s p id 4 2 2
D o ub le  v a lv e 23 18 5
T r ip le  v a lv e 2 1 i
T o ta l 200 170 30
*22 p a t ie n ts  had s ing le  v a lv e  rep lacem en t p lu s  co ro n a ry  a rte ry  bypass; 1 d ie d .
T ab le  IV— C auses  o f E a r ly  and Late Death
C au se
Early  dea th , 
<  30 d
La te  death, 
>  30 d
C o n g e s t iv e  card iac fa ilu re
—  ca rd iog en ic  shock 6 9
A rrh y th m ia 1 —
T e c h n ic a l e r ro r 2 —
C e re b ro v a s cu la r  acc id en t — 1
H em o rrhage  ( in tra - and  p ostope ra tive ) 3 —
P seu do an eu rysm  of le f t  v e n tr ic le 2 —
P n e um o n ia  (Serratia) 1 —
E n d o ca rd it is  (funga l) — 1
P u lm o n a ry  em bolism — 1
A c c id e n ta l deaths — 1
S u p e r io r  m esen teric  aneu rysm 1 —
H em operica rd ium — 1
T o ta l (and  % ) 16 (8.0) 14 (7.6)
T a b le  V - -C om p lica tion s  R e la ted  to Po s it io n  o f V a lv e
V a lv e  p os it io n
C o m p lic a t io n A o rt ic M itra l T r icu sp id Pu lm onary
T e c h n ic a l e rro rs — 2 — —
P e r ip ro s th e t ic  leaks 1 3 — —
E n d o ca rd it is — 1 — —
Throm boem bo lism 2 9 — —
G ra ft  p a tho logy — — — —
Pseu doan eu rysm  of v e n t r ic le — 2 — —
T o ta l 3 17 0 0
dium was attributed to anticoagulant 
therapy and the one due to fungal 
endocarditis was caused by mucormy­
cosis effecting obstruction of the mitral 
prosthesis.
The complications related to the 
various valve sites, irrespective of un­
derlying pathologic changes and treat­
ment, are analysed in Table V. Such 
complications were most common in 
the mitral position.
There were no instances of pathologic 
changes in or disruption of the valve 
prosthesis. Microscopic studies of por­
cine valves retrieved at autopsy were 
not performed.
There were five cases of early throm­
boembolism and six cases of late throm­
boembolism (Table VI). Since antico­
agulant therapy was instituted in the 
postoperative management of patients 
in whom contributing thrombogenic 
factors were discovered, thromboem­
bolism has occurred in only three in­
stances—one early and two late.5 In all 
11 cases of thromboembolism, early or 
late, atrial fibrillation was present. The 
rate of early thromboembolism of 
the aortic prosthesis was 2.0% per pa­
tient-year and the rate of late throm­
boembolism was zero. The respective 
figures for mitral valve replacement 
were 2.0% and 3.9%.
The majority of thrombogenic fac­
tors that are unrelated to the prosthesis 
coexist with chronic atrial fibrillation. 
They result in vascular stasis and 
thrombus formation in the left atrium. 
It is noteworthy that the only 
death related to thromboembolism 
in the entire series was attributable to 
such thrombogenic factors. The pa­
tient had chronic atrial fibrillation and 
died of a recurrent cerebrovascular ac­
cident. At autopsy there was a sub­
valvular aneurysm of the left ventricle 
filled with friable thrombus and a 
mural thrombus on the left atrial wall; 
the valve prosthesis was unaffected by 
thrombosis.5
Actuarial curves analysing valve
T a b le  V I— Sum m ary of Cases of 
Throm boem bo lism
V a r ia b le Ea rly La te
N um ber 5 6
M o rb id ity 5 5
M o r ta lity 0 1
A o rt ic  va lve 2 0
M itra l va lve 3 6
C o n tr ib u t in g  fa c to rs  
P re v io u s  ce re b ro va scu la r
acc id en t 1 1
A tr ia l f ib r i l la t io n 5 6
A t r ia l th rom bus 1 0
A n t ic o a g u la n t the rapy 1 2
E m b o li/p a t ie n t-ye a r , %
A o rt ic  v a lve 2.0 0
M itra l v a lv e 2.0 3.9
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durability in our series show that the 
glutaraldehyde-preserved heterografts 
maintained good function after 30 
months in 81% of cases in the mi­
tral position and in 97.6% in the aortic 
position (Fig. 1).
The quality of life of our patients 
has been significantly improved by the 
use of the porcine heterograft (Fig. 2). 
Among the survivors, the number in 
class I (New York Fleart Association 
classification) increased from 1 pre- 
operatively to 124 postoperatively and 
the number in class IV decreased from 
35 to 1.
Discussion
The porcine heterograft appears to 
be highly reliable since its performance 
approaches the criteria of a satisfactory 
valve substitute.1'3 The purpose of our 
evaluation was to consider the throm- 
bogenicity of the prosthesis; the period 
of study is too short to permit conclu­
sions in regard to valve durability.
Months
FIG. 1—Actuarial curves to demon­
strate valve durability in various positions. 
AVR =  aortic valve replacement; MVR =  
mitral valve replacement.
Preoperative Postoperative
NYHA Functional Classification
FIG. 2—Preoperative and postopera­
tive functional classification (New York 
Heart Association) of 170 surviving pa­
tients undergoing porcine heterograft 
valve replacement.
Furthermore, we have no catheteriza­
tion data to determine the hemodynamic 
status of the prosthesis; nevertheless, 
our patients were hemodynamically sta­
ble on clinical assessment.
There is impressive evidence to indi­
cate that tissue prostheses have a lower 
degree of thrombogenicity than mechan­
ical valves.1,8 The porcine heterograft 
inserted without postoperative antico­
agulant coverage is associated with a 
reduced rate of thrombosis.2,3,8"15
Anticoagulant therapy was not used 
in our first group of patients. In our 
second group, we reduced the rate 
of thromboembolism with the use of 
anticoagulants in the presence of throm- 
bogenic factors not related to the pros­
thesis. There is reason to believe that 
anticoagulation was not adequately 
controlled in those patients who did 
incur thromboembolic episodes while 
on anticoagulant therapy.
The thrombogenic factors unrelated 
to the prosthesis are primarily asso­
ciated with vascular stasis in the left 
atrium (resulting from chronic atrial 
fibrillation, large dilated left atrium 
and calcified left atrial wall) and con­
tribute to cerebrovascular, visceral and 
peripheral embolism. In all our patients 
who experienced thromboembolic epi­
sodes one or m ore of these contributing 
factors was present and all patients had 
chronic atrial fibrillation.
In conclusion, we recommend that 
anticoagulants be administered follow­
ing mitral valve replacement when con­
tributing thrombogenic factors are evi­
dent. Furthermore, anticoagulant thera­
py should not be discontinued until the 
patient maintains a cardiac rhythm un­
complicated by atrial arrhythmias.
We thank Drs. W.G. Trapp and L.H. 
Burr for permitting us to include a num­
ber of their patients in our study. We 
also thank Gayle Henderson, Joan Madi­
son and Diane Borgon for their help in 
the preparation of the manuscript.
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Permanent Transvenous Atrial Pacing*
B.S. G o ld m a n , m d , f r c s [c ], A .W . C h is h o l m , m d , f r c p [c], D .C . M acG r eg o r , m d , f r c s [c] and
G .M . F roggatt , m d , f r c p [c ]
Atrial pacing has electrophysiologic 
and hemodynamic advantages for 
patients with symptomatic bradyarrhyth- 
mias and intact atrioventricular 
conduction or with certain refractory 
tachyarrhythmias. Permanent atrial 
pacing has been achieved in 29 patients 
followed up for periods of up to 7 years 
at two institutions. At Sunnybrook 
Medical Centre, Toronto, 16 patients 
have had coronary sinus electrodes 
introduced pervenously using standard 
bipolar or special unipolar catheters. 
Initial pacing thresholds were acceptably 
low (mean, 2.0 mA); chronic thresholds 
in three patients were similar. At the 
Toronto General Hospital, 13 patients had 
endocardial J-electrodes, bipolar or 
tined unipolar, inserted in the right 
atrial appendage. Initial thresholds were 
low (mean, 1.3 mA) and P-wave voltage 
was adequate (3.4 mV) for pacemakers 
with standard sensitivity. In both series, 
conventional R-inhibited, asynchronous 
or rate-programmable units have been 
employed. Radiofrequency self-conversion 
pacemakers were used in three patients. 
Preliminary His bundle studies were 
done in 10 patients; the others were 
tested by rapid atrial pacing during 
insertion of electrodes. Early and late 
electrode stability in both series was 
excellent; one electrode became dis­
lodged from the coronary sinus position 
and one from the right atrial appendage.
La stimulation auriculaire possede des 
avantages electrophysiologiques et 
hemodynamiques pour les patients 
presentant une bradyarythmie avec 
conduction atrioventriculaire intacte 
ou certaines tachyarythmies rebelles. 
Une stimulation auriculaire permanente 
a ete obtenue chez 29 patients suivis
*From the departments of medicine 
(cardiology) and surgery (cardiovascular), 
Sunnybrook Medical Centre 
and the Toronto General Hospital, 
University of Toronto, Toronto, Ont.
Presented at the annual meeting of the 
Canadian Cardiovascular Society, Toronto, 
Oct. 19-22, 1977
Reprint requests to: Dr. B.S. Goldman, 
Toronto General Hospital, 101 College 
St., Toronto, Ont. M5G 1L7
dans deux etablissements pour des 
periodes allant jusqu'a 7 ans. Au 
Sunnybrook Medical Centre de Toronto, 
16 patients ont eu des electrodes intro- 
duites par voie veineuse dans le sinus 
coronaire, a I'aide de catheters bipolaires 
reguliers ou de catheters unipolaires 
speciaux. Les seuils initiaux de stimu­
lation ont ete faibles et acceptables 
(moyenne, 2.0 mA); chez trois patients, 
les seuils chroniques etaient semblables. 
Au Toronto General Hospital, 13 
patients ont recu des electrodes 
endocardiques J, bipolaires ou unipolaires 
a pointes, inserees dans I'appendice 
auriculaire droit. Les seuils initials 
etaient faibles (moyenne, 1.3 mA) et 
le voltage de I'onde P adequat (3.4 mV) 
pour les stimulateurs cardiaques de 
sensibilite normale. Pour les deux series, 
des unites classiques a inhibition R, 
asynchrones ou a rythme programmable, 
ont ete utilisees.
Des stimulateurs a auto-conversion 
de frequence radio ont ete utilises 
chez trois patients. Des etudes 
preliminaires du faisceau de His 
ont ete realisees chez 10 patients; les 
autres ont eu une verification par 
stimulation auriculaire rapide durant 
I’insertion des electrodes. Dans le deux 
series, la stability precoce et retardee 
des electrodes a ete excellente; 
une electrode s’est delogee de sa 
position dans le sinus coronaire et une 
de I'appendice auriculaire droit.
Atrial pacing has significant hemody­
namic and electrophysiologic advantages 
over ventricular pacing. Direct stimula­
tion of the atrium ensures atrioventri­
cular synchrony, normal depolarization 
of the ventricle and suppression of 
ectopic rhythms. The reduced need for 
oxygen, regular ventricular filling and 
resultant increase in cardiac output 
may be important to patients with an 
ischemic or poorly contractile myo­
cardium.1 Direct atrial pacing is ideal 
for symptomatic atrial bradyarrhythmias 
and for overdrive suppression of re­
current ventricular irritability.
Permanent atrial pacing has been 
accomplished at thoracotomy by means 
of electrodes sutured or clipped on the 
epicardium, by the retrocardiac ap­
plication of electrodes through medi­
astinoscopy and by the transvenous 
endocardial route using trans-septal 
barbed leads, coronary sinus catheters, 
or atrial leads with wire hooks, nylon 
barbs or preformed curves.
This report concerns 29 patients 
paced for up to 7 years by atrial 
catheters in either the coronary sinus 
or the right atrial appendage.
Clinical Material
Sixteen patients (group 1) were 
managed at the Sunnybrook Medical 
Centre and 13 (group 2) at the Toronto 
General Hospital. Their ages ranged 
from 44 to 85 years (mean, 66.6 
years) and they were paced for a total 
of 589.5 pacer months (mean, 30.7 
months at Sunnybrook Medical Centre 
and 7.5 months at Toronto General 
Hospital). The indications for cardiac 
pacing are listed in Table I. Sinus-node 
dysfunction was present in 21 patients 
and was manifest as a variety of symp­
tomatic bradyarrhythmias. Of interest 
are two patients with marked sinus 
bradycardia in whom atrial pacing was 
used as an adjunct to high doses of 
propranolol for severe angina pectoris; 
both had inoperable coronary artery 
disease demonstrated by angiography.
Four patients were paced for tachy­
arrhythmias—recurrent ventricular ta­
chycardia (two patients) and resistant 
paroxysmal atrial tachycardia (two pa-
Table 1—Indications for Atrial Pacing
Indication No. of patients
Sinus-node dysfunction 21
Bradycardia-tachycardia 7
Sinus bradycardia 5
Sinoatrial arrest 4
Junctional bradycardia 2
Slow atrial fibrillation 1
Sinus bradycardia —>
ventricular tachycardia 2
Sinus bradycardia
(propranolol) 2
Resistant paroxysmal atrial
tachycardia 2
Refractory ventricular
tachycardia 2
Complete heart block 2
Total 29
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T a b le I I — E lectrodes U sed  in  S e rie s
No. of N o . o f
C o ro n a ry  s in u s p a tie n ts A t r ia l  a p p e n d ag e p a tie n ts
M e d tro n ic *  b ip o la r 8 M e d tro n ic  u n ip o la r  t in e d 7
( la te r  u n ip o la r , 4 ) A m e ric a n  O p t ic a l!  b ip o la r 6
“ H y b rid ”  b ip o la r 3 (a s  u n ip o la r , 4 )
C o rd is f u n ip o la r  (2  m m ) 
C ord is  u n ip o la r  “ p ig ta i l”
2
3
’ M e d tro n ic  In c ., M is s is s a u g a , O n t.
(C o rd is  C o rp o ra t io n , M ia m i, FL. 
^ A m e ric a n  O p tic a l C o rp ., B e d fo rd , M A .
tients). Three of these were supplied 
with radiofrequency, self-conversion 
units for rapid atrial stimulation.3 Two 
patients with complete heart block and
FIG. 1— Lateral chest roentgenogram 
showing Cordis unipolar electrode in coro­
nary sinus position for permanent atrial 
pacing.
mitral valve prolapse had atrial-syn­
chronous ventricular pacing units in­
troduced using atrial-sensing catheters 
(one coronary sinus, one atrial J-lead) 
and a pervenous ventricular pacing 
electrode.
The electrodes used in this series are 
listed in Table II. The preferred coro­
nary sinus catheter is now the Cordis 
unipolar “pigtail” catheter (Cordis 
Corporation, Miami, FL) that applies 
cathodal stimulation near the coronary 
sinus orifice. The Medtronic unipolar 
pliant tined J-electrode (Medtronic Inc., 
Mississauga, Ont.) is the preferred 
catheter for right atrial appendage fixa­
tion.3 Figs. 1 and 2 show a unipolar 
and a bipolar J-electrode in position 
for permanent atrial pacing.
The types of pulse generators con­
nected to these atrial electrodes are 
listed in Table III. In group 1 pre­
dominant use was made of the asyn­
chronous pacing mode. In group 2 rate- 
programmable pulse generators were 
the type mainly employed.
Results, Follow-up and
Complications
The initial threshold for stimulation 
in the coronary sinus position ranged 
from 1.0 to 4.5 mA (mean, 2.2 mA) at 
the time of implantation. There was no 
significant difference in the chronic 
thresholds observed at the time of 
battery-pack replacement. Initial thresh­
olds with the J-electrodes were similar­
ly satisfactory and ranged from 0.5 to 
2.5 V (mean, 0.82 V), and from 0.8
to 5.0 mA (mean, 1.7 mA). P-wave 
voltage was surprisingly consistent and 
averaged 3.12 mV, with a range of 0.8 
to 4.9 mV, allowing the use of con­
ventional demand pacemakers with a 
1.0-mV sensitivity.
The problems encountered during 
long-term pervenous atrial pacing are 
listed in Table IV. Three patients with 
coronary sinus electrodes and demand 
units experienced refractory period 
bradycardia, that is, a lowering of the 
expected pacemaker rate because of 
inhibition by retrograde conduction and 
sensing of the R-wave from atrially 
paced beats, with subsequent pacer re­
cycling.4 These units were converted to 
the asynchronous mode. Pacemakers 
currently available have a sufficiently 
long refractory period to avoid this 
problem. In one patient atrioventricular 
block occurred after 10 months of 
coronary sinus pacing and required 
conversion to ventricular pacing. One 
coronary sinus electrode slipped into 
the ventricular cavity and continued to 
provide satisfactory ventricular pacing. 
In one patient a bipolar J-electrode be­
came dislocated into the right ventricle 
and required repositioning at 1 month, 
again 3 months later and for the third 
time after another month. Three pa­
tients, one with coronary sinus and two 
with atrial J-catheters, experienced 
temporary catheter instability, with 
inadequate sensing and occasional 
premature atrial contractions. However,
T a b le  IV — P ro b le m s  E n c o u n te re d  D u r in g  
L o n g -T e rm  (5 8 9 .5  P a t ie n t -M o n th s )  A t r ia l  
P a c in g  in  29 P a t ie n ts
C o m p lic a tio n N o . o f  p a t ie n ts
C a th e te r  d is lo d g e m e n t 2
C a th e te r  in s ta b i l i t y 3
A t r io v e n t r ic u la r  b lo ck 1
H ig h  th re s h o ld 1
R e fr a c to ry  p e r io d  
b ra d y c a rd ia 3
P e r fo ra t io n 0
T h ro m b o s is 0
C o ro n a ry  s in u s  o b s tru c t io n 0
P a c e m a k e r - re la te d  d e a th s 0
T o ta l 10
FIG. 2— Lateral chest roentgenogram 
showing American Optical bipolar J-elec­
trode in right atrial appendage for per­
manent atrial pacing.
T a b le  I I I — P u ls e  G e n e ra to rs  U s e d *
C o ro n a ry  s in u s
N o . o f  
p a tie n ts A t r ia l  a p p e n d a g e
N o . o f  
p a t ie n ts
A s y n c h ro n o u s 4 D em a n d 2
P ro g ra m m a b le  a s y n c h ro n o u s 12 H ig h  s e n s i t iv i t y  d e m a n d 1
D em a n d 7 P ro g ra m m a b le  d e m a n d 6
P -tr ig g e re d 2 P -tr ig g e re d 1
— R a d io fre q u e n c y  ra p id  a t r ia l
s t im u la t io n  u n its 3
25 —
13
’ In c lu d e s  re p la c e m e n ts .
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in each instance the catheter became 
fixed in place spontaneously and did 
not require repositioning. One other 
patient with an atrial J-electrode had 
an early increase of the initial thresh­
old value within the first month after 
implantation that required a higher 
current output program before capture 
was ultimately achieved.
There were no pacemaker-related 
deaths although five patients in 
whom coronary sinus catheters were 
inserted died over the 7 years. The 
first patient in whom a J-electrode was 
inserted for sinus-node dysfunction in 
1976 was a long-distance runner with 
some early electrode instability. He died 
suddenly after a long run, 10 months 
after insertion of the electrode. A 
coroner’s report stated that cardiac ar­
rest was due to massive myocardial in­
farction; the atrial J-electrode was 
firmly in position. Autopsies performed 
on two patients who had coronary sinus 
electrodes showed endothelialization 
but no thrombus formation in the coro­
nary sinus vein. There was no evidence 
of thrombosis or perforation in either 
the coronary sinus or right atrial ap­
pendage.
In two patients, one with a coronary 
sinus and the other with an atrial ap­
pendage J-electrode, atrial-synchronous 
ventricular pacing was established using 
an Omni-atricor pulse generator (Cor­
dis Corporation, Miami, FL). In both 
patients symptoms of low cardiac out­
put disappeared.
In three patients with radiofrequency 
self-conversion units in situ, one with 
refractory ventricular tachycardia and 
two with refractory paroxysmal atrial 
tachycardia, no difficulties were en­
countered when the patient used the 
self-conversion rapid atrial stimulating 
device.
Discussion
Permanent transvenous ventricular 
pacing is universally accepted and 
widely applied. However, astute ob­
servers have noted that, although ven­
tricular pacing may alleviate syncope, 
it does not produce good cardiac re­
habilitation, and a significant number 
of patients still require digitalis and 
diuretics and complain of postural 
dizziness, exertional fatigue, or dys­
pnea. These symptoms are usually at­
tributed to old age and a poor myo­
cardium. However, ventricular pacing 
results in irregular filling and output, 
aggravates mitral insufficiency and 
produces inappropriate mitral valve 
closure. Retrograde conduction may 
produce re-entry tachycardias and 
worsen atrial tachyarrhythmias in the 
sick sinus syndrome.5'6 Furthermore, 
ventricular pacing has been shown to 
increase myocardial oxygen require­
ments and aggravate angina in some 
ischemic patients. The advantages of 
atrial and related modes of pacing are 
the preservation of atrioventricular 
synchrony, normal ventricular depola­
rization and the suppression of ectopic 
rhythms in both atrium and ventricle. 
These benefits can result in improved 
cardiac output, reduction of congestive 
failure and ischemic pain, increased 
tolerance to propranolol, regular ven­
tricular filling and prevention of re­
entry arrhythmias and retrograde con­
duction. Despite these advantages, less 
than 1% of pacemakers with this 
capability have been implanted.7 The 
failure to appreciate and to utilize more 
fully the potential benefits of atrial 
stimulation and related modes of pac­
ing is largely a result of difficulties in 
the past of obtaining secure position­
ing of atrial electrodes. When faced 
with the choice of atrial pacing achieved 
at thoracotomy and ventricular pacing 
by the transvenous route, surgeons have 
almost always selected the latter.
Some of the disadvantages ascribed 
to permanent transvenous atrial pacing 
have been difficulty in achieving elec­
trode access, dependence on unreliable 
or unstable endocardial electrodes, dif­
ficulty in establishing adequate initial 
pacing or sensing thresholds, the late 
loss of atrial sensing capacity and the 
occasional need to enhance the sensi­
tivity of existing pulse generators. The 
physiologic limitation of atrial pacing is 
the loss of patient protection when 
atrioventricular conduction block oc­
curs, or when the atrial stimulation 
threshold becomes markedly elevated. 
However, our experience confirms other 
recent reports that initial and chronic 
sensing and pacing thresholds from 
both the coronary sinus and right atrial 
appendage positions are not only ade­
quate but assure security of long-term 
pacing.4’6
However, indications for atrial pac­
ing are not universally defined and 
many are not even accepted. The selec­
tion of appropriate subjects often re­
quires a preliminary His bundle study 
(only 10 patients in our series 
had intracavitary conduction studies). 
At Sunnybrook Medical Centre each 
patient was paced by a temporary 
catheter in the coronary sinus for 24- 
hours before implantation of a per­
manent device. At Toronto General 
Hospital, suitable subjects had atrial 
tachypacing on the operating table to 
120 beats per minute. If no evidence 
of bifasicular block, prolongation of 
P-R interval beyond 0.24 milliseconds, 
dropped beats, or anginal pain ensued, 
then it was assumed that distal con­
duction was adequate and atrial pacing 
appropriate.
The presence or delayed onset of 
intermittent or partial atrioventricular
block and the late development of 
atrial flutter-fibrillation may be factors 
limiting atrial pacing. In some clinical 
instances atrial pacing is simply an 
alternative to ventricular pacing. In 
others, however, atrial pacing is dis­
tinctly to be preferred, as in the sick 
sinus syndrome, which is unresponsive 
to drugs or ventricular pacing, or both, 
and when there is suppression of ven­
tricular irritability by overriding con­
ducted atrial rhythms.6 More wide­
spread application of atrial-synchronous 
ventricular pacing or atrioventricular 
sequential pacing is indicated in con­
genital or surgical heart block in 
younger patients, or in heart block 
associated with congestive failure de­
spite ventricular pacing.6 Bifocal pacing 
and the current use of radiofrequency 
self-conversion demand units make 
possible the surgical management of a 
wider variety of cardiac dysrhyth­
mias.1’2'10
The experience gained at this univer­
sity of endocardial atrial and atrial- 
synchronous ventricular stimulation 
using coronary sinus or right atrial ap­
pendage J-electrodes, or both, has been 
highly valuable and we believe further 
exploration of this mode of cardiac 
pacing should be encouraged.
We are grateful to Barouh V. Berkovits, 
D.Eng., for his stimulation and continued 
assistance in the field of atrial and bifocal 
pacing.
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Clinical Application of Doppler Ultrasonography 
in the Thoracic Outlet Syndrome*
Z. Adam Pisko-Dubienski, frcsi, frcs( edin), frcs[cJ1' and John H ollingsworth, mdJ
Difficulties in diagnosing the thoracic 
outlet syndrome prompted a pilot 
study of noninvasive Doppler ultra­
sonography in 160 thoracic outlets of 
healthy volunteers. Encouraged by the 
results we applied the technique to 
the clinical evaluation of flow 
disturbances during various provocative 
maneuvers. Ninety-four thoracic outlets 
were examined; of these, 32 were 
operated upon. Severe flow occlusion 
which was detected by Doppler 
ultrasonography reproduced symptoms 
of which the patients had originally 
complained. All patients were relieved 
of their symptoms, and only five had 
minor flow disturbances after resection 
of the first rib and scalenotomy. 
Resection of cervical ribs was carried 
out in seven of nine patients with this 
anomaly.
Doppler ultrasonography was found 
to be a most valuable diagnostic 
modality and its wider application in 
this field is recommended.
Les difficultes que pose le diagnostic 
du syndrome du scalene anterieur ont 
incite a realiser une etude pilote de 
I'ultrasonographie non envahissante de 
Doppler dans 1’evaluation de 160 canaux 
thoraciques chez des volontaires sains. 
Encourages par les resultats obtenus, 
nous avons applique cette technique a 
(’evaluation clinique des dereglements 
de la circulation durant diverses 
manipulations. Quatre-vingt-quatorze 
canaux thoraciques ont ete examines; 
de ceux-ci, 32 ont ete operes. Une 
occlusion severe de la circulation decelee 
a I’ultrasonographie de Doppler a 
reproduit les symptomes dont s’etaient 
plaints les patients initialement.
Tous les patients ont ete soulages de
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leurs symptomes et seulement cinq 
montraient des derangements faibles 
de la circulation apres resection de 
la premiere cote et scalenotomie. La 
resection des cotes cervicales a ete 
effectuee chez sept des neuf patients 
souffrant de cette anomalie.
L'ultrasonographie de Doppler s’est 
averee un outil de diagnostic des plus 
utiles et son application plus 
repandue dans ce domaine est 
recommandee.
Much information has accumulated 
about the thoracic outlet syndrome 
(TOS) since the first recorded reference 
to it by Hunald in 1743.' The syndrome 
now encompasses costoclavicular com­
pression,2 the cervical rib syndrome,3 
the scalenus anticus (Adson’s) syn­
drome,4 the hyperabduction syndrome5 
and the Paget-Schroetter syndrome.8 
Thoracic outlet disorders are also 
known to be associated with Raynaud’s 
phenomenon,7 with subclavian steal 
syndrome,8 with whiplash injuries9 and 
even with tetany of the hands.10 These 
disorders can cause dilatation, aneur­
ysm" and thromboembolism of the sub­
clavian vessels and can mimic at least 
16 other conditions, such as cervical 
spondylosis, superior sulcus tumour 
(Pancoast’s syndrome) and metastatic 
disease of the spinal cord. No wonder 
Naffziger and Grant12 were impelled to 
state: “The bizarre symptoms and
insidious onset render early diagnosis 
difficult as does the fact that objective 
signs may appear rather late.” The 
clinician’s difficulties are compounded 
by the lack of satisfactory diagnostic 
tests. Palpation and the use of conven­
tional pressure cuffs to monitor pulse 
changes during various maneuvers are 
gross techniques to say the least. It is a 
known fact that the pulse disappears at 
a pressure of 70 mm Hg while con­
tinued flow can be demonstrated by 
the Doppler flow detectors to a pres­
sure as low as 20 mm Hg. Measure­
ment of conduction velocity of the 
ulnar nerve, introduced by Caldwell, 
Crane and Krusen in 1971,13 has a 
great deal of merit but many limitations. 
Angiography should be restricted to 
cases where strong suspicion of vascu­
lar complications exists.
The accessibility of subclavian and 
axillary vessels to Doppler ultrasound 
probes prompted a pilot study in which 
160 thoracic outlets of 80 randomly 
selected healthy adults (41 men, 39 
women) under the age of 40 years were 
examined. This paper is presented in 
two parts, one part dealing with the 
feasibility study designed to evaluate 
the usefulness of Doppler ultrasono­
graphy in the detection and measure­
ment of vascular flow at the thoracic 
outlet, and the other detailing its 
clinical application in the pre- and post­
operative assessment of patients.
The Pilot Study
Instruments and M ethod
The instruments employed were a 
Med Sonics Versatone bidirectional 
Doppler model D9 with P92 and P84 
probes (Med Sonics, Mountain View, 
CA), a Med Sonics Doppler stethoscope 
calibrated to 5.3 mHz, a chart recorder 
and occasionally a Parks Electronics 
directional Doppler model 806 (Parks 
Electronics, Beaverton, OR). Either one 
or two scanning points were selected, 
one below the midpoint of the clavicle, 
the other 2.5 cm above the medial epi- 
condyle of the humerus. In each case 
the point chosen was directly over the 
vessel under study (Fig. 1). Arterial 
and venous blood flows were examined 
in six different postures: at rest, on 
deep inspiration, in the exaggerated 
military position, on abduction to 90°, 
in hyperabduction and during Adson’s 
maneuver. It was observed quite early 
in the study that arterial flow dis­
turbances occurred frequently by the 
time the arm was abducted to 90°. For 
this reason scanning was conducted 
both in abduction and hyperabduction. 
It should be mentioned that arterial and 
venous flows sound totally dissimilar 
on Doppler studies. Different flow 
velocities have flow signals in different 
frequency ranges, which, once heard, 
are never forgotten (like the bark of 
one’s own dog). The patient’s age, sex, 
occupation and whether the patient had 
a history of related symptoms and signs 
or presented any unusual findings, were 
recorded. Note was made of the point
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PROBE ON RT. SUBCL. ART. OVER 1st RIB WITH
SHOULDER SAGGING. EQUIVALENT POSITION ON LEFT.
FIG. 1— Doppler pencil probe shown over subclavian artery below clavicle. Flat probe over brachial artery. For graphic 
record-taking flat probe is more convenient. Top left: notching produced by partial compression of artery between clavicle and first 
rib in resting position. Top right: normal flow in contralateral artery in resting position. Bottom: total arrest of flow in exaggerated 
military position.
of onset of turbulence (bruits), the ap­
pearance of Korotkoff sounds, and the 
point of disappearance of pulses and of 
flow signals.
Results
In the 160 outlets studied, the exag­
gerated military position evoked flow 
disturbances in 21, and symptoms were 
provoked in 14 instances. Abduction 
to 90° caused arterial compression at 
15 outlets, and symptoms in 10 in­
stances. Hyperabduction precipitated 
turbulence 31 times and provoked 
symptoms on 15 occasions. In seven 
cases Adson’s maneuver caused signi­
ficant turbulence; in six of these it re­
produced symptoms of which the 
subjects had been previously vaguely 
aware. Unexpected bruits were found 
at rest in four volunteers, two of whom 
admitted to a definite history of symp­
toms. No aneurysms or dilatations were 
found. Another interesting observation 
was the total cessation of venous re­
turn in the subclavian vein on deep in­
spiration, noted in the case of all but 
six (3.7%) of the outlets (Fig. 2). Bear­
ing this information in mind and con­
sidering that most venograms are taken 
during deep inspiration, physicians 
perhaps ought to re-examine many 
existing venograms.
Since the results of the pilot study 
indicated that the Doppler modality 
might be useful in a clinical setting, it 
was applied to the clinical evaluation 
of 47 patients all of whom were re­
ferred with either a suspicion or a tenta­
tive diagnosis of TOS.
Clinical Evaluation
Patients and Methods
Using the above protocol we studied 
47 patients, 16 of whom were men. 
Nineteen of these (six men) underwent 
a total of 32 operations, which included 
anterior scalenotomy, resection of the 
first rib, division of fibrous bands and 
excision of seven (of nine) cervical ribs 
(the two left in situ were vestigial rudi­
ments that were buried deep in the 
muscle mass and could not possibly 
have caused any symptoms).
A history of possibly related acci­
dents was elicited from 17 patients; 
10 had suffered falls, 7 had suffered 
whiplash injuries and 4 had sustained 
ipsilateral upper rib fractures. Another 
interesting observation was related to 
age distribution. Patients aged 20 to 30 
years were generally muscular, athletic 
and at times obese individuals with well- 
developed musculature of the pectoral 
girdle. Those over 40 years of age 
were typically frail, often debilitated, or 
grossly unfit with obviously drooping 
shoulders.
Predominant symptoms were pain, 
numbness, paresthesia and muscle 
weakness (Table I). In four of the pa­
tients complaining of anterior chest 
pain, angina pectoris had been diag­
nosed and treated, in two instances for 
over 2 years. Excessive muscularity 
was noted in four young adults whereas 
muscle wasting in the hands occurred 
in three patients. A further three pa­
tients had Raynaud’s phenomenon in 
their hands. No aneurysms were en­
countered in this series, but poststeno­
tic dilatation of the subclavian artery 
was observed three times. Two patients 
complained of hyperesthesia over the 
brachial plexus. Unfortunately this was 
first observed towards the end of the 
series and had not been sought 
earlier; consequently no valid state­
ment can be made regarding its inci­
dence beyond that it does occur and 
should be looked for.
Arterial flow disturbances as demon­
strated by Doppler flow detectors oc­
curred most frequently on hyperabduc­
tion and on costoclavicular compression 
(Table II). Subclavian-axillary vein 
thrombosis of effort, the Paget-Schro- 
etter syndrome, was diagnosed three 
times. Doppler flow detectors accurate­
ly located the extent of thrombosis to 
within a few millimetres. Calibrated as 
they are, commercially available Dop­
pler instruments pick up venous flow 
signals provided the flow velocity is in
Table ^ P re s e n tin g  Symptoms in the Tho­
racic Outlet Syndrome (94 Outlets in 47 
Patients)
Symptom No. of instances
Pain 30
Numbness 25
Paresthesia 23
Muscle weakness 14
Anterior chest pain* 7
Sympathetic overactivity 5
Burning sensation 3
Anesthesia 2
•Angina pectoris was recorded in 4 instances.
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FIG. 2— (a) Arrest of venous return on deep inspiration found in 96.3%  of patients in pilot study. Transient obstruction 
is caused by first rib riding up to clavicle, compressing vein against it. This is artefact and should not be confused with deep vein 
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excess of 4 cm /s. Venous flow  signals 
are in a low frequency range whose 
peak is between 3 and 4 kHz. They 
sound somewhat like a wind storm and 
are often phased with respiration. Com­
pression of the limb below the point of 
auscultation increases the venous flow 
velocity and as a result raises the fre­
quency pitch. This maneuver is known 
as augmentation and adds much in­
formation on the nature of the venous 
flow.
Symptoms were o f sufficient severity 
to cause sleep disturbance in 14 pa­
tients, disruption o f working time in 11 
and interference with driving in 11. 
These disabilities occurred singly or in 
combination and formed the basis for 
selection for surgery. This group in­
cluded nurses, waitresses, housewives.
Table II— Positive Provocative Tests Occur­
ring Singly or in Combination in 94 Outlets 
Studied
Test
No. of outlets 
giving positive 
result
Costoclavicular compression 47
Abduction to 90° 21
Hyperabduction 51
Scalenus anticus (Adson's) 
syndrome 7
Paget-Schroetter syndrome 3
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teachers, policemen, barbers, nursing 
mothers, labourers and a choirmaster. 
All were incapacitated to a significant 
degree in their respective activities.
The factor common to all com po­
nents o f the TOS is the first rib. It acts 
either by direct compression or like one 
limb in a scissors, shearing the neuro­
vascular bundle against the clavicle. In 
Adson’s syndrome it acts as a mooring 
point for the scalenus anterior muscle. 
The removal o f the first rib and the 
attendant scalenotomy have been cura­
tive in all cases in this series. When 
cervical ribs are removed as the pri­
mary procedure, the first rib is excised 
routinely as well. In addition a careful 
search should be made for fibrous 
bands traversing the apical space.
Although there are five approaches 
to the first rib, the axillary approach as 
described by Roos7 was used exclusively 
in this series. After puncture o f the 
axillary fascia with a scalpel the re­
mainder o f the exposure was achieved 
by two-finger blunt dissection. This 
avoids injury to the intercostobrachial 
nerve, which traverses the apex o f the 
axilla and becomes vulnerable at this 
stage o f the operation. The neurovascu­
lar bundle was retracted as gently as 
possible. The first rib was identified by 
the scalene tubercle and the attachment 
o f the scalenus anterior muscle. The 
periosteum was elevated and the rib
was detached from  Sibson’s fascia. 
Puncture o f the pleura at this point (as 
happened on seven occasions) was o f 
no real consequence as at the time of 
closure the lung was fully inflated and 
a Hemovac drain aspirated any free 
air. Great care was taken to keep close 
to the first rib when performing scale­
notomy lest the phrenic nerve be in­
jured. The rib was freed fore and aft 
and divided with one clean bite o f  the 
costotome. Rongeurs were not used as 
they are apt to leave ragged edges which 
can result in shooting pains during the 
postoperative period. Starting at the 
posterior angle o f the rib approximately 
two thirds was removed. Excessive re­
section anteriorly may leave a mobile 
and cosmetically disfiguring stump.
Results
Postoperative results were extremely 
gratifying. All patients were relieved o f 
their symptoms. Doppler flow  studies 
showed minor disturbances in only five 
patients and in none was the flow  obli­
terated, even with the use o f provoca­
tive tests in extreme positions. Minor 
aches and patchy paresthesias were 
transient. One patient suffered a stretch 
injury to the ulnar and median nerves, 
which has persisted for almost a year. 
In another patient the first root o f the 
brachial plexus was similarly injured, 
but progressive recovery is taking place.
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Calcimar
(calcitonin-salmon)
The patient shown was once 
a paraplegic due to Paget’s 
Disease of the vertebral 
column. Treatment with 
CALCIMAR now enables 
him to rise from a chair 
and walk unassisted.
Clinical comments on reduction of 
bone pain
“ Bone pain is generally improved or com­
pletely relieved within several weeks of 
instituting treatment, although this has not 
yet been studied in a double-blind 
manner.” 1
“ ...25 patients had prominent skeletal or 
radicular pain, and 21 of them (84 per 
cent) had significant relief of pain assoc­
iated with increased exercise tolerance 
and partial to complete return to normal 
activity.” 2
“ Bone pain caused directly by Paget’s 
disease was ameliorated in 12 of 13 
patients, but pain resulting from skeletal 
deformity or mechanical stress was not 
alleviated.” 3 (from abstract.)
A c lin ic ian ’s comment on improved 
patient m obility
“ Among the most dramatic improve­
ments is the relief of spinal cord impinge­
ment, with restoration to full ambulation,
which in one series occurred in three of 
four patients with pure spinal cord 
involvement.” 4
A clinician’s comment on improvement 
in neurologic function 
“ Neurologic deficits other than auditory 
were found in 28 patients(57 per cent)... 
Twenty-one of these 28 patients (75 per 
cent) showed significant subjective or 
objective improvement during calcitonin 
treatment.” 2
The facts about bone deformity and 
pathologic fractures 
There is no long-term evidence that bone 
deformity or pathologic fractures will be 
forestalled with the use of CALCIMAR 
(calcitonin-salmon) therapy, however, 
there are numerous cases of improved 
bone structure with the use of 
CALCIMAR therapy.
CALCIMAR (calcitonin-salmon) therapy 
generally produces an immediate fall in 
urinary hydroxyproline levels, an indica­
tion that the drug limits bone-destroying 
osteoclastic activity. Serum alkaline
phosphatase levels will usually decrease 
after one to two weeks of CALCIMAR 
therapy, an indication that bone-forming 
osteoblastic activity has slowed. 
C lin icians’ comments on laboratory 
parameters
“ With chronic treatment an approx­
imately 50% decrease is usually noted 
in urinary hydroxyproline excretion and 
serum alkaline phosphatase activity. If 
these biochemical parameters are 
greater than twice normal before 
treatment, they usually are not suppres­
sed to normal.” 1 
“ During the first 4 to 8 months of 
treatment with either PCT or SCT 
(porcine calcitonin or synthetic salmon 
calcitonin), there is a good correlation 
between the clinical response and the 
changes in serum alkaline phosphatase 
and urinary hydroxyproline values.” 2 
“ Administration of salmon calcitonin to 
patients with Paget’s disease decreases 
bone turnover without affecting calcium 
and phosphorus balances.” 5
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“Calcimar'
(calcitonin-salmon)
DESCRIPTION
The active ingredient of CALCIMAR is a 
synthetic calcitonin consisting of 32 amino 
acids in the same linear sequence as that 
found in salmon calcitonin. It is a white or 
slightly yellowish powder. It is provided in 
sterile lyophilized form and its calcitonin 
activity is stated in International Units. 
Equivalency of M.R.C. and I.U.:
An International Unit for Calcitonin, salmon, 
is defined as the activity contained in
0. 02525.mg of the International Reference 
Preparation of Calcitonin, salmon, for 
BioassayO).
By agreement, the International Unit is 
identical to the pre-existing Medical Research 
Council (MRC) unit.
ACTIONS
CALCIMAR participates in the regulation of 
the homeostasis of calcium by acting primar­
ily on the bone. In Paget’s disease the rate 
of bone turnover appears to be decreased, 
presumably by an initial blocking effect on 
accelerated bone resorption.
CALCIMAR participates in the regulation of 
urinary excretion of phosphate and calcium. 
Administration of CALCIMAR decreases the 
volume and acidity of the gastric juice and 
decreases the volume as well as trypsin and 
amylase content of the pancreatic juice.
(For further details see clinical pharma­
cology section in the product monograph) 
INDICATION
Treatment of symptomatic Paget's disease of 
the bone.
CONTRAINDICATIONS
Known hypersensitivity to salmon calcitonin or 
its gelatin diluent.
WARNINGS
1. Pregnancy:
Reproduction studies in two species (rats 
and rabbits) have revealed decreases in 
fetal birth weight, and data in humans are 
not available to exclude a possible adverse 
effect on the fetus. Use of this drug in 
women who are or may become pregnant 
requires a determination that the potential 
benefit to the patient outweighs the possi­
bility of risk to the fetus.
2. Nursing Mothers:
CALCIMAR has been shown to inhibit lac­
tation in animals and should not be admin­
istered to nursing mothers.
3. Children:
The safety of the use of CALCIMAR in 
children has not been established. 
PRECAUTIONS
1. Potential allergenicity o f CALCIMAR 
and gelatin diluent:
Skin testing should be considered prior to 
treatment of patients with suspected sensi­
tivities to calcitonin or to gelatin. The follow­
ing procedure is suggested: Reconstitute 
CALCIMAR at a concentration of 200 I.U. per 
ml with CALCIMAR Diluent. Prepare a dilu­
tion of 10 I.U. per ml by withdrawing 1/20 ml 
(0.05 ml) of the reconstituted CALCIMAR in 
a tuberculin syringe and filling it to 1.0 ml 
with Dextrose Injection 5%, U.S.P. (or Saline 
Injection, U.S.P.). Mix well, discard 0.9 ml 
and inject intracutaneously 0.1 ml (approx­
imately 1 I.U.) on the inner aspect of the 
forearm. Observe the injection site 15
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minutes after injection. The appearance of 
more than mild erythema or wheal const­
itutes a positive response.
Because calcitonin and gelatin (diluent) 
are protein in nature, the posibility of a sys­
tematic allergic reaction cannot be over­
looked. The usual provisions should be made 
for the emergency treatment of such a reac­
tion should it occur.
2. Possibility of hypocaicemic tetany:
The administration of calcitonin possibly could 
lead to hypocaicemic tetany under special 
circumstances although no cases have yet 
been reported. Provisions for parenteral cal­
cium administration should be available dur­
ing the first several administrations of 
calcitonin.
3. Laboratory Tests:
Periodic examinations of urine sediment of 
patients on chronic therapy are recom­
mended.
Coarse granular casts and casts contain­
ing renal tubular epithelial cells were report­
ed in young adult volunteers at bed rest 
who were given salmon calcitonin to study 
the effect on immobilization osteoporosis. 
There was no other evidence of renal abnor­
mality and the urine sediment became 
normal after calcitonin was stopped. Urine 
sediment abnormalities have not been re­
ported by other investigators.
4. Instructions for the patient:
Careful instruction in sterile injection tech­
nique should be given to the patient, and to 
other persons who may administer 
CALCIMAR.
5. Interactions with other drugs:
At the present time there are no known 
interactions with other drugs.
ADVERSE REACTIONS
Nausea with or without vomiting has been 
noted in about 10% of patients treated with 
CALCIMAR. It is most evident when treat­
ment is first initiated and tends top decrease 
or disappear with continued administration.
Local inflammatory reactions at the site of 
injection have been reported in about 10% 
of patients.
Facial flushing occurred in about 2% of 
patients.
Other systemic effects included anorexia, 
a metallic taste and tingling of the hands.
These effects usually occurred early in the 
treatment and tended to diminish with con­
tinued therapy.
The usual laboratory parameters of liver 
and kidney function and of hematologic 
status remained within normal limits. Evi­
dence of systemic allergic reactions was 
minimal and no anaphylactic reactions were 
seen. In approximately one-half the patients 
tested after six months or more of treatment, 
indications of circulating antibodies to calci­
tonin were obtained. In most of the patients 
the level of antibodies was not high enough 
to interfere with the effect of exogenous cal­
citonin. In a few patients resistance to calci­
tonin was attributed to high levels of anti­
bodies. Secondary hyperparathyroidism did 
not develop in patients with Paget’s disease 
as a result of the transient hypocalcemia 
following a calcitonin administration.
DOSAGE AND ADMINISTRATION 
Adults:
The recommended starting dose of CAL­
CIMAR in Paget’s disease is 100 International 
Units per day administered subcutaneously 
(preferred for out-patient self-administration) 
or intramuscularly. Drug effect should be 
monitored by periodic measurement of serum 
alkaline phosphatase and 24-hour urinary 
hydroxyproline (if available) and evaluation of 
symptoms. A decrease toward normal of the 
biochemical abnormalities is usually seen, if 
it is going to occur, within the first few months. 
Bone pain may also decrease during that 
time. Improvement of neurologic lesions, 
when it occurs, requires a longer period of 
treatment, often more than one year.
In many patients doses of 50 International 
Units per day or every-other-day are suffic­
ient to maintain biochemical and clinical im­
provement. At the present time, however, 
there are insufficient data to determine 
whether this reduced dose will have the same 
effect as the higher dose on forming more 
normal bone structure. It appears preferable, 
therefore, to maintain the higher dose in any 
patient with serious deformity or neurological 
involvement.
In any patient with a good response initially 
who later relapses, either clinically or bio­
chemically, the possibility of antibody forma­
tion should be explored. Although specialized 
tests for antibody titer are not widely avail­
able, the following test will detect titers that 
interfere with the action of calcitonin:
After overnight fasting, a sample of the 
patient’s blood is taken for determination 
of serum calcium and 100 International 
Units of CALCIMAR are injected IM. The 
patient is then permitted to eat his usual 
breakfast. At 3 and 6 hours post-injection 
additional blood samples are drawn and 
the patient is released. The serum calcium 
values are then compared. A decrease of
0.5 mg % or more from fasting level at 
3 and 6 hours is usually seen in the re­
sponsive patient. Decreases of 0.3 mg % 
or less constitute an inadequate response 
to calcitonin in the patient with active 
Paget’s disease. If the hypocaicemic 
action of calcitonin is lost, further therapy 
with CALCIMAR will not be effective.
Patient compliance should also be assessed 
in the event of relapse. In patients who re­
lapse, whether because of antibodies or for 
unexplained reasons, a dosage increase be­
yond 100 International Units per day does 
not usually appear to elicit an improved 
response.
DOSAGE FORMS
CALCIMAR, Calcitonin, is available as a 
sterile, lyophilized powder, 400 International 
Units per vial, with 20 mg of hydrolyzed 
Gelatin. Each package contains one vial of 
CALCIMAR and one vial of CALCIMAR 
DILUENT (sterile 16% gelatin solution with
0. 5 .  phenol) 4 ml. (NOTE: 1 International Unit 
is equivalent to MRC unit).
RECONSTITUTION
For intramuscular or subcutaneous use: The 
contents of a vial of CALCIMAR are recon­
stituted with an appropriate volume of CALC­
IMAR DILUENT so that the final injection 
volume is approximately 0.5 ml. Solubiliza­
tion of CALCIMAR in the gelatin diluent re­
quires two or three minutes of gentle agita­
tion. After reconstitution, CALCIMAR in gela­
tin is stable for up to two weeks in the re­
frigerator.
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These injuries are attributed to retrac­
tion at operation. One patient had 
pseudotumour cerebri in the postoper­
ative period.* Early in the series one 
second rib was resected in error; a 
second operation was performed 1 week 
later. Not one instance of venous ob­
struction on deep inspiration was re­
corded after resection of the first rib. 
Postfixation of the brachial plexus was 
seen only once during the 32 opera­
tions; when it is present the lowest cord 
of the brachial plexus (T-2) becomes 
vulnerable both in this operation and 
in cervicodorsal sympathectomy and its 
existence should be borne in mind. 
Careful placement of the incision may 
account for absence of sepsis in this se­
ries. A 5- to 7-cm incision below the 
axillary hair line and not encroaching 
upon the axillary folds leaves an unob­
trusive scar.
Discussion
Involvement of nerves of the brachial 
plexus was cited in the past as the ma­
jor cause of symptoms in the TOS. In 
this modest series operative results 
based on flow evaluation by Doppler 
ultrasonography and on clinical assess­
ment suggest that arterial flow occlu­
sion plays an important if not a domi­
nant part in the symptomatology of this 
syndrome. Predominance of neurologic 
symptoms was observed in the presence 
of cervical ribs, in the scalenus anticus 
syndrome, in the one patient with post­
fixation of the brachial plexus and in 
the patients with a history of whiplash 
injury. Attempts at differentiating on 
clinical grounds between arterial com­
pression and primary nerve irritation 
proved fruitless as no distinct pattern 
emerged.
It is noteworthy that the patients fell 
into two distinct groups based on age. 
In the younger age group were healthy 
individuals in their 20s, some of whom 
indulged in calisthenics. These patients 
displayed uniformly excessive muscular 
development, which contributed to the 
narrowing of the thoracic outlet and 
thereby to the symptoms. Such persons 
cannot be expected to benefit from 
remedial exercises. In contrast, in the 
older age group muscle wasting was so 
advanced at times that, at operation, 
the first rib could be fully mobilized by 
finger dissection. In this age group 
atrophy of muscles of the pectoral gir­
dle must be considered as a precipitat­
ing cause of the TOS and, initially, 
shoulder strengthening exercises should 
be advocated rather than surgery. The
*She had previously received psychiatric 
treatment over a long period; the throm­
bosis of the lateral sinus could have re­
presented a recrudescence of a pre-exis­
tent condition.
latter can be resorted to if no improve­
ment occurs after physiotherapy con­
tinued for 6 months.
Poststenotic dilatation of the subcla­
vian artery results from compression by 
the scalene muscles, by a bulbous end 
of a cervical rib or by an exostosis of 
either the clavicle or a rib. When it is 
present it is usually in a patient in the 
younger age group.13 Subclavian aneur­
ysms, on the other hand, occur in the 
older patients, and one may speculate 
whether poststenotic dilatations become 
frank aneurysms with the passage of 
time.
Wright5 claims that in the hyperab­
duction syndrome obstruction of the 
subclavian artery is caused by the ten­
don of the pectoralis minor or by pro­
trusion of the head of the humerus into 
the axilla. Flow studies by Doppler ul­
trasonography in this condition indicate 
that no flow occurs beyond the first 
rib. Cessation of flow can be pinpointed 
with a high degree of accuracy, hence 
the great value of such investigations 
in locating an arterial embolus. It would 
therefore seem reasonable to surmise 
that the head of the humerus or, indeed, 
the tendon of the pectoralis minor acts 
as a lever causing compression of the 
artery against the first rib. Another 
factor in arterial obstruction during 
hyperabduction is inner rotation of the 
forward bulge of the medial third of 
the clavicle causing compression of the 
artery against the first rib.5 In any 
case, compression of the artery occurs 
at the level of the first rib, and not 
beyond. Arteriography confirms that 
compression, when it does occur, takes 
place at the point where the clavicle 
crosses the first rib. It is equally diffi­
cult to disregard the vise-like action 
between the first rib and the clavicle as 
a causative factor in axillary—subclavian 
vein thrombosis of effort, particularly 
since this condition is frequently asso­
ciated with prolonged, unaccustomed 
and peculiar activity. In Alberta this 
condition is still known as “haymaker’s 
arm” (Pow R: Personal communication, 
1976) and rightly so as the term reflects 
accurately the mechanism of repeated 
thoracic outlet compression, which also 
occurs in the painting of a wall or of 
a ceiling. Repeated scissor-like action 
of the two bones upon the vein or the 
artery can damage the intima and ini­
tiate thrombosis. Doppler flow detec­
tors can also be put to good use in this 
condition as they will diagnose throm­
bosis with great facility.
All the patients in this study were 
assessed pre- and postoperatively by 
Doppler ultrasonography. They have 
shown a uniform degree of improve­
ment, are free of their symptoms and 
have been able to return to their full 
activities and the enjoyment of an un­
interrupted night’s sleep. Resection of
the first rib and a scalenotomy abolished 
all but the most minor flow disturb­
ances even in extreme postures. Follow­
ing surgery not a single instance of 
venous flow obstruction on deep in­
spiration was recorded.
On the basis of our results we con­
clude that Doppler ultrasonography is a 
valuable new modality in the diagnosis 
and assessment of the TOS and we 
recommend its wider use in this con­
dition.
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Alterations in Red Cell Metabolism During and 
Following Cardiac Bypass Surgery*
Robert T. Card, md, frcp[c], Guy G. Lemire, md, frcs[c] and Baikunth Bharadwaj, md, frcs[c]
Reduced concentrations of red cell 
organic phosphates and increased 
hemoglobin-oxygen affinity have been 
reported during and following cardiac 
bypass surgery. Some have related 
these changes to low concentrations 
of ATP and 2,3-diphosphoglycerate 
(DPG) in stored blood while others 
have related them to use of the pump 
oxygenator. There was a 10% decrease 
in DPG concentration in seven dogs 
on cardiac bypass although the animals 
received no transfusions. In 16 patients 
who received 0 to 7 units of blood 
during cardiac bypass there was a 
decrease of 10% in the red cell DPG 
concentration from the preoperative 
value, but it did not relate to the con­
centration of DPG in the transfused 
blood bags. The magnitude of the 
decrease was not sufficient to impair 
oxygen delivery severely. The results 
suggest that a re-evaluation of indica­
tions for the use of fresh red cells in 
cardiac surgery is necessary.
line diminution des concentrations 
des phosphates organiques dans les 
hematies avec une augmentation de 
I’affinite hemoglobine-oxygene ont ete 
signalees durant et apres les operations 
de pontage cardiaque. Certains ont 
relie ces changements aux faibles 
concentrations d’ATP et de 2,3-diphos­
phoglycerate (DPG) dans le sang 
entrepose, alors que d'autres les ont 
relies a I 'utilisation de I’oxygenateur 
a pompe. II y a eu une baisse de 10% 
de la concentration en DPG chez sept 
chiens qui ont subit une operation de 
pontage, bien que ces animaux n'aient 
recu aucune transfusion. Chez 16 
patients qui ont recu de 0 a 7 unites 
de sang pendant une intervention de 
pontage cardiaque, il y a eu une baisse
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de 10% de la concentration en DPG 
des hematies comparativement aux 
valeurs preoperatoires, mais il n’y a 
pas eu de relation avec la concentration 
de DPG dans les sacs de sang pour 
transfusion. La grandeur de la baisse 
n’etait pas suffisante pour affecter 
serieusement le transport d’oxygene. 
Ces resultats indiquent la necessity de 
reevaluer les indications d’utiliser 
des globules rouges frais dans la 
chirurgie cardiaque.
Reduced oxygen delivery during car­
diac surgery may have detrimental ef­
fects, especially in patients with 
pre-existing ischemic heart conditions; 
it is therefore necessary to establish the 
cause of this reduction. The hemo­
globin-oxygen dissociation, curve can 
be altered by changes in the concentra­
tions of red cell organic phosphates, 
A T P  a n d  2,3-diphosphoglycerate 
(DPG). Reduced values of ATP and 
DPG will shift the curve to the “left”, 
increasing hemoglobin-oxygen affinity 
and theoretically reducing oxygen 
delivery.1 Since red cells become de­
pleted of ATP and DPG during blood 
storage the above theoretical considera­
tions have been offered as one indica­
tion for the use of fresh blood during 
cardiac surgery. Separate blood com­
ponents will likely be used more often 
during cardiac surgery and therefore it 
is important to establish whether or not 
red cells provided separately from co­
agulation factors should be fresh. Hypo­
phosphatemia and reduced ATP and 
DPG concentrations with increased 
hemoglobin-oxygen affinity have been 
reported during and following open- 
heart surgery.2-6 Some authors have 
postulated that the decrease is related 
to a direct effect of the use of the 
membrane oxygenator,2,5 whereas others 
have related these changes to transfu­
sion of stored blood with a reduced 
concentration of DPG.3,4,6 Dennis and 
colleagues4 and Giannelli and col­
leagues7 have provided evidence that 
decreasing the hemoglobin-oxygen af­
finity artificially by manipulation of 
the transfused red cells can have bene­
ficial effects on the patient during 
cardiac surgery.
The exact cause of the reduced con­
centrations of inorganic and organic 
phosphates following cardiac surgery 
remains in doubt and most studies 
have incorporated few controls. Be­
cause relatively few reports compared 
exact measurements of the interme­
diates in the blood products used in 
each case, we studied the effect of 
cardiac bypass upon red cell meta­
bolism both in dogs and in human 
beings during cardiac bypass, and for 
up to 8 days following bypass in the 
human subjects.
M ateria l and Methods
Dogs
Eleven mongrel dogs (weight, 15 to 
22 kg) were studied. Seven were placed 
on cardiopulmonary bypass for 120 
minutes at normothermia, using a 
standard roller pump and the Harvey 
H-1000 oxygenator (William Harvey 
Research Corp., Santa Ana, CA) with 
bloodless prime. In four dogs acting as 
a control group, the chest was opened 
for the same period of time and blood 
samples were taken to correspond to 
those obtained in the bypass group. 
During this time the pH was maintained 
at 7.27 ±  0.15. Blood samples were 
obtained before induction of anesthe­
sia, at the onset of bypass and at 30- 
minute intervals until the end of bypass.
Human Beings
Of 16 patients who underwent car­
diopulmonary bypass for a variety of 
indications, 9 had valve replacements, 
6 underwent aortocoronary bypass and 
1 had closure of an atrial septal defect. 
These patients required cardiopul­
monary bypass for an average of 65 ±  
27 minutes. The conditions of bypass 
included the use of the Harvey H-1000 
oxygenator, moderate hypothermia 
(30°C) and intermittent anoxic arrest. 
Arterial blood pH was maintained at 
7.40 ±  0.04 throughout the procedure. 
A bloodless prime was used in all cases. 
Blood samples were drawn before op­
eration, as soon as the patient was on 
the pump, 30 minutes later, at the end 
of the pump run, at the end of the 
operation and again 3 hours later, then 
24 hours postoperatively and approx­
imately every other day for a further 7 
days. The patients received 0 to 7 units
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of whole blood during bypass or later 
on the operative day. One patient who 
received 17 units of blood in a 24-hour 
period of cardiac bypass was also 
studied and is reported separately. Six 
patients who underwent noncardiac op­
erations constituted a control group.
Assays
Hematologic values were obtained 
by standard methods used at Univer­
sity Hospital in Saskatoon. Blood was 
collected into tubes containing heparin 
as an anticoagulant. These were imme­
diately placed on ice, and perchloric 
acid extracts were made within 1 hour 
of blood-letting by Beutler’s method.8 
Intracellular phosphate was measured 
by washing the sample with normal 
saline immediately following blood­
letting, prior to the preparation of the 
extract. Red cell ATP concentration 
was measured by the method of Lowry 
and associates9 and DPG concentration 
by Keitt’s method.10 Red cell and plas­
ma phosphate values were measured by 
the method described by Chen, Tori- 
bara and Warner.11
FIG . 1— Decrease in hemoglobin con­
centration during cardiac bypass in seven 
dogs. Values are compared with those of 
four animals in whom sham operation 
was performed.
Results
Dogs
In the bypass group of seven dogs 
the hemoglobin value decreased by 
8.3 ±  2.5 g/dL during 1 to 2 hours of 
cardiac bypass (Fig. 1). Red cell and 
plasma inorganic phosphate values did 
not change appreciably and neither 
did the ATP (Fig. 2). A 10% decrease 
in red cell DPG concentration did, how­
ever, occur early during cardiac bypass, 
but the concentration returned to con­
trol values at 2 hours (Fig. 2). 
The decrease in DPG concentration 
tion did not correlate significantly with 
plasma or red cell phosphate concen­
trations, pH or ATP. A summary of the 
relevant data is set forth in Table I.
Human Beings
In the 16 patients who underwent 
cardiac bypass and who received 0 to 
7 units of blood, the hemoglobin value 
decreased to 5.3 ± 1 . 4  g/dL from the 
preoperative value (Fig. 3); the extent 
of the decrease did not relate to the 
number of units of blood transfused. 
There was no significant change in red 
cell or plasma phosphate values during
FIG. 2—Red cell ATP and DPG con­
centrations in seven dogs undergoing car­
diac bypass compared with those of control 
group of four dogs.
cardiac bypass, but there was a delayed 
minor fall between days 2 and 5 fol­
lowing the operation (Fig. 4). Despite 
these decreases, which are similar to 
those reported previously, there was no 
significant change in the red cell ATP 
concentration during the follow-up pe­
riod (Fig. 5). However, in these subjects 
the concentration of red cell DPG de­
creased significantly during bypass and 
remained low for up to 24 hours post- 
operatively; the concentration then 
returned to normal and subsequently 
increased to 134% ±  15% of the pre­
operative value after 8 days (Fig. 6, 
Table II). Surprisingly, the average
FIG. 3— Changes in hemoglobin con­
centration during and after cardiac bypass 
surgery in 16 patients.
FIG. 4— Changes in red cell and plasma 
phosphate concentrations during and after 
cardiac bypass surgery in 16 patients.
Table I—Changes in Hemoglobin, Plasma and Red Cell Inorganic Phosphate Concentrations and Red Cell ATP and DPG Values During Cardiac Bypass
in Seven Dogs and in Four Control Dogs. Results are Mean ±  SD
Inorganic phosphate, 
mmol/L
Hemoglobin, ----------------------------------------------------------------  Red cell ATP, Red cell DPG,
Time g/dL Plasma Red cell (xmol/g Hb p.mol/g Hb pH
Bypass group
Preop 16.2 ±  1.5 1.61 ±  0.24 0.58 ±  0.25 2.24 ±  0.65 20.8 ±  2.3 7.32 ±  0.04
Pump—0 min 9.9 ±  2.0* 1.26 ±  0.14* 0.80 ±  0.23 2.12 ±  0.46 18.7 ±  1.6* 7.42 ±  0.07f
60 min 8.5 ±  1.5* 1.58 ±  0.86 0.83 ±  0.24 2.42 ±  0.43 20.4 ±  2.5 7.27 ±  0.10
120 min 7.1 ±  1.2* 2.37 ±  0.73f 1.56 ±  0.94) 2.87 ±  0.29f 22.5 ±  1.2 7.23 ±  0.20
Control group
Preop 15.5 ±  1.5 2.01 ±  0.58 0.53 ±  0.15 2.74 ±  0.61 20.9 ±  0.9 —
30 min 16.1 ±  1.1 1.83 ±  0.60 0.68 ±  0.23 3.06 ±  0.75 21.4 ±  0.5 —
60 min 16.1 ±  1.2 2.02 ±  0.61 0.70 ±  0.20 2.95 ±  0.83 21.4 ±  1.1 —
120 min 15.9 ±  1.4 2.36 ±  0.86 0.79 ±  0.28 2.77 ±  0.85 21.3 ±  0.8 —
"Significantly lower than preoperative value (P <  0.05). 
fSignificantly higher than preoperative value (P <  0.05).
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values of DPG in the blood bags used 
for the patients could not be correlated 
with the decrease in DPG concentration 
during bypass (Fig. 7, Table II). There 
were no differences in DPG values 
between those who received 0 to 3 
units and those who received 4 to 7 
units of blood (Table II). In the patient 
who received 17 units of blood, which 
included units that were an average of 
8 days old (range, 1 to 16 days), the 
overall decrease in DPG concentration 
was relatively small. The red cell DPG 
value did not decrease in the control 
group of six patients (Table II).
Discussion
Authors who previously have re­
ported hypophosphatemia and low
I
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FIG. 5— Changes in red cell ATP con­
centration during and after cardiac by­
pass surgery in 16 patients.
centration during and after cardiac bypass 
surgery in 16 patients.
values of ATP and DPG following 
cardiac surgery have commented on the 
possible detrimental effects of these 
changes.2'7 Our results confirm that a 
fall in DPG concentration occurs dur­
ing cardiac bypass. Since the fall oc­
curred in dogs who were not transfused, 
and since it did not relate to the num­
ber of blood bags given or the blood 
bag concentration of DPG, the results 
suggest that this decrease relates to the 
use of the pump oxygenator and not 
to the effects of the transfused blood 
as suggested by others.2-5 The average 
DPG concentrations in the blood bags 
used for our patients were always great­
er than 50% of normal adult values 
since half of the blood that was given 
had been stored for less than 4 days. 
Thus, it is still possible that if our pa­
tients received blood that was totally 
depleted of DPG, then an additional 
effect on DPG might have been seen, 
as occurred in the studies of Dennis 
and associates4 in which DPG-depleted 
blood was compared to DPG-enhanced 
blood. However, in our patient who re­
ceived 17 units of blood for severe 
postoperative bleeding, one half of the 
units had been stored for longer than 
8 days and had less than 50% of the 
normal DPG concentration, yet the de­
crease in the DPG value was relatively 
minor.
BLOOD BAG DPG (»anol/g Hb)
FIG. 7—Relation of change in D PG  
value in 14 patients undergoing cardiac 
bypass surgery who received transfusion 
to average value of blood bag DPG.
Table II— Changes in Red Cell DPG Concentration (ixmol/g Hb) During and Following Cardiac 
Bypass Surgery in 17 Patients Compared with Values for a Control Group of Six Patients 
Undergoing Noncardiac Operations. Results are Mean ±  SD
Bypass group
0-3 units 4-7 units 17 units Control
Time blood blood blood group
Number 10 6 1 6
Preop. 17.9 ±  2.5 18.1 ±  0.9 23.9 14.0 ±  3.8
Pump— 0 min 16.8 ±  2.4 17.0 ±  1.0‘ 17.1 —
end 15.9 ±  3.1 17.1 ±  1.8 20.7 —
Postop day— 0 16.3 ±  2.2 16.5 ±  2.0 19.6 14.5 ±  4.5
1 15.8 ±  2.7‘ 15.8 ±  1.2* 17.6 13.9 ±  4.0
2 16.5 ±  1.9 16.7 ±  1.0* — 13.1 ±  4.0
4 19.6 ±  2.4 20.1 ±  3.2 20.0 16.2 ±  5.6
8 22.9 ±  1.1* 23.1 ±  2.7* 21.3 16.9 ±  4.4
‘Significantly different from preoperative value (P <  0.05).
Despite the finding of mild hypo­
phosphatemia we were unable to con­
firm the presence of reduced ATP con­
centrations following cardiac surgery 
found by Young, Lichtman and Cohen3 
and cannot explain the difference be­
tween our results and theirs. Hypo­
phosphatemia has been reported12 fol­
lowing noncardiac surgery when dex­
trose in water was used as the sole 
fluid replacement for 5 days after op­
eration, and it is possible that Young, 
Lichtman and Cohen3 observed a con­
dition in their patients that may occur 
under certain circumstances following 
any surgery.
The 10% decrease in red cell DPG 
concentration on cardiac bypass was 
not of such magnitude that hemoglobin 
oxygen delivery would be severely im­
paired.1 Our data suggest that the de­
crease is an effect of the use of the 
pump oxygenator and not of blood 
storage.
Two authors4-7 have artificially de­
creased hemoglobin-oxygen affinity by 
various manipulations of the red cell 
and have shown improved myocardial 
performance during cardiac surgery by 
increasing the DPG value to 150% of 
normal. Further investigations in this 
important area are necessary to estab­
lish the overall magnitude of this bene­
fit.
It is a routine procedure in our hos­
pital and most centres to prepare 
“fresh” whole blood (less than 3 days 
old) for cardiac bypass surgery to com­
pensate for reduced platelets and fibri­
nogen. The discovery of the increased 
oxygen affinity in stored red cells1’1* 
has added another possible indication 
for the use of fresh whole blood. Blood 
products will be provided increasingly 
as separate components (red cells and 
coagulation factors). We suggest that 
fresh red cells are unlikely to be neces­
sary for routine maintenance of ade­
quate DPG concentrations after cardiac 
bypass surgery and that stored red cells 
should be satisfactory where citrate- 
phosphate-dextrose (CPD) blood is 
used. Further studies are required in 
patients receiving stored blood totally 
depleted of DPG and direct measure­
ments of hemoglobin-oxygen affinity 
are necessary. A recent paper14 has 
questioned the provision of coagulation 
factors as an indication for the use of 
fresh blood or platelets during routine 
cardiac bypass surgery. Our findings 
suggest that a re-evaluation of the in­
dications for fresh blood components 
in cardiac bypass surgery is indicated.
C onclusions
During cardiac bypass the red cell 
DPG concentration was reduced by 
10% and, while this reduction was 
maintained for up to 24 hours, the
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value increased to 134% of the preop­
erative value by day 8 after operation. 
The reduction was found to be inde­
pendent of blood transfusion and not 
related to DPG values in CPD blood 
bags. No such reduction was recorded 
during noncardiac operations. The fall 
in D PG  concentration is apparently an 
effect of the use of the pump oxygena­
tor and does not serve as an indication 
for the use of fresh blood.
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AMINOSYN INDICATIONS AND CLINICAL USES
Aminosyn 5% Injection is indicated for peripheral vein infusion as 
a source of nitrogen in the intravenous treatment of acute surgical 
patients with adequate stores of body fat, in whom, for short 
periods of time, oral nutrition cannot be tolerated or is not desira­
ble. In such instances, the patient's caloric needs are met from 
their own fat stores.
Amino acids when administered with concentrated dextrose solu­
tions also are indicated for central vein infusion as an adjunct in 
the prevention of nitrogen loss or in the treatment of negative 
nitrogen balance in patients where: (1) the alimentary tract, by the 
oral, gastrostomy or jejunostomy route, cannot or should not be 
used, (2) gastrointestinal absorption of protein is impaired, or 
(3) metabolic requirements for protein are substantially increased, 
as with extensive burns. In such usage, intravenous feeding for 
prolonged periods, up to 100 days or more, has been success­
fu lly employed7 .
CONTRAINDICATIONS
This preparation should not be used in patients with hepatic coma 
or anuria or metabolic disorders involving impaired nitrogen utili­
zation. Patients with azotemia from any cause should not be in­
fused with amino acids without regard to total nitrogen intake.
WARNINGS
Peripheral intravenous infusion of amino acids may induce a rise 
in blood urea nitrogen (BUN) especially in patients with impaired 
hepatic or renal function. Appropriate laboratory tests should be 
performed periodically and infusion discontinued if BUN levels 
exceed normal post-prandial limits, and continue to rise. It should 
be noted that a modest rise in BUN normally occurs as a result of 
increased protein intake.
PRECAUTIONS
Safe use during pregnancy has not been established: therefore, 
infusion of amino acids should be undertaken during pregnancy 
only when this is deemed essential to the patient's welfare as 
judged by the physician.
1 . Protein-sparing (peripheral use)
When amino acids (without dextrose) are infused peripherally, 
care should be taken to avoid oral ingestion of carbohydrate or 
infusion of carbohydrate-containing solutions if fat mobilization is 
desired as the source of energy. Otherwise, full utilization of body 
fat may not occur.
Serum electrolytes should be monitored and appropriate electro­
lytes added to the daily infusion regimen. Acid-base balance also 
should be monitored and disturbances in equilibrium corrected as 
needed. The amino acid solution as formulated has no potential 
fo r increasing hydrogen ion concentrations.
Do not withdraw venous blood for blood chemistries through the 
peripheral infusion site, as interference with estimations of 
nitrogen-containing substances may occur.
Intravenously administered amino acids should be used with cau­
tion in patients with history of renal disease, pulmonary disease, 
or with severe congestive heart failure so as to avoid excessive 
fluid replacement. The effect of infusion of amino acids, without 
dextrose, upon carbohydrate metabolism of children is not known
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at this time. Therefore, such usage of Amino Acid Injection 5% 
in children is not recommended.
. Adjunctive for total parenteral nutrition 
For long-term total nutrition, or if a patient has inadequate fat 
stores, it is essential to provide adequate exogenous calories 
concurrently, if parenterally administered amino acids are to be 
retained by the body and utilized for protein synthesis. Concen­
trated dextrose solutions are an effective source of such calories. 
Special care must be taken when giving hypertonic glucose to 
diabetic or pre-diabetic patients. In such cases crystalline insulin 
should be added to the solution8. Such strongly hypertonic nu­
trient solutions should be administered through an indwelling in­
travenous catheter with the tip located in the superior vena cava
ADVERSE REACTIONS
See WARNINGS and DOSAGE AND ADMINISTRATION.
Peripheral Infusions
Local reactions consisting of a warm sensation, erythema, 
phlebitis and thrombosis at the infusion site have occurred with 
peripheral intravenous infusion of amino acids particularly if other 
substances, such as antibiotics are also administered. In such 
cases the infusion site should be changed promptly to another 
vein. Use of large peripheral veins and slowing the rate of infusion 
may be helpful in decreasing the incidence of local venous irrita­
tion. Electrolyte additives should be spread throughout the day, 
and irritating additive medications may need to be injected at 
another venous site. Generalized flushing, fever and nausea also 
have been reported during peripheral infusions of crystalline 
amino acids.
DOSAGE AND ADMINISTRATION
. Protein-sparing (peripheral vein)
This preparation (without dextrose) can be administered by the 
peripheral intravenous route. It should not be infused via a central 
vein, unless it is admixed with sufficient dextrose to provide full 
caloric energy requirements in patients who require prolonged 
total parenteral nutrition.
For peripheral intravenous infusion, 1 to 1.5 g/kg/day of total 
amino acids will achieve optimal fat mobilization and spare protein 
catabolism if no carbohydrate is infused or ingested.
As with all intravenous fluid therapy, the primary aim is to provide 
sufficient water to compensate for insensible, urinary and other 
(nasogastric suction, fistula drainage, diarrhea) fluid losses. 
Those requirements as well as electrolyte and acid/base needs 
should be estimated and appropriately prescribed.
Given an amino acid solution of specified total concentration, the 
volume required to meet amino acid requirements per 24 hours 
can be calculated. Then, after making an estimate of the total daily 
fluid (water) requirement, the balance of fluid needed beyond the 
volume of amino acid solution required, can be provided as a 
non-carbohydrate electrolyte solution. Vitamins and additional 
electrolytes (except bicarbonate) as needed to correct imbalances 
may be added to the amino acid solution. If desired, one-half of an 
estimated daily amino acid requirement of 1.5 g/kg can be given 
on the first day The degree of fat mobilization can be gauged by 
the presence and amount of acetonuria. Amino acid dosage may 
be increased on the second day. Amino acid infusion into a
peripheral vein can be continued as long as oral nutrition is im­
paired However, if a patient is unable to take oral nourishment at 
the end of Oto 7 days, institution of total parenteral nutrition with 
exogenous calories should be considered.
2 . Adjunctive for total parenteral nutrition
For central vein infusion with concentrated dextrose solution, the 
total daily dose of the amino acid solution depends on daily pro­
tein requirements and on the patient's metabolic and clinical re­
sponse. The determination of nitrogen balance and accurate daily 
body weights, corrected for fluid balance, are probably the best 
means of assessing individual protein requirements. For patients 
in a stable metabolic condition the provision of amino acids as a 
3.5% concentration with 20 to 25% dextrose is usually considered 
adequate. Vitamins, minerals and electrolytes should be added as 
indicated.
DOSAGE FORMS
Aminosyn 5% Injection is supplied in 1000-ml ABB0-VAC* 
containers.
A 1000-ml unit provides a total equivalent of 50 g of protein and 
7.86 g of nitrogen. Each 100 ml contains crystalline amino acids 
5 g and potassium metabisulfite not more than 60 mg (equivalent 
to 5.4 mEq K*/litre); pH 5.25 (approx.), adjusted with acetic acid 
30 mEq/litre (approx.)
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Medical Litigation in Canada*
It is impossible to predict the future of 
medical malpractice litigation in Canada. 
However, the statistics indicate that 
medical malpractice claims are steadily 
increasing. Action should be taken now 
to ensure that the problem does not 
reach crisis proportions. In so far 
as the medical profession itself is 
concerned, it should ensure that the 
competence of medical practitioners 
remains on the highest possible level.
II est impossible de predire le futur 
en ce qui concerne les causes pour 
negligence medicale au Canada. Toute- 
fois, les statistiques indiquent que le 
nombre de poursuites pour negligence 
intentees contre les medecins est en 
augmentation constante. On devrait 
prendre action immediatement afin de 
s’assurer que le probleme ne devien- 
dra pas hors de proportion. En ce qui 
concerne la profession medicale, elle 
devrait s’assurer que la competence 
des praticiens demeure au plus haut 
niveau possible.
The recent crisis in insurance rates for 
medical practitioners and hospitals in 
the United States, created by the trend 
in the US towards large medical mal­
practice damage awards, has led to a 
great deal of speculation in Canada as 
to the future of medical litigation in 
Canada. It should be noted at the out­
set that there are a number of legal 
and sociologic differences between 
Canada and the US which promulgate 
the current differences in recovery in 
medical litigation cases. It is necessary
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to add a caveat at this point in that the 
big difference in the malpractice scene 
should not be explained by comparing 
Canada and the US but should be ex­
plained and examined in the light of 
the passage of time.
In most cases Canada seems to lag 
behind the US by about a decade, but 
eventually adopts most of its institu­
tions, its principles and its way of 
doing business. Canada’s survival on 
many fronts—including medical mal­
practice—is going to depend on our 
ability to selectively adapt and adopt 
the laws in the US.
If Canadian medicine adopts the 
American system holus bolus it will 
suffer an absolute disaster. If the Cana­
dian medical profession wants to con­
tinue to enjoy its independence and to 
practise scientific medicine, it will have 
to intervene in the political process, as 
best it can, on three fronts. In the first 
place, the profession must satisfy itself 
whether contingency fee litigation is 
a good or bad thing and react accord­
ingly. Secondly, the profession must 
satisfy itself that there is available to 
the plaintiff in a medical malpractice 
case the expertise necessary to wage a 
fair lawsuit. Thirdly, the profession 
must acquaint itself with the judicial 
process and must determine whether or 
not to participate in the defence of the 
present system where it does not follow 
the American system.
General Principles
Before embarking on an evaluation 
of the differences between the Cana­
dian and American medical malprac­
tice areas, it is useful to consider the 
general principles of tort liability. Med­
ical malpractice litigation generally in­
volves the torts of assault and battery 
or negligence. Success in a negligence 
suit is dependent upon the existence 
of four conditions. Firstly, there must 
be a legal duty owed by the doctor 
towards his patient. This duty arises 
as a matter of law after the doctor 
accepts the patient; it is completely
independent of contract. Secondly, 
there must be negligence on the part 
of the doctor; such negligence consists 
of the breach of the legal duty owed 
to the patient. Thirdly, the patient 
must prove loss or injury resulting 
from such negligence. Fourthly, the 
patient’s loss or injury must be directly 
related to the doctor’s negligence. It 
should also be noted that a doctor can 
be found negligent whether or not his 
services were rendered gratuitously or 
for reward.1
The standard of skill imposed on a 
doctor depends on the position that 
the doctor holds in the medical com­
munity. In other words, a specialist 
who holds himself out as possessing 
special skill and knowledge has a 
much greater duty to his patient. A 
specialist is expected to possess a great­
er degree of skill in the particular field 
of his expertise than is possessed by a 
general practitioner. Moreover, a phy­
sician or surgeon practising in a coun­
try village is not ordinarily held to the 
same standard of proficiency as a phy­
sician or surgeon practising in a big 
city.2
Although there are a number of im­
portant medical litigation cases, it is 
interesting to note that the concept of 
“medical negligence” was defined as 
early as 1902 by Chief lustice Falcon- 
bridge, of the King’s Bench.
Malpractice (mala praxis) is bad or 
unskilful practice by a physician or 
surgeon, whereby the health of the patient 
is injured. Negligent malpractice means 
gross negligence and lack of the attention 
which the situation of the patient requires; 
as if a physician while in the state of 
intoxication should administer improper 
medicines: .. . what is charged is ignorant 
malpractice, namely a course of treatment 
which was calculated to do injury, which 
has done harm, and which a well-educated 
and scientific surgeon ought to know was 
not proper in the case.3
This approach to the problem has been 
followed in many cases since that time 
and is still applicable.
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Statistics
Statistics on medical malpractice 
litigation in Canada and the US shed 
some light on the problem which now 
exists in the US and indicate the direc­
tion in which Canada is headed. The 
Canadian Medical Protective Associa­
tion (CMPA) is particularly interested 
in this subject and is continually moni­
toring the statistics in regard to med­
ical malpractice litigation in Canada. 
The figures for the cases in which the 
CMPA has been involved in the period 
between 1966 and 1976 are set forth 
in Table I (Brown FN: Personal com­
munication, 1977). They demonstrate 
that the number of claims against doc­
tors is steadily growing in Canada and 
the total amount of settlements is also 
rising. It should be noted that there was 
a substantial increase in awards, partic­
ularly in the years 1975 and 1976. 
In considering the total amount 
of the awards, of course, the number 
of settlements and awards made in 
those years must be taken into account.
It is also interesting to compare the 
number of claims in respect of the 
number of physicians in Canada during 
those years. An analysis of the statis­
tics for medical malpractice litigation 
by Geekie4 sets forth the comparison 
thus:
In 1945, while representing 3367 phy­
sicians, CMPA members were involved in 
nine new legal actions, or one per 374 
physicians. There was no appreciable rate 
change in the number of new legal actions 
until 1965.. . In the 10 years 1965-74 the 
annual number of new legal actions in­
creased from 49 to 220. The ratio in­
creased from one per 325 physicians to 
one per 132. The experience of the first 
half of 1975 indicates the trend is con­
tinuing. During these months, 126 new 
legal actions were lodged against CMPA 
members compared to 100 in the cor­
responding period last year.
The author also compares the increase 
in the average amount of awards:
In 1950, CMPA paid an average of $2942 
on behalf of members to conclude 11 
malpractice claims. In 1974, the average 
amount had risen to $13 386.
He then goes on to compare the settle­
ment rates in the period between 1955 
and 1975:
In 1955, three cases were settled out of 
court for every one concluded in the 
courts. In the past 3 years the ratio has 
approximated 7:1, 16:1 and 6.5:1.
These statistics indicate a steady rise 
in the number of medical malpractice 
cases in Canada and the amount of the 
awards or settlements in the various 
cases. Moreover, there has been an 
increase of claims against related per­
sonnel such as hospital staff. Geekie 
states that
it is interesting that a sizable proportion 
of legal actions for medical malpractice is 
not related to surgical or anesthetic 
mishaps. During 1974, of 220 legal actions 
against members, 91 had no relationship 
to surgery or anesthesia.
In a recent case, for example, the 
Supreme Court of Canada upheld a 
finding of a trial judge in Ontario to 
■he effect that the staff of a hospital 
had been negligent in caring for a 
patient who had been placed in a 
Stryker frame after surgery (Joseph 
Brant Memorial Hospital et al vs 
Koziol et al May 17, 1977). In that 
case both the staff and the hospital 
were held liable, but the doctor was 
not held liable.
Comparative statistics for the US 
and Canada also shed an interesting 
light on the subject.
In 1970, 160 suits were filed against the 
21,959 members of the Canadian Medical 
Protective Association, or one suit for 
each 137.2 physicians. By comparison 
there were approximately 6,400 suits filed 
against approximately 279,000 U.S. phy­
sicians in the same year, or one suit for 
each 43.6 physicians.5
It is clear from the statistics that the 
number of claims per physician in the 
US is far in excess of the number of 
claims per physician in Canada. With 
each passing year, the ratio of claims 
to physicians in the US approaches 1:1.
If  malpractice claims against doctors 
in the US ever reach that ratio it will 
be more than a crisis; it will be a disas­
ter. The statistics in Canada indicate 
that the number of claims per physician 
is increasing to the extent that the posi­
tion in Canada is now analogous to the 
position in the US approximately 10 
years ago. If the trend continues, Can­
ada may soon experience a medical 
malpractice crisis.
Before leaving the area of statistics, 
it is of particular interest to note the 
number of settlements in the US which 
have exceeded $3 million. In 1969 
there were three such awards; in 1970 
there were 5; in 1971, 9; in 1972, 13; 
in 1973, 24; and, finally, in 1974 there 
were approximately 36 awards greater 
than $3 million. These awards are 
taken from California statistics only.6 
The largest personal injury award in 
medical malpractice litigation was 
made in February 1973, when a 13- 
year-old San Rafael boy received an 
award of $4 025 000 in his suit against 
a San Francisco hospital and pedia­
trician.7
In Canada there have been a num­
ber of personal injury awards that have 
exceeded $1 million but none of them 
has involved medical malpractice liti­
gation. Most of the cases have been 
motor vehicle accident claims against 
defendant drivers. In Teno et al vs 
Arnold et als the Ontario Court of 
Appeal reduced a trial judgement ex­
ceeding $1 million to $875 000. The 
Teno case was followed in McLeod vs 
Hodgins and Hodgins (Robins J: June 
1976), in which judgement was given 
for $1 041 197.85. Similar judgements 
have also been given in Alberta9 and 
British Columbia.10 It should be noted, 
however, that these judgements are not 
only for general damages but also in­
clude special damages (such as medical 
costs). Moreover, the awards are based 
on the loss of future income caused by 
the plaintiff’s inability to work. The 
irony, of the situation is that if the 
plaintiff had died, the awards would 
have been much smaller. The Teno, 
Andrews, and Thornton cases are on 
appeal to the Supreme Court of Can­
ada and will be heard at the same time 
in the hope that the proper principles 
for assessing damages will be estab­
lished. These principles would be ap­
plied nationally and would be relevant 
to medical malpractice litigation.
A fundamental sociologic question 
arises which has been neglected and 
ignored in the US and that is the ap­
propriate level of awards. In the Niles
Table I—Malpractice Litigation in Canada—Statistical Review of Canadian Medical Protective
Association Activities
Total amount
Year
No. of 
awards
No. of 
settlements
of
settlements, $
No. of 
members
No. of writs 
served
Dismissed/
discontinued
1966 0 22 132 137 17 275 73 23
1967 5 17 154 812 18 265 64 25
1968 5 20 122 819 19 971 65 22
1969 0 15 439 247 21 280 62 25
1970 8 21 223 951 21 959 80 35
1971 10 22 276 292 23 668 131 45
1972 4 29 253 371 24 945 152 30
1973 2 32 325 087 26 588 168 44
1974 9 58 896,858 29 096 220 60
1975 9 43 951 609 30 022 229 115
1976 7 64 2 664 103 30 316 234 142
No. of physicians in Canada: 1976, approximately 40 000; 1977, approximately 42 000.
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and San Rafael case, for example, it 
is impossible to rationalize an award 
exceeding $4 million unless the spectre 
of contingency fees is considered. Two 
million dollars goes to the lawyer and 
the jury knows it. So they make what 
would have been a $2 million award a 
$4 million dollar award. But even 
taking the $2 million and investing it 
at today’s prime rate could give the 
plaintiff an annual income that is 
about twice our prime minister’s salary. 
Consequently, the principles utilized in 
assessing damages need to be re-evalu­
ated and restructured.
Causes
Conspiracy of Silence
There has been a great deal of 
criticism in the US and Canada of the 
reluctance of doctors to testify in cases 
involving other doctors. In many cases 
this reluctance has been classified as 
“a conspiracy of silence”. It has been 
said that this reluctance on the part 
of medical practitioners to testify in 
cases involving other medical practition­
ers is a factor in the development of 
large medical malpractice awards in 
the US. For instance, the reaction to 
this “conspiracy of silence” has brought 
about legal doctrines which facilitate 
recovery in medical malpractice litiga­
tion (for example, the development of 
the concept of res ipsa loquitur in Cali­
fornia, discussed below).
In California in the 1960s a break­
through in the “conspiracy of silence” 
occurred and a number of well-qual­
ified medical expert witnesses became 
available for medical malpractice litiga­
tion cases.11 The problem is, however, 
that these expert witnesses are, in truth, 
plaintiffs’ witnesses. Hence the avail­
ability of such expert testimony assisted 
in the development of the large awards 
in California litigation cases. It can be 
said that if the expert witnesses were 
objective, the awards might not be 
quite so high.
The problem of the availability of 
expert witnesses has caused some con­
cern in Canada, Sharpe and Weisstub12 
consider the problem and cite an ar­
ticle written by Mr. Justice Haines of 
the Ontario Supreme Court:
In contrast, Mr. Justice Haines of the 
Ontario Supreme Court wrote some 
twenty years ago in the Canadian Bar 
Review that the time has come for the 
profession to assume corporate responsi­
bility for providing an injured claimant 
with the necessary medical evidence to 
enable him to place before the court the 
appropriate standards of care, so that 
justice can be done between the parties.
The authors then go on to discuss the 
current situation in Canada:
In support of this judgment of the Cana­
dian context, a recent statement has em­
phasized the “infernal silence” that afflicts 
the medical profession. Empirical evidence 
obtained in a questionnaire completed by 
Ontario physicians reveal that few, if any, 
would volunteer information to a patient 
victimized by an act of gross negligence. 
Based on this study, it appears a discon­
certing number would face contempt 
charges rather than make a disclosure in 
court.
The authors also point out that one of 
the reasons for the development of the 
“conspiracy of silence” is the belief 
among medical practitioners that test­
ifying against other practitioners will 
result in a bad reputation in the profes­
sion. They go on to say that
one should not underestimate the factor 
of loss of business. Once a physician loses 
cordial relations with his fellow-practi­
tioners and is branded a plaintiff’s witness, 
he may suffer loss of referrals and pre­
judicial treatment in appointments to 
hospitals’ staffs, which can easily result 
in a serious downgrading of status and in­
come.
Unfortunately, the absence of objective 
witnesses can lead to the development 
of the “plaintiff’s expert witness”, 
which can ultimately lead to an in­
crease in injury awards.
In 1965, Mr. Justice McRuer was 
appointed to a commission to study 
the problem of expert witnesses in med­
ical malpractice litigation. That com­
mission evaluated the various altern­
atives proposed in the US. In their re­
port the commission rejected the use 
of court-appointed witnesses and sug­
gested that a body of expert witnesses 
should be appointed by the medical 
profession and made available at the 
request of an injured party. The re­
commendation of the commission was 
that medical reports should be ex­
changed by the parties. As a result of 
that report, the Ontario Evidence Act 
was amended to provide for such ex­
change of medical reports prior to 
trial.
The current experience in Ontario 
is that there is always a well-qualified 
medical practitioner available for mal­
practice cases. In every case such wit­
nesses have remained objective and 
have been of great assistance to the 
courts. In this respect, the judge is 
better able to evaluate the issues and 
the evidence and can make a more 
objective assessment of the plaintiff’s 
injuries. Consequently it appears that 
the “conspiracy of silence” is no longer 
of great concern in the medical—legal 
context of malpractice litigation in 
Canada. Fortunately, we were able to 
avoid the type of development which 
occurred in the US as an offshoot of 
such factors as the “conspiracy of 
silence”.
Contingency Fees
The concept of contingency fees in 
litigation in the US has a history which 
reaches back to the American Revolu­
tion. Even before the revolution, 
Thomas Jefferson advocated the use 
of contingency fees in litigation. Jef­
ferson conceived that if the lawyer 
were given part of the damage award 
he would take a case on for nothing 
and thus open the courts to impecu­
nious litigants. In addition, he felt that 
the poorest member of the community 
would be able to get the best lawyer 
or have equal access to the best lawyers 
because he could offer the same reward 
as the richest member of the com­
munity.
On the other hand, the American 
Constitution prohibits the awarding of 
costs to a successful claimant. Costs is 
a deterrent conceived by the British 
500 years ago to make the courts 
available to those who have genuine 
causes and to penalize those whose 
causes have no merit. But in the US 
there is no penalty, no retardant, for 
the man who abuses his right to go to 
court, either for the plaintiff who drags 
the doctor into court unnecessarily or 
for the doctor who defends unneces­
sarily.
Indeed, the impact of the contin­
gency fee system in the US is almost 
beyond imagination. Essentially, the con­
tingency fee system is a partnership deal 
between the lawyer and the person 
having the claim. The lawyer foots the 
bill in staging the lawsuit, and where 
there is no state intervention he gets 
about half the award.
The contingency fee was tried in 
England about two centuries before 
Jefferson and was eventually pro­
hibited. Now in England a contingency 
fee arrangement is a disbarment of­
fence for the legal profession and is 
also an offence in the nature of con­
tempt of court. The English see it as a 
perversion of the role of the lawyer 
who is an officer of the court. If he is 
in the pay of one of the litigants on the 
basis that he shares in the outcome, he 
cannot give independent advice.
Besides doctors, there are at least 
three segments of society that have 
an interest in watching how the con­
tingency fee operates. The first group 
is the general public which bears the 
cost of these “bizarre fights” in the law 
courts. Through taxes, the public pays 
for the hospital insurance premiums, 
and where medicare schemes are not 
in effect, the public pays the contin­
gency fee through increased rates 
charged by doctors and hospitals. Sec­
ondly, the government itself has an in­
terest if it is financing hospitals and 
medical care. Thirdly, the courts have 
an interest in watching the contingency
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fee system. If the courts are going to 
be deluged by litigation on a specul­
ative basis—which is what happens— 
then the courts become clogged and 
other people with legitimate claims 
cannot get access to them, or, altern­
atively, the taxpayer must foot the bill 
to expand the number of courts.
It is often said that the use of con­
tingency fees has contributed to the de­
velopment of the large injury award in 
the US. In a speech delivered to the 
American Orthopaedic Association in 
Hot Springs, Virginia, in June 1975, 
Mr. Justice Haines of the Ontario Su­
preme Court stated:
In my opinion the contingent legal fee 
whereby the lawyer receives 25-50% of 
the recovery is at the very top of the list 
[of differences between Canada and 
U.S.] . .. this is the reason why American 
verdicts in tort litigation have always 
been higher than the Canadian. Your 
jurors know of the contingent fee system. 
How much do they add for the lawyer?
Similar statements have been made by 
a number of lawyers and medical prac­
titioners in both Canada and the US.
On the other hand, Professor Wil­
liam J. Curran of Harvard believes 
that contingency fees may be a neces­
sary part of the litigation system in the 
US. He states:
There is a good deal of hostility on the 
part of the medical community against.. . 
[contingency fees] .. . No physicians 
function on this basis and most cannot 
understand it. They object not only to the 
contingency itself, which they consider 
gambling over human misfortunes, but to 
the amount of money the plaintiffs’ 
lawyers recover in the spectacular cases 
which receive publicity in the medical 
publications or are talked about in medi­
cal group gatherings. Some physicians 
insist that the “contingent fee” system is 
the largest single factor in the allegedly 
sharp increase in malpractice claims and 
suits in recent years. No amount of ar­
gument about the social value of the 
practice as “the poor man’s opportunity 
to obtain effective legal representation” 
can convince these doctors that the evils 
don’t outweigh any advantages.13
The same type of reasoning is applied 
in the report of the Commission on 
Medical Malpractice in the US. The 
commission reported in 1973 and one 
of its conclusions was to the effect 
that
the commission believes that most phy­
sicians generally place undue emphasis on 
the influence of the contingent fee system 
upon malpractice litigation, and that only 
harm will result from perpetuation of the 
common beliefs about its role in the 
overall problem. Our study data show that 
the contingent fee systems tend to discour­
age acceptance of legally meritorious mal­
practice cases involving minor injury and
relatively small potential recovery, and 
we view this as a wholly undesirable and 
unfair result of the system. However, most 
individuals are also unable to afford legal 
services in malpractice cases on a fixed 
fee basis. The net result is the same in 
both instances: recovery for injury de­
nied.14
It should be noted that the problem set 
out above does not really exist in Can­
ada. The successful litigant can obtain 
the costs of the litigation. Moreover, 
legal aid exists for those parties who 
cannot afford to bear the cost of litiga­
tion themselves. The very fact that the 
successful party is awarded costs acts 
as a deterrent.
The CMPA does believe that contin­
gent-fee billing is a factor in large 
awards and settlements.
Contingency billing and ambulance-chas­
ing lawyers who make a practice of pro­
moting medical malpractice litigation on 
a contingency billing system in the United 
States are generally considered to have 
been a major factor contributing to the 
US medical malpractice insurance fiasco. 
The Canadian Medical Protective Asso­
ciation, however, believes that to date con­
tingency billing has not been a major 
factor in the increase in legal actions or 
the size of awards in Canada. Never­
theless, it admits that if contingency bil­
ling were to become a widespread practice 
and if lawyers were to alter their normal 
system of practice and to begin active pro­
motion of medical malpractice lawsuits on 
the basis of contingency billing, both 
could contribute to a major problem in 
the not-too-distant future.4
It should be noted that a number of 
jurisdictions in Canada are moving 
towards the contingency-fee billing sys­
tem. Indeed, there are current discus­
sions in Ontario relating to the prob­
lem, and it is not entirely clear what 
the result of these discussions will be. 
The general impression gained from 
such discussions is that the profession, 
as it is now constituted, is against the 
use of contingency billing in Ontario.
Trial by Jury
The right to trial by jury is constitu­
tionally guaranteed in the US. As a 
result, a litigant can come before the 
court in a medical malpractice case and 
insist that a jury try the case on the 
facts and assess the amount of the 
award. It is generally felt in Canada 
that the presence of a jury leads to 
higher awards in malpractice litigation 
cases.
In his speech to the American Or­
thopaedic Association in June 1976, 
Mr. Justice Haines stated:
In medical malpractice cases there is no 
constitutional right to trial by jury in
Canada. . . as a result a prospective liti­
gant cannot rely on the jury sym­
pathetically bending the law against the 
doctor whose ability to bear the loss is 
probably underwritten by insurance. Loss­
bearing capacity is always a potent factor 
in doubtful cases.
These sentiments were reflected in the 
case law as early as 1902. Chief Jus­
tice Falconbridge, chief justice of the 
King’s Bench, stated:
Actions of this kind were, as a matter of 
course, formally tried, both here and in 
England, by a jury; and it was the almost 
inevitable result that juries, perhaps in­
nocently and unconsciously, looked more 
favourably upon the case presented by the 
patient than on that presented by the phy­
sician or surgeon. To remedy this condi­
tion of affairs, and not to leave doctors 
entirely at the mercy of juries, the courts 
in this country early became astute to lay 
down limitations and restrictions on the 
actions of the twelve; or, rather as to what 
matters ought to be left to them to deal 
with. For example, in 1869 the Court of 
Queen’s Bench held in Jackson v. Hyde, 
28 U.C.R. 294, that in an action against a 
surgeon for negligent malpractice, where 
the evidence is as consistent with the ab­
sence [as] with the existence of negligence, 
the case should not be left to the jury. . . 
The next step in the practice was the sug­
gestion by the courts that this class of 
cases ought more properly to be tried by 
a judge without a jury. This was the corol­
lary that this case is tried by me without a 
jury, the parties having practically con­
sented to my so doing.3
The reasoning of Chief Justice Falcon- 
bridge has been consistently followed 
in Canadian and English cases. I t is 
often repeated by academics when dis­
cussing the problem of trial by jury in 
medical malpractice litigation.
There is no constitutional guarantee 
in Canada that permits a party to in­
sist on the use of a jury in a civil case. 
There is legislation that requires the 
use of a jury in certain cases, such as 
libel and slander and malicious prose­
cution, but apart from this legislation 
there is no “constitutional guarantee”. 
In this respect the Canadian experience 
is different from that of the US and 
that difference is reflected in the med­
ical malpractice area.
Sociologic Factors
The sociologic differences between 
Canada and the US are very difficult to 
pinpoint; it is almost impossible to assess 
the impact of such factors on the differ­
ence between Canadian and American 
medical malpractice litigation. How­
ever, it is a common belief that various 
sociologic differences are factors in 
the development of the larger medical 
malpractice awards in the US. In  a re­
port issued by the California State As-
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sembly,6 there is a reference to a num­
ber of sociologic factors which have 
contributed to the large medical mal­
practice awards in that state. The re­
port concludes that more patients are 
electing to sue. According to the Cali­
fornia State Assembly there are at least 
five major reasons for this trend: a) a 
changing doctor-patient relationship; 
b) the legal rights explosion; c) the im­
pact of the media; d) increased profi­
ciency of trial lawyers; e) change in 
legal doctrines. This trend towards in­
creased litigation can be said to be a 
product of the “affluent society”.
There can be no doubt that there 
has been a substantial change in the 
physician-patient relationship. The Ca­
lifornia State Assembly points out 
(page 22) that “the neighbourly kind 
and benevolent family doctor epitom­
ized by the television physician ‘Mar­
cus Welby’ is fast disappearing”.6 
There are a number of reasons for this. 
In the first place, there is a definite 
trend away from personal care. The 
tremendous demand for services and 
on the physician’s time have meant 
that the physician is not able to 
give an individual the personal at­
tention that is necessary to establish 
a patient-physician rapport. More­
over, the trend towards specialization 
in medical practice has also con­
tributed to the problem. A patient 
may be seen by a number of different 
physicians in the course of any one 
given illness. No doubt the patient 
benefits from the technical expertise 
of the specialists, but it is also clear 
that there is little time for each special­
ist to establish a relationship with the 
patient. This lack of physician-patient 
rapport is reflected in the fact that 
specialists such as anesthesiologists and 
orthopedists are subjected to a higher 
frequency of medical malpractice liti­
gation claims.6
A part from the physician-patient re­
lationship itself, the trend towards ur­
banization has also played an import­
ant role in decreasing the physician- 
patient rapport. The trend towards 
social stratification tends to make the 
physician more alien to his patients 
than he was in the past. The physician 
is no longer the recognizable member 
of the community that the doctor in 
bygone years was.8
Added to  this development is the 
legal rights explosion which began in 
the 1960s. Americans are a more li­
tigious society today than ever before. 
There is a growing feeling among the 
citizenry that newly perceived rights 
should be enforced by litigation, if ne­
cessary. The California State Assembly 
suggests (page 25) that this develop­
ment may be a product of the highly 
technologic western society.6 On the
other hand, the California State Assem­
bly believes (page 26) that some blame 
must lie with the government:
. .. other branches and levels of govern­
ment, including the legislature, must 
assume some responsibility for our citizens’ 
propensity to seek judicial relief. After 
all, the recent civil rights explosion began 
in the courts-and was only later carried to 
the legislatures, because the legislatures 
had initially defaulted in their representa­
tion of discrete and insular minorities, of 
those without political clout.6
The development of associations dedi­
cated to the enforcement of legal rights 
has also assisted in the legal rights ex­
plosion. For example, the existence of 
such groups as “N ader’s Raiders” has 
meant that a party who feels aggrieved 
can now seek redress through an as­
sociation with sufficient strength to 
match the power of the offender. The 
development of the class action has 
also assisted the small claimant to pur­
sue his action. The existence of legal 
aid in many jurisdictions has also con­
tributed to the legal rights explosion.
It is generally felt that Canadians 
are not as “claims-conscious” as Amer­
icans. In his speech Mr. Justice Haines 
stated:
Canadian people are not claims-conscious. 
I think they look in astonishment at their 
neighbours and their astronomical verdicts. 
With respect it seems to me the American 
people are fascinated with litigation of all 
kinds. Their television programs bear 
eloquent testimony. Every high school 
student is imbued with the history of your 
courts in the protection of great rights. As 
a people you are more familiar with the 
law and its institutions than most and you 
are prepared to engage in the use of them. 
Not only are malpractice actions more 
numerous in the United States, but so are 
personal actions of all kinds, defamation, 
injury, products liability, workmen’s com­
pensation and a host of others. Your 
courts may be utilized without expense. 
Jury trials are guaranteed in most cases. 
So it is only natural that a disgruntled 
citizen should exercise his felt rights so 
long as he can find a lawyer to assist him. 
As a result the American people are 
probably the most litigation-conscious in 
the western world.
On the other hand, Canadians are not 
as conscious of their constitutional 
rights. It is not that we do not respect 
the rights and freedoms of other peo­
ple, it is just that we are less oriented 
towards individual rights and are more 
concerned with the rights and freedom 
of the community as a whole. More­
over, Canadians tend to look towards 
government to provide the protection 
necessary in specific instances. For this 
reason there is a plethora of legislation 
dealing with consumers’ rights and 
other areas of interest to the individual.
Media
The media have a tremendous impact 
on medical malpractice litigation. In 
the first place the media contribute to 
the belief that medicine is an exact 
science and that medical practitioners 
should not err in the performance of 
their duty. In its report on medical 
malpractice, the California State As­
sembly states:
Another factor influencing more patients 
to file malpractice claims is the attention 
given by the media to the practice of 
medicine and malpractice litigation. Both 
printed and electronic media continually 
discuss and praise the technological ad­
vances made by modern medicine. The 
impression these reports make with the 
public is that modern medicine is an exact 
science capable of correcting or alleviating 
a vast variety of human maladies.6
Moreover, the media have paid partic­
ular attention to the size of awards in 
medical malpractice litigation. The re­
port goes on to say that
medical malpractice litigation has also 
been given considerable attention by the 
media, particularly those cases involving 
substantial dollar verdicts or settle­
ments. . . Virtually every major medical 
malpractice verdict and settlement in 
California in the past year has been 
publicized in the local press. This public­
ity makes more persons aware of their 
legal rights and remedies, and understand­
ably prompts some to fully investigate the 
desirability of litigation when they have 
suffered an untoward medical injury.
This is much like the controversy over 
violence on television. It is said that 
the glorification of violent behaviour 
is a factor in the increase in violence 
in the real world. Finally, it is not clear 
what impact the information dissemin­
ated by the media in medical malprac­
tice cases has on the citizen who will 
sit on a jury in a future case. Perhaps 
there is a natural tendency to go one 
better as each case comes before a 
jury.
Specialization
The growth of a bar specialized in 
the practice of medical malpractice 
litigation in the US has also contributed 
to the problem in that country. Mr. 
Justice Haines stated:
We have not in Canada claimant’s lawyers 
specializing in malpractice litigation. We 
have some excellent general counsel of the 
highest quality, but the presentation of a 
contested malpractice claim in the Cana­
dian climate requires expenditure of 
enormous legal fees which the average 
client will not invest.
It should be noted, however, that there 
is a specialized defence bar in Canada.
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Most of these legal specialists are re­
tained by the insurance companies who 
cover the medical field or other areas. 
In representing their client on an on­
going basis these counsel attain a great 
deal of specialized knowledge in the 
defence of such claims. Indeed, the 
existence of a specialized defence bar, 
in juxtaposition to the nonexistence of 
a specialized plaintiff’s bar, may be 
a factor in keeping the amount of 
damage awards in Canada at a reason­
able level in relation to the amount 
of damage awards in the US.
Legal Doctrines
Res Ipsa Loquitur
The concept of res ipsa loquitur has 
very little application in negligence 
law. The basic premise of the concept 
is that the situation speaks of neg­
ligence. The concept is designed to 
facilitate the plaintiff’s burden of 
proving his case. In “Charlesworth On 
Negligence,”15 the author states:
The maxim is not a rule of law. It is ‘no 
more than a rule of evidence affecting 
onus. It is based on common sense, and 
its purpose is to enable justice to be done 
when the facts bearing on causation and 
on the care exercised by the defendant 
are at the outset unknown to the plaintiff 
and are or ought to be within the know­
ledge of the defendant’.
It should be clear that where the 
maxim of res ipsa loquitur applies, the 
onus on the plaintiff to prove his case 
is effectively reduced. If the concept 
were applied in medical malpractice 
litigation cases it would facilitate rec­
overy for the patient.
The problem is that the concept has 
been applied improperly in medical 
malpractice litigation in the US, par­
ticularly in California. The report of 
the California State Assembly states 
(page 29) that
res ipsa loquitur (the thing speaks for it­
self) is an evidentiary rule of law which 
allows the jury to draw an inference of 
negligence based upon circumstantial evi­
dence. Generally speaking, the jury is only 
allowed to draw this inference when the 
circumstantial evidence is such that it in­
dicates the probability of negligence. Yet 
in a couple of notable California Supreme 
Court decisions, the doctrine has been 
applied in cases involving rare medical in­
juries without consideration as to whether 
or not such injuries indicate a probability 
of negligence. This has substantially eased 
the plaintiffs burden of proof in rare 
medical injury cases, thereby widening 
the scope of liability.6
The Assembly comes to the conclusion 
that
res ipsa was extremely important in devel- 
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oping the present malpractice situation in 
California. Indeed, throughout the coun­
try, the medical profession has called for 
legislation eliminating res ipsa entirely in 
actions against physicians.6
Moreover, it is not clear what effect 
the concept has on the jury; it is dif­
ficult to determine whether the jury 
can fully understand the application of 
the concept.
We say the doctrine can only be 
applied where the circumstances are 
all within the control of the people 
acting in the event and where negli­
gence is probably present. In the US, 
by what I think is judicial careless­
ness, the doctrine has been allowed to 
drift to the position where now “the 
thing speaks for itself’ if the jury 
thinks it does. If the events are not en­
tirely controlled by the defendant why 
should he be deemed liable in negli­
gence because the jury thinks the se­
quence of events leads inexorably to 
damages.
Development of Concept of
Informed Consent
The doctrine of informed consent is 
the most controversial of the legal doc­
trines. It exposes doctors to daily liabil­
ity and it is a doctrine which cannot 
be precisely defined by the legal pro­
fession today.
The doctrine is not new, nor is it 
confined to medical matters. It covers 
all contracts and simply means that a 
consent is not valid and binding un­
less the person giving it has been ade­
quately informed of his position. The 
concept of informed consent places a 
substantial burden on the physician. 
The physician must take all reasonable 
precautions to communicate all neces­
sary information to the patient in 
order to enable the patient to make an 
informed decision on surgery. Without 
such informed consent the doctor may 
be liable in battery and negligence.
In the US the issue of informed con­
sent is generally left to the jury. The 
jury is allowed to determine for them­
selves whether the doctor has given the 
patient sufficient information to obtain 
informed consent. There is no presump­
tion of informed consent which the 
patient must rebut by showing such 
things as emotional duress or inca­
pacity.
In Ontario, the requirement of in­
formed consent has not reached a very 
high level. The law requires informed 
consent, but the patient does not have 
to have independent legal advice be­
fore consenting.
The doctrine itself goes back to the 
1880s. Unfortunately, it has been 
turned into a kind of racket in the US. 
Lawyers advertise for patients who
have had operations recently and are 
not satisfied with the results. Then they 
get the persons into their offices and 
go over the effect of the operation and 
decide whether or not the doctor ac­
quainted them with all statistics of the 
risks attending the treatment they re­
ceived.
In a discussion of the problem Robert 
C. Strodel16 states:
There is nothing more fundamental than 
the right of an individual to make in­
telligent, free, personal choices of what is 
or is not to be done to his person by 
someone else. A person has a right to 
enough information to be able to choose 
alternative treatments or to accept or 
reject recommended treatment. .. the doc­
trine of informed consent applies to elec­
tive procedures and is intended to give the 
patient a choice in keeping with his intel­
ligence and mental capacity to understand. 
The Courts recognize these distinctions 
and apply a rule of reason, often going 
so far as to require expert testimony as to 
what the standards are in the particular 
area for the explanation to a given patient 
regarding a given procedure.
The legal concept of informed con­
sent in Canada does not differ much 
from that in the US. The difference 
arises in the application of the concept. 
As stated above, the issue is left to the 
jury in the US, whereas it is decided 
by the judge in Canadian cases.
The concept of informed consent is 
discussed at great length by Mr. Jus­
tice Haines in Reibl vs Hughes.11 In 
that case the plaintiff, Reibl, developed 
constant headaches and sought med­
ical advice from the defendant, 
Hughes. The defendant conducted a 
number of tests on the plaintiff. The 
defendant discovered a murmur over 
the left carotid artery in the plaintiff’s 
neck, slightly behind and below the 
ear. Subsequent arteriographic examin­
ations revealed a build-up of plaque 
which significantly narrowed the left 
internal carotid artery about 2.5 cm 
above the bifurcation. The narrowing 
or stenosis had reduced the cross-sec­
tion of the artery at that point by ap­
proximately 80% to 90% , permitting 
only about 15% of normal blood flow 
through the vessel. The defendant con­
cluded that the major occlusion in the 
left internal carotid artery was asymp­
tomatic, in that it was not causing any 
detectable neurologic dysfunction or 
abnormality at that time. Despite this 
opinion the defendant concluded that 
the occlusion should be surgically re­
moved to reduce the risk, over the next 
several years, of a stroke caused by 
diminution of blood supply to the brain. 
The operation was subsequently per­
formed on the plaintiff. Immediately 
after the operation the plaintiff suf­
fered a massive stroke which paralysed 
the right side of his body and left him
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impotent. Mr. Justice Haines found 
that the plaintiff was unfit for work 
and would remain so for the rest of his 
life. On the basis of the evidence, Mr. 
Justice Haines concluded that there 
were a num ber of risks inherent in such 
a surgical procedure. In his judgement, 
he lists these as being:
First, manipulation of the artery during 
the initial stages of surgery and before the 
artery is clamped can dislodge platelets 
from the stenosis which would per force 
be carried up into the brain with the flow 
of blood and possibly block a smaller 
vessel; second, once the artery is clamped, 
there is the danger to which I have alluded, 
of collateral supply from the three other 
sources being insufficient to supply the 
brain during the period of the surgery; 
third, there is the danger that the upper 
severed edge of the inner lining of the 
vessel may be left loose from the wall of 
the artery, allowing the resumed upward 
flow of blood to force it back, blocking 
the artery as a flap or valve; fourth, there 
is a danger of a blood clot forming in 
the vessel at the operative site after the 
operation, either blocking blood flow to 
the brain at that point, or breaking off to 
occlude smaller vessels in the brain; fifth, 
there is the danger of the artery being 
narrowed by sutures too tightly drawn; 
and finally there is the danger of blood 
leaking from the sutured vessel after the 
outer incision is closed, clotting in the sur­
rounding tissue and by compression of the 
artery restricting the flow of blood 
through it. Each realized eventuality re­
sults in a restricted supply of blood to the 
cells of the brain, which when starved of 
oxygen, become dysfunctional or die.17
Mr. Justice Haines also dealt with the 
qualifications of the defendant and his 
knowledge of the risks. He states (page 
6) that
between 1953 and 1970, prior to perform­
ing this operation on the plaintiff, the 
defendant had carried out between 60 and 
70 like operations. Between 8 and 10 of 
those operations had resulted in fatalities, 
although most of those occurred in the 
earlier years when the technique was re­
latively new. The defendant’s understand­
ing was that given the state of the devel­
opment of technique by 1970, the risk of 
his patient dying as a result of the opera­
tion was less than 4% and that the risk of 
neurological damage or non-fatal stroke 
was about 10%. Those risks he knew to 
be cumulative: in 1970 a patient on whom 
he performed this operation was subject 
to roughly a 14% risk of mortality or 
morbidity as a result of the operation 
itself.17
In discussing the defendant’s liability, 
Mr. Justice Haines notes that there 
was no allegation of malpractice in the 
performance of the operation. The 
plaintiff’s case was based on two allega­
tions: first, that the plaintiff had not 
given his informed consent to the per­
formance of the endarterectomy and 
second, that the defendant was negli-
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gent in the postsurgical treatment of 
the plaintiff once it was discovered that 
the plaintiff was in danger of a stroke.
The issue of liability essentially re­
volves around the issue of informed 
consent. Before discussing the law in 
relation to this specific case, Mr. Jus­
tice Haines refers to a judgement of 
Mr. Justice Morden in Kelly vs Hazlett 
(unpublished, July 29, 1976). Mr. Jus­
tice Haines quotes from that judge­
ment:
Broadly speaking a battery is the inten­
tional, unconsented to, touching of the 
person of the plaintiff by the defendant, 
while negligence (in the context of the 
case such as this) consists of the sub­
standard execution of a duty of care by 
the doctor resulting in damage. The doc­
tor’s general duty of care includes not 
only the duty to exercise due skill and 
competence in diagnosis and treatment, 
but also to give reasonable information 
and advice to the patient. This latter duty 
is one of variable content depending on 
the circumstances of the case and the 
determination of its proper scope is very 
often a matter of considerable difficul­
ty. . .The issue of informed consent can 
arise in both battery and negligence cases: 
with respect to the former a lack of 
proper information communicated by the 
doctor to the patient can vitiate an ap­
parent consent while, with respect to the 
latter, failure to see to it that the pa­
tient is properly advised can amount, in 
certain circumstances, to an act of negli­
gence.17
Mr. Justice Haines points out that the 
issue of informed consent revolves 
around ‘the right of an adult person 
of sound mind to determine what shall 
be done with his own body”.17 Fur­
ther, where the issue of informed con­
sent is raised, the onus to prove con­
sent as a defence falls upon the de­
fendant doctor.17 (In Canada, where 
there is a written consent, there is a 
presumption of consent and the onus 
is then on the plaintiff to establish that 
there was not “informed consent”.)
In deciding what information should 
be brought to  the attention of the pa­
tient, the doctor must also consider 
“collateral risks”. Mr. Justice Morden 
in Kelly vs Hazlett, stated that: “Fur­
ther, even if a risk is truly collateral, 
but still material, it could be said that 
its disclosure is so essential to an in­
formed decision to undergo the oper­
ation that lack of such disclosure 
should vitiate the consent.”17 Mr. Jus­
tice Morden refers to a case in which 
the defendants performed experimental 
surgery on the plaintiff. The plaintiff 
had volunteered for the surgery. It 
was decided that the defendants had 
not given the plaintiff sufficient infor­
mation on which to base his decision 
to proceed with the experimental sur­
gery.18
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In deciding what information and 
what risks should be brought to the at­
tention of the patient, it is not incum­
bent on the doctor to point out dangers 
that are incident to or possible in any 
surgical procedure, such as the dangers 
of anesthesia or the risk of infection.17 
Such matters are presumed to be within 
the ordinary knowledge of all men and 
it is further presumed that the patient 
appreciates such risks.
In determining whether informed 
consent has been given, the courts will 
rely heavily on expert medical testi­
mony. Mr. Justices Haines points out 
that
the difficulty evident for the independent 
evaluation of these factors by a lay tri­
bunal has caused the law of this jurisdic­
tion to leave the definition of the scope 
of this duty in any particular case a 
matter essentially of medical judgment, 
one to be determined by the court on the 
basis of expert medical evidence.17
Moreover, the duty of the surgeon in 
the particular circumstances is defined 
by accepted general practice in the 
community of surgeons.17
In the circumstances of the partic­
ular case, Mr. Justice Haines finds 
that there was not informed consent. 
He states:
I am satisfied had Dr. Hughes said to the 
plaintiff — calling him in and making a 
sketch if necessary to clarify his meaning 
— “I propose to remove a partial plug of 
an artery a few inches from your brain. 
There is a risk that as a result a fragment 
of tissue may slip into your brain and if it 
does, you have a 4% chance of dying and 
a further 10% chance of having a stroke”, 
there is no question the plaintiff would 
flatly have refused.17
Mr. Justice Haines finds that the 
plaintiff was entitled to know the 
nature of the risk involved in the sur­
gery. The specific finding of Mr. Jus­
tice Haines can be found in the follow­
ing:
First, I find that although the defendant 
did impart to the plaintiff an understand­
ing of the mechanics of the operation, to 
the extent that the plaintiff was made 
aware the pluggage was to be surgically 
removed from an artery leading to his 
brain, the defendant did not take sufficient 
care to communicate to the plaintiff the 
purpose of the operation. I find that as a 
result the plaintiff was probably left with 
the misunderstanding that the operation 
was being undertaken to alleviate his 
headaches and hypertension and to permit 
him to function effectively at his job. 
Further, and most importantly, I find that 
the defendant did not take sufficient care 
to convey to the plaintiff and assure that 
the plaintiff understood the gravity, nature 
and extent of risks specifically attendant 
on the endarterectomy, in particular the
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risk that as a result of the operation he 
could die or suffer a stroke of varying 
degrees of severity. . . I find that he did 
not address with the attention required of 
him the specific risks of an adverse result 
of the operation itself.17
As a result, Mr. Justice Haines finds 
the defendant liable both in negligence 
and by the tort of battery.
In so far as damages are concerned, 
Mr. Justice Haines takes into consi­
deration the fact that the defendant is 
unable to work and has been ren­
dered impotent by reason of the 
stroke suffered after the operation. 
Given the facts of the case, Mr. Justice 
Haines assesses the total damages 
at $225 000.17
The decision in Reibl vs Hughes is 
now under appeal to the Ontario Court 
of Appeal and we do not have the final 
word on the subject. However, one 
should note that the damages awarded 
in the case are in no way similar to 
the awards granted in the US.
In both Canada and the US the de­
fendant must show that valid consent 
to the operation was obtained. In Can­
ada, if a signed consent form is avail­
able, there is a presumption of consent. 
(This is one of the changes proposed 
in the US.) It is then incumbent on 
the plaintiff to demonstrate that in­
formed consent was not given. This can 
be shown by proof of mental incapacity 
or emotional duress. In the US, how­
ever, the issue of informed consent is 
left to the jury; the jury also makes 
the final assessment of damages in the 
case. Consequently, the issue of in­
formed consent is integrally related to 
the impact of the role of the jury in the 
US on medical malpractice litigation, 
as discussed above.
Effects
Insurance Rates
As a result of the enormous damage 
awards in the US in medical malprac­
tice litigation, insurance rates in the 
US have risen dramatically in the past 
few years. In the article already 
alluded to, Geekie4 states: “In recent 
months Canadian physicians have read 
. . . reports on the USA medical mal­
practice insurance fiasco. That annual 
malpractice insurance premiums could 
be an average $4000 and even as high 
as $35 000, for a few specialties in 
some states, was difficult to believe.” 
As a result of the insurance fiasco, it 
appeared that a number of hospitals 
would have to close down and that a 
number of doctors would have to go 
out of business. Consequently, a num­
ber of states passed legislation requi­
ring insurance companies to cover 
hospitals and doctors and limiting the 
amount of liability of doctors and hos-
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pitals in particular situations. M ore­
over, some states passed statutes set­
ting up compensation funds in place of 
medical malpractice litigation. It re­
mains to be seen whether such legisla­
tion can effectively deal with the prob­
lem. Other legislation dealing with 
limitation of rights in the malpractice 
field has been challenged as uncon­
stitutional and the courts have struck 
down such legislation in many states.
Defensive Medicine
In the summary of recommendations 
of the Secretary’s Commission on Med­
ical Malpractice,19 reporting in 1973, 
the commission dealt with the effect 
of the medical malpractice “fiasco” on 
the medical profession. One of the ef­
fects found to exist by the commis­
sion was that of “defensive medicine”. 
The commission states:
The Commission finds that defensive 
medicine is the alteration of modes of 
medical practice, induced by the threat of 
liability, for the principle purposes of 
forestalling the possibility of law suits by 
patients as well as providing a good legal 
defense in the event such law suits are 
instituted.19
The commission then goes on to de­
fine three types of defensive medicine.
Positive defensive medicine is the conduct­
ing of a test or the performance of a 
diagnostic or therapeutic procedure which 
is not medically justified but is carried out 
primarily (if not solely) to prevent or 
defend against the threat of medical-legal 
liability. . .Negative defensive medicine 
occurs when a physician does not perform 
a procedure or conduct a test because of 
the physician’s fear of a later malpractice 
suit, even though the patient is likely to 
benefit from the test or procedure in 
question.19
A third form of defensive medicine 
was also brought to the commission’s 
attention.
There appears to be a reluctance on the 
part of some physicians to publish in 
medical journals case reports describing in 
detail noted adverse effects of diagnostic 
and therapeutic procedures. The fear is 
that the material will be picked up and 
used as evidence in a law suit.19
The quality of medical care can only 
suffer by such techniques.
It also appears that the concept of 
“defensive medicine” is not unknown 
in Canada. In her valedictory address 
as president of the Canadian Medical 
Association, Dr. Bette Stephenson 
stated:
Perhaps the most hazardous result of mal­
practice litigation phobia is defensive 
medicine. In order to protect themselves
in the possible event of suit, physicians 
may submit each and every patient to the 
full range of laboratory testing procedures 
and radiographic examinations. Already 
some evidence of this phenomenon has 
been exhibited in physicians’ practice pro­
files. Widespread advocation of such 
superdefensive practice is fraught with 
real danger for both individual patients 
and society as a whole. The individual pa­
tient may be subjected to bad medical care 
and the hazards of excessive investigation 
and at the same time be denied access to 
the benefits of relatively new treatments. 
Society as a whole suffers the impedence 
of advances in medical science and the in­
tolerable burden of explosively expanding 
costs of medical care. The picture of a 
malpractice inhibited medical profession is 
neither encouraging nor pretty.4
In a climate of medical malpractice 
phobia, the quality of medical care 
can only suffer. As a result, it may be 
incumbent on the legislature to deal 
with the problem.
Cures
Limitation Periods
In Ontario, the limitation period for 
medical malpractice is set out in the 
Health Disciplines Act (Statutes of O n­
tario, 1974, chapter 47). By virtue of 
section 17 of that act
no duly registered member of a college 
is liable to any action rising out of 
negligence or malpractice in respect of 
professional services requested or rendered 
unless such action is commenced within 
one year from the date when the person 
commencing the action knew or ought to 
have known the fact or facts upon which 
he alleges negligence or malpractice.
This change in the limitation period 
increases the time in which a patient 
may sue a doctor in that the period 
runs from the date when the person 
commencing the action knew or ought 
to have known of the facts of the 
negligence. In the past, the limitation 
period was related simply to the act 
of surgery. Although the new legisla­
tion basically extends the limitation 
period it is generally felt that it is 
much fairer than previous legislation.
In the US, many states have taken 
up the challenge and have passed legis­
lation dealing with the problem of m ed­
ical malpractice litigation. In  this re­
spect. many of the states dealt with the 
question of limitation periods for m ed­
ical malpractice cases.
Professor Curran13 sets out the types 
of changes which have occurred:
The most common substantive legal 
change was a reduction in the statute of 
limitations for malpractice claims. 
Changes of some type were enacted in 17 
states. (California, Florida, Illinois, In-
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diana, Iowa, Louisiana, Maryland, Mas­
sachusetts, Michigan, Nevada, New York, 
North Dakota, Ohio, Oregon, South 
Dakota, Tennessee and Texas.) Most of 
the statutes covered all practitioners of the 
healing arts and health-care institutions, 
but some were limited to physicians, as in 
Maryland. There was no pattern at all to 
the periods. They ranged from one to ten 
years for all actions including later dis­
coveries of foreign bodies left behind in 
operations. All laws covered both tort and 
contract actions of malpractice. The most 
common feature of the amendments was a 
stated limitation on the time within which 
later-discovered matters could be brought. 
Most of the statutes allowed an added two 
years for these situations, though Illinois 
allowed ten years. Most also controlled 
the time for filing by minors. The strictest 
law was that of Indiana where all actions 
without exception must be brought within 
two years except for minors under six who 
have until their eighth birthday to bring 
the action. Next strictest was Louisiana 
where the time was cut to one year for all 
actions except later discovered matters 
where the action must be brought within 
one year of its discovery, but in no event 
more than three years after the original 
operation or treatment.
It can be seen from this that the legis­
lation in Ontario is much simpler in 
its approach and basically much fairer 
in its application. The existence of a 
10-year limitation period places a sub­
stantial burden on the medical profes­
sion and undoubtedly leads to an in­
crease in insurance rates.
The problem is, again, that such 
legislation has been challenged in the 
courts. In the December 1976, issue 
of the Association of Trial Lawyers of 
America Newsletter, there is a com­
ment on an Idaho case which dealt 
with the constitutionality of such le­
gislative remedies. In many cases such 
legislation has been struck down. The 
cases are not right on point in so far 
as limitation periods are concerned 
but they do indicate that legislative 
remedies are not always the best solu­
tion to  a problem. Given the trend in 
the courts in the US, it remains to be 
seen whether legislation dealing with 
the medical malpractice dilemma will 
be as effective as hoped for.
Limitation o f Amount
M any states in the US have imposed 
limits on the amount of recovery in 
medical malpractice litigation. Curran13 
states:
Six states have imposed flat limits on total 
recovery from source (California, Idaho, 
Illinois, Indiana and Louisiana [sic]). Wis­
consin imposed an automatic limit of 
$500,000 if the pooled fund should fall be­
low $2,500,000; otherwise there is no limit 
on recovery from the pool. The most com­
mon limit for practitioners is $100,000 
imposed in Florida, Indiana, Louisiana,
and for one class of physicians in Oregon. 
The Oregon law covers only physicians 
(all others cover different types of 
practitioners plus hospitals or other facil­
ities) in six classes with the highest two 
groups covered for $500,000. No total 
limits are imposed in Florida or Oregon 
but “caps” are put on recoveries from cer­
tain groups of providers. In these states 
the remainder of the recovery must come 
from the pool arrangement.
As of Apr. 1, 1977, Virginia has im­
posed a limitation of $750 000 in re­
spect of medical malpractice litiga­
tion.20
Again, such legislation has been 
challenged as being unconstitutional 
in many courts. In Illinois21 and Ohio22 
the legislation has been held to be un­
constitutional. These cases are not bind­
ing on the other states but the trend 
may persist and the legislation may 
be held to be unconstitutional in many 
more states.
Notwithstanding the issue of con­
stitutionality it is not clear whether the 
legislation will be effective. Curran13 
also points out that
even if these laws were to survive consti­
tutional attack they would have little ef­
fect on insurance rates. Recoveries in six 
figures and over constituted only 3% of 
all payouts in 1970. They may constitute 
more now, but not much more. Also, 
these large verdicts have been covered by 
two methods which take them out of the 
regular rate computation: (1) reinsurance; 
and (2) separately purchased “umbrella 
policies” for very large dollar awards. . . if 
the limitation were to survive constitu­
tional attack, they would affect the in­
come of the highly paid trial lawyers like 
those in the selective survey of the legal 
systems study, since these attorneys handle 
nearly all the large recovery cases. It 
should be recalled that this group 
averaged a recovery of $81,000 in the 
cases they handled during the survey 
period.
This approach to the problem, there­
fore, is not entirely effective.
Compulsory Arbitration
There is also a trend in the US to 
remove medical malpractice litigation 
from the courts and place it with civil 
tribunals. This is similar to what was 
done for workmen’s compensation 
cases in Ontario. Again, however, the 
states of the US face particular prob­
lems in this respect. In an article en­
titled “Medical malpractice arbitra­
tion: a comparative analysis”23 it is 
stated:
The element of compulsion creates new 
problems, however. Forty-eight states 
guarantee the right to jury trial in civil 
suits; a state requirement that parties in­
voluntarily submit to arbitration must pro­
vide an opportunity at some time to 
present the dispute to a jury. The right of 
appeal to a jury and conditions governing 
such appeal will have a substantial effect 
on the arbitration process itself.
Despite these pitfalls, the authors con­
clude that arbitration is a desirable 
alternative to the present system.
Arbitration is one alternative that an 
increasing number of states are choosing. 
Since January 1975, nine states have en­
acted arbitration statutes applicable ex­
clusively to medical malpractice claims 
(Alabama, California, Louisiana, Mary­
land, Michigan, Pennsylvania, South Da­
kota, Virginia, Ohio). These statutes 
variously permit, encourage, or require 
parties to malpractice disputes to avail 
themselves of arbitration. Despite the 
similarity of each state’s problems and 
goals, clear difference between arbitration 
models are emerging that reveal funda­
mental value choices.
It should be noted that there is a 
distinct difference between compul­
sory arbitration and voluntary arbitra­
tion by agreement. In respect of com­
pulsory arbitration there is the prob­
lem of constitutionality; in respect of 
voluntary arbitration, there is the prob­
lem of judicial review of the arbitration 
decision.
Despite the handicaps inherent in a 
system of arbitration, it is felt that 
there are many advantages to such le­
gislation. In the same article,23 it is 
stated:
Louisell and Williams state three primary 
advantages of arbitration for medical 
malpractice claims. First, substituting 
arbitration panels including medical ex­
perts for lay juries may result in more 
accurate determinations in less time with 
less evidentiary input. Second, the presence 
of legally-expert panel members may per­
mit relaxation of technical rules intended 
to protect juries from unreliable evidence, 
resulting in less-formal, speedier hearings. 
Third, panel expertise and informality 
plus the finality of arbitral awards prom­
ise more rapid resolution once disputes 
get to actual hearings, reducing costs and 
saving the time of parties, lawyers, 
witnesses and triers of fact.
It is still too early to tell whether such 
legislation will be so effective.
In Canada, arbitration is not blocked 
by constitutional provisions. Moreover, 
there are distinct advantages to this 
method of solving malpractice dis­
putes. We may be well advised to util­
ize arbitration because it relieves the 
courts of a substantial burden, it allows 
the community to appoint experts to 
the arbitration panels from the medical 
profession and related disciplines, and 
in most cases arbitration boards can 
act more quickly and at less cost than 
the courts.
It may well be that Canada is head-
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ing for a similar alternative. In a 
speech to the annual meeting of the 
Canadian Hospital Association, Justice 
Minister Otto Lang stated: “If we want 
to pay compensation to persons who 
have injuries during the course of med­
ical treatment, I believe it ought to be 
done through a scheme that directs it­
self to the purpose of compensation 
and is not based on fault.”4 Lang’s con­
cept is a revolutionary one, perhaps 
unique in the world. It involves a state- 
supervised fund for the payment of 
injuries, and payments are made with­
out reference to fault. We are moving 
into no-fault insurance with respect 
to automobile accident cases, and per­
haps in time we will move in that di­
rection in the medical litigation field.
In any event, there has been an up­
surge in arbitration in labour law and 
in general contractual disputes. I think 
it should be tried in the medical field. 
Some day we may find provincial le­
gislation analogous to workmen’s com­
pensation laws which will allow the 
state to intervene and settle malpractice 
claims.
Screening
An alternative to the compulsory 
arbitration or voluntary arbitration tri­
bunal is a “screening mechanism”. A 
screening mechanism is basically a tri­
bunal which would be designed to 
eliminate nuisance suits. The parties 
would be required to come before the 
tribunal before going to court and it 
would be necessary to demonstrate a 
prima facie case before they could pro­
ceed to trial. This procedure would also 
be designed to cut down on trial time 
and to define the basic issues.*
The California State Assembly re­
commended that such a screening me­
chanism should be made mandatory.' 
At this point, however, the California 
State Assembly has not passed such 
legislation (but other legislation has 
been passed in t!:r* state, as mentioned 
above). In an article entitled “Malprac­
tice weather: stormy on coasts but 
calmer inland”, it is stated that
Florida and Tennesses legislatures both 
have Indiana-type laws that establish 
review boards before which plaintiffs must 
present their cases before suing in court. 
The boards can recommend settlements 
but they are not binding (though panel
*The Supreme Court of Ontario is 
currently conducting pretrial conferences 
in both civil and criminal cases with 
the intention of resolving various issues 
and expediting the trial. It is expected 
that current draft rules will eventually be 
embodied in the rules of procedure in 
respect of civil cases. These conferences 
are not a screening mechanism but they 
are designed to encourage settlements 
which are satisfactory to both sides.
statements can then be used in court as 
evidence). There is no limit to the awards 
that can be set by the review boards 
though in Florida all malpractice judg­
ments over $100,000 would be paid out 
of a compensation fund that costs phy­
sicians $1,000 a year and hospitals $300 
a bed (in Florida last month, a paralyzed 
dentist and his wife were awarded — 
under the old system — $1.6 million in 
damages from a Lake Worth neuro­
surgeon who operated on the dentist after 
an automobile accident).
The mechanism for the screening tri­
bunal can be quite elaborate. In Flo­
rida, Illinois, Massachusetts and Ten­
nessee, for example, the system is close 
to a court hearing and is headed by a 
trial court judge. In some states the 
panel consists of members of the pub­
lic and a lawyer as well as physicians. 
In all current legislation, except that in 
Nevada, the decision of the panel is ad­
missible in evidence at trial.13
Compensation Fund
As pointed out above, Florida has 
established a compensation fund for 
medical malpractice litigation. For 
judgements over $100 000 the judge­
ment is paid out of a compensation 
fund that costs physicians $1000 a year 
and hospitals $300 a bed. It is thought 
that such compensation funds spread the 
cost of liability among the profession. 
In this way insurance rates are de­
creased and the cost of practising med­
icine is supposedly reduced. In the 
speech by Otto Lang quoted above, it 
appears that a compensation fund 
could be established in Canada. It is up 
to the medical profession to decide 
whether such a fund would be a de­
sirable alternative.
Changes in Legal Doctrines
Res Ipsa Loquitur
As pointed out above, the concept of 
res ipsa loquitur assists the plaintiff 
in obtaining a judgement in a medical 
malpractice litigation case. Again, many 
of the states of the US are moving 
towards legislation dealing with the 
problem of the doctrine of res ipsa 
loquitur. In the legislation that now 
exists, however, there is no indication 
that the doctrine has been substantially 
altered. In most legislation the applica­
tion of the doctrine has been defined, 
but the extent of the doctrine has not 
been limited.13 Therefore, one would 
question the efficacy of such legislation.
Ad Damnum Clauses
In preparing pleadings in any case, 
the lawyer will include the amount
claimed for the client. In negligence 
cases this means that the amount 
claimed is included in the pleadings. 
In the US this amount may go before 
the jury. In Canada there is no ques­
tion that the amount pleaded in the 
statement of claim is not put before 
a jury. In a trial by judge alone, of 
course, the judge may be aware of the 
amount pleaded in the statement of 
claim, but this is not known to have 
any effect on the judge’s decision. In 
most cases the amount claimed in the 
pleadings is far in excess of the amount 
which the lawyers hope to obtain at 
trial. It is felt, however, that an excess 
amount should be claimed in case the 
amount awarded is higher than ex­
pected. If a low amount is claimed and 
the amount awarded is higher, the 
excess over the amount claimed may 
not be collected. In other words, the 
client loses the excess over the amount 
claimed unless the pleadings are amen­
ded by the trial judge.
In California, the report of the Ca­
lifornia State Assembly recommended 
that the ad damnum clause, which in­
cludes the amount claimed, should be 
eliminated. The report states: “This 
clause gives the public a distorted 
view of the value of the typical mal­
practice case. A study by the Califor­
nia Hospital Association showed that 
these demands were, on the average, 
some fifty-three times higher than the 
actual awards.”6 There is no comment 
in the report on the effect which such 
claims may have in a jury trial. In 
other states, ad damnum clauses have 
been amended because of the fear that 
such claims will have an adverse effect 
on the jury. In Florida, Indiana, Iowa, 
Louisiana, Massachusetts and Ohio 
the ad damnum  clause was eliminated 
altogether. In Wisconsin the pleadings 
only contain a statement of whether 
the claim is above or below $10 000. In 
Tennessee the ad damnum clause is re­
tained but there can be no disclosure 
of the amount claimed to the jury. In 
this respect the Tennessee legislation 
faces the problem squarely and deals 
with the precise issue.13
Contingency Fees
As pointed out above, the contingency 
fee is said to be one of the major fac­
tors in the current medical malprac­
tice litigation crisis. Professor Curran13 
sets out the changes in this area:
The physician’s favourite bugaboo, the 
contingent fee arrangement, was reformed 
in seven states. The fee percentage cannot 
exceed one-third in Oregon and Tennessee, 
though in the latter the judge can set it 
below this figure depending on the time 
and effort expended. Idaho imposed a flat 
limit of 40%, thus possibly increasing the 
fees of most lawyers who usually charge
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one-third. Indiana imposed a 15% maxi­
mum on the amount recovered from the 
pooled arrangement which allows pay­
ments in cases from $200,000 to $500,000. 
No limit is imposed on the fee recovered 
in the first $100,000 from providers. Since 
this limit is tied closely to the pool it 
might be declared invalid along with the 
general limitation on recoveries, if that 
plan is attacked in the courts. California 
imposed a graduated reduction in the per­
centage of the fee as the recovery goes 
up: 40% of the first $50,000; one-third of 
the next $50,000; 25% of the next 
$100,000; and 10% of recoveries over 
$200,000. Iowa merely authorizes the 
courts to set reasonable contingent fees. In 
Wisconsin the attorney must allow a client 
to pay on a pro diem basis if he desires. 
The contingent fee is not controlled in 
Wisconsin except to the extent that it 
cannot be assessed against medical ex­
penses, past or future. Indiana’s law also 
gives the client the right to pay on a 
mutually acceptable per-diem basis.
The changes in this area will not 
dramatically affect medical malpractice 
litigation. For example, in California, 
if a judgement of $1 million is granted, 
the lawyer stands to gain about 
$140 000 in fees. If a judgement of $4 
million is granted, the lawyer stands 
to gain approximately $440 000 in fees. 
As the cases in California indicate, rec­
overies between $ 1 million and $4 
million are not that unusual. Therefore, 
lawyers in California still stand to 
gain a great deal of money in medical 
malpractice litigation cases. As a re­
sult, the damage awards will remain 
high in order to compensate the 
plaintiff for the cost of the contin­
gency fee.
Collateral Sources
This is one area of concern which 
has not been discussed above. In Cali­
fornia, for example, a plaintiff can 
obtain recovery from the defendant for 
monies which he has obtained from 
other sources. In other words, if the 
plaintiff receives disability benefits 
from another source, this does not pre­
clude him from obtaining full recovery 
in the subsequent medical malpractice 
case. In essence, therefore, the injured 
patient obtains double recovery in re­
spect of the injury in so far as he is 
obtaining payments from more than 
one source. The same problem exists 
in many other states. At present many 
of the states in the US are moving to 
change this situation.
Six states installed some reform in the 
collateral source rule which is applicable 
in the majority of the states at present. 
Under the rule, plaintiffs are allowed to 
recover economic losses from the de­
fendant in personal injury suits even if 
they have already recovered them, or can 
recover them, from other sources such as 
insurance. Many commentators in a num­
ber of states consider this allowance un­
fair in providing double recoveries. In 
many situations, however, it is not double 
since the providers of the other benefits 
have subrogation rights to recover the 
money. . . The reform statutes are rather 
complicated and require close analysis. As 
I read them, only two states (Indiana and 
Iowa) totally bar the recovery of such 
elements. New York and probably Cali­
fornia merely allow submission into evi­
dence at trial of the fact of payment from 
other sources and leave it to the trier of 
fact to consider. Tennessee eliminates bene­
fits paid by any third party, including an 
employer, but allows them if paid for by 
the plaintiff or his immediate family out 
of assets or by insurance. Ohio bars re­
covery only of benefits paid by third 
parties, not if received as a result of pay­
ment of premiums or otherwise by the 
plaintiff, his employer, or anyone on his 
behalf.13
In Ontario the problem is solved sim­
ply by the understanding that when the 
plaintiff sues he is deemed to be suing 
on behalf of all other parties who have 
rights in the issue. For example, the 
plaintiff sues on behalf of Ontario Hos­
pital Insurance Plan for recovery of 
medical costs. Moreover, where insu­
rance is involved the plaintiff also sues 
on behalf of the insurance company 
for recovery of insurance amounts paid 
out. In this respect, there is no need 
for such complicated legislation in Can­
ada as exists in the US. The proposed 
solution in California does not deal 
adequately with the problem; the jury 
is still free to give double recovery.
Informed Consent
As discussed above, the concept of 
informed consent is also one of the 
major issues in medical malpractice 
litigation. In the legislation dealing 
with the problem of medical malprac­
tice litigation, many states have dealt 
with the issue of informed consent. 
Professor Curran13 states in his report:
Eight states passed legislation in 1975 
regarding the requirement of informed 
consent (Florida, Idaho, Iowa, Louisiana, 
Nevada, New York, Ohio and Tennessee). 
The objectives of the legislation were much 
clearer than what one would gather from 
the Malpractioe Commission Report. The 
first aim was to provide some prior pro­
tection for the physician so as to remove 
somewhat the uncertainty of the applica­
tion of the doctrine years later in a court. 
This took the form of imposing a pre­
sumption of valid consent when the con­
sent was obtained in writing and meeting 
certain standards. The most elaborate ef­
fort in this regard was in Ohio where the 
statute contains an actual suggested con­
sent form with check-offs and added 
blanks for filling in specific risks of the 
procedure or treatment. The Iowa, Loui­
siana and Ohio laws are quite detailed and 
very similar in the content of what must
be told to the plaintiff about major risks. 
The law requiring the least informing, 
that of Nevada, creates the strongest 
presumption (conclusive) of validity if 
followed. The Tennessee law requires the 
court to make a determination about in­
formed consent before submitting the case 
to the jury.
Again, it remains to be seen whether 
such legislation will be sustained, given 
constitutional challenges. As pointed 
out above, in Canada there is a pre­
sumption of consent when the patient 
has signed a consent form. However, 
the issue of informed consent can still 
arise. It is hoped that recent cases will 
give doctors some idea of what must 
be communicated to a patient in order 
to obtain informed consent.
Conclusion
Basically, it is impossible to predict 
the future of medical malpractice 
litigation in Canada. However, the sta­
tistics indicate that medical malprac­
tice claims are steadily increasing. We 
should act now to ensure that the prob­
lem does not reach crisis proportions. 
In so far as the medical profession it­
self is concerned, it should ensure that 
the competence of medical practitioners 
remains on the highest possible level. 
To quote the time-worn proverb, “An 
ounce of prevention is worth a pound 
of cure.” Moreover, competence is 
one of the best legal defences avail­
able.
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Angiography in Determining the Cause and Treatment
of Gastrointestinal Bleeding*
D.M. G race, m d , fr c s[c] and R.E. G old , m d , f r c p [c ]
Angiography is useful in the diagnosis 
of active gastrointestinal bleeding if 
the rate is greater than 0.5 mL/min. 
For upper gastrointestinal bleeding, 
endoscopy is the preferred initial 
investigation and angiography is used 
for diagnosis only if the site of bleeding 
is still obscure. Angiography is the 
preferred method for investigation 
of massive lower gastrointestinal 
bleeding if results of sigmoidoscopy 
are negative. Vasopressin infusion is 
most useful for control of bleeding 
from esophageal varices, erosive 
gastritis and diverticular disease of 
the colon. Embolization with Gelfoam 
or clot is possible for massive 
hemorrhage from a single source in 
poor-risk patients. This is most
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successful for gastric or duodenal 
bleeding since the collateral blood 
supply prevents infarction. Some of the 
methods and complications of 
embolization are discussed and 
examples are given. Standard surgical 
principles should still apply in most 
cases.
L’angiographie est utile dans le diagnos­
tic du saignement gastrointestinal 
lorsque le taux est superieur a 0.5 
mL/min. Pour les saignements gastro- 
intestinaux superieurs, I’endoscopie 
est la methode de choix initialement, 
et I'angiographie n'est utilisee pour fin 
de diagnostic que lorsque le foyer 
hemorragique demeure obscur. 
L’angiographie est la methode de 
premier choix pour la recherche des 
saignements gastrointestinaux inferieurs 
massifs si les resultats de la 
sigmoi'doscopie sont negatifs. La 
vasopressine en perfusion est des plus 
utiles pour controler le saignement des 
varices oesophagiennes, d'une gastrite 
erosive et d’une diverticulose du colon. 
L’obliteration du vaisseau par le 
Gelfoam ou un ca i I lot est possible 
pour les hemorragies massives 
provenant d'un seul foyer chez les
patients a risque eleve. Ceci reussit 
particulierement dans les hemorragies 
gastriques et duodenales car la 
circulation collateral previent 
I'infarcissement. On discute quelques 
unes des methodes d’obliteration des 
vaisseaux et leurs complications, et 
on en donne des exempted. Les principes 
chirurgicaux standards devraient 
s'appliquer dans la plupart des cas.
Gastrointestinal bleeding continues to 
be a problem for the general surgeon. 
To locate the site of bleeding in the 
operating room can be difficult, and 
emergency operation during a massive 
bleed carries a high mortality. Angio­
graphy is valuable in determining the 
site of bleeding and offers an oppor­
tunity to  control acute bleeding by 
means of vasopressin infusion or oc­
clusive techniques. We propose to re­
view briefly its usefulness from  both 
standpoints.
Gastrointestinal bleeding may be 
acute or chronic and its source 
high or low. High, or upper, gastro­
intestinal bleeding, defined as bleeding 
from a source above the ligament of 
Treitz, is usually from  peptic ulcers, 
superficial gastritis including stress ul-
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cers, or esophageal varices.1 Other 
causes include Mallory-Weiss tears, 
gastric tumours and carcinomas, and 
hiatus hernias. The most frequent 
causes of lower gastrointestinal bleeding 
are diverticular disease, ulcerative col­
itis, Meckel’s diverticulum (in children) 
and hemorrhoids. Arteriovenous mal­
formations are being recognized with 
increasing frequency as a source of 
such bleeding.2
Initial Assessment
In the investigation of gastrointestin­
al bleeding a careful history-taking and 
physical examination are essential. A 
history of bowel disease, peptic ulcera­
tion or epigastric pain, excessive alco­
hol intake or ingestion of drugs con­
taining acetylsalicylic acid is important. 
The vomiting of blood or passage of 
black stool may help to define the 
level of bleeding; dark red stools do 
not indicate the level of bleeding. 
In physical examination the blood 
pressure and pulse must be recorded 
early and repeatedly in the case 
of an acute hemorrhage. Signs of 
liver disease should be sought. Rectal 
examination must never be omitted. If 
the patient is vomiting blood or the 
site of bleeding is uncertain, a naso­
gastric tube should be inserted. Essen­
tial laboratory studies include baseline 
hemoglobin and clotting measurements 
as well as those necessary for assess­
ment of renal and hepatic function.
Upper Gastrointestinal Bleeding
For acute upper gastrointestinal 
bleeding aggressive investigation and 
treatment have decreased mortality.3 
Barium studies may be useful in the 
case of chronic bleeding or after acute 
bleeding is controlled, but barium must 
not be given early, since it will inter­
fere with endoscopy and angiography. 
Endoscopy should be carried out early 
in every case of upper gastrointestinal 
bleeding. It may not only demonstrate 
several lesions, but will indicate which 
one is bleeding. Acute gastric erosions 
are common4 and may be recognized 
only by this means. Endoscopic elec­
trocoagulation of bleeding lesions is 
now possible5 although still an experi­
mental procedure.
Angiography is of value if the diag­
nosis is still uncertain, since operation 
without a diagnosis carries an increased 
mortality.1 If endoscopy is impossible or 
difficult owing to poor patient coopera­
tion, continued active bleeding, massive 
clots, an obstructing neoplasm or a pre­
vious gastrectomy, then angiography 
may be helpful in diagnosis. Its role in 
the investigation and treatment of up­
per gastrointestinal bleeding is summar­
ized in Table I. Since patients often
bleed at inconvenient times, the angio­
graphic team must be available on short 
notice. To be seen at the time of angio­
graphy, bleeding must be active and at 
a minimum rate of 0.5 mL/min from 
a single site.6 The bleeding site is most 
likely to be located in patients who 
have been in shock or who have re­
ceived multiple transfusions.7 Since 
bleeding is often intermittent, the cath­
eter may be left in place to allow 
further studies if a bleeding site is not 
discovered. Because of the dual blood 
supply to the stomach and duodenum, 
both celiac and superior mesenteric an- 
teriography should be carried out, util­
izing selective studies for suspicious 
areas. Extravasation of blood from eso­
phageal varices cannot be detected by 
angiography although the venous phase 
of the arteriogram may allow detection 
of portal hypertension or esophageal 
varices.
We have often confirmed by angio­
graphy the source of bleeding when 
this has been a duodenal ulcer, gastric 
stress ulcer or Mallory-Weiss tear. Un­
usual sites of bleeding also have been 
identified, such as a pseudoaneurysm in 
the head of the pancreas. The following 
example illustrates the value of angio­
graphy in locating the site of bleeding. 
A patient was transferred to our hospital 
after laparotomy had failed to discover 
the source of active upper gastrointesti­
nal bleeding. The patient had previously 
had a Billroth II gastrectomy and no 
bleeding site could be found by en­
doscopy although there was blood in 
the stomach. Angiography revealed a 
bleeding tumour in the third part of 
the duodenum. This proved to be a 
leiomyoma, which was successfully re­
sected. Lesions of this area are parti­
cularly difficult for the operating sur­
geon to identify.
Vasopressin Infusion
Infusion of vasoconstrictive agents
Table I—Angiography for Upper Gastro­
intestinal Bleeding
1. Diagnosis
Active bleeding
Site not clear after endoscopy
2. Therapy
Vasopressin infusion 
Esophageal varices 
Erosive gastritis 
Other: Mallory-Weiss tear, ar­
teriovenous malformation, etc.
Embolization
In poor-risk patients only 
For bleeding stress ulcers, some 
gastric and duodenal ulcers 
As palliation in case of extensive 
bleeding tumours 
Rarely in Mallory-Weiss tears 
For transhepatic obliteration of 
esophageal varices (on experi­
mental basis)
has controlled the bleeding from some 
lesions. Bleeding from erosive gastritis 
or esophageal varices is most likely to 
be affected8,9 although there are some 
dissenting voices.10 Epinephrine was 
formerly used but vasopressin is now 
the standard agent, infused at a rate 
of 0.1 to 0.2 pressor units/min. Infu­
sion into the left gastric artery is used 
for bleeding gastric lesions and into the 
superior mesenteric artery for bleeding 
varices. In our experience the success 
rate has been high and catheters have 
been left in place as long as 1 week 
without complications. Systemic effects 
of vasopressin, which include vaso­
constriction and angina, seem to be 
reduced by local infusion. However, 
we do not yet have evidence showing 
that local infusion of vasopressin is 
more successful and less dangerous 
than peripheral administration. Because 
of the high mortality associated with 
gastric resection for bleeding gastritis 
and with portal-systemic shunting for 
bleeding esophageal varices, vasopressin 
infusion should be tried before resort­
ing to emergency operation.
Vasopressin infusion is not successful 
for rapid arterial bleeding11 or for 
bleeding from erosion of a major 
branch of the gastroduodenal artery by 
a duodenal ulcer.9 In such cases early 
operation is indicated, especially for 
older patients, since the mortality is re­
lated to age and the amount of blood 
transfused.1 Embolization techniques 
may rarely be indicated for the very 
poor-risk patient.
Embolization
Control of gastric bleeding by ar­
terial embolization was first reported 
as recently as 1972.12 A number of 
cases have been described and the sub­
ject has recently been reviewed.13 Bleed­
ing from a wide variety of lesions has 
now been controlled by embolization. 
Because of the potential complications 
(Table II), embolization is usually re­
served for high-risk patients; many com-
Table I I—Complications of Vascular 
Occlusion
Technical
Arterial obstruction at entry site 
Perforation of artery by guide wire 
Due to dye overload 
Pulmonary edema 
Renal failure 
Infarction
Especially of small or large bowel 
Associated with shock, vasopressin 
infusion and increasing age 
Misplacement of emboli to liver, kidneys or 
extremities 
Continued bleeding 
Failure to occlude vessel 
From collaterals of stomach and duodenum 
Delayed operation
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plications have probably not been re­
ported. Stomach and duodenum are 
suitable for the use of this technique 
because their rich collateral blood sup­
ply decreases the chance of infarction. 
However, this is still a highly experi­
mental procedure and should be carried 
out only by experienced angiographers 
willing to perfect their technique by 
animal experimentation. The methods 
of vascular occlusion are listed in 
Table III. We have most often used 
Gelfoam, but this agent usually causes 
permanent vascular occlusion, hence 
infarction is a danger. Clot is con­
venient but may lyse early. Balloon 
catheters offer temporary control, and 
silicone solutions may be applicable
Table I I I— Methods of Vascular Occlusion by 
Angiography
1. A rteria l
Embolization 
Blood clot
Clot +  aminocaproic acid or 
thrombin 
Gelfoam 
Ivalon sponge 
Oxycel (oxidized cellulose) 
Autogenous muscle or fa t 
Other: Silastic or silicone micro­
spheres, glass beads, lead shot, 
stainless-steel pellets 
Perfusion
lsobutyl-2-cyanoacrylate
Silicone
Balloon tamponade 
Electrocoagulation
2. Venous
Embolization —  clot, Gelfoam 
Sclerosis —  hypertonic glucose
for arteriovenous malformations or vas­
cular tumours in the future.
We have applied embolization tech­
niques infrequently and only in very 
poor-risk patients; our experience is 
summarized in Table IV. We have had 
considerable reported and unreported 
experience with this procedure in 
dogs.11,14 We used electrocoagulation 
successfully in one patient, but in an­
imals this carries a high risk of vessel 
perforation. A recent area of interest 
has been the transhepatic catheteriza­
tion and obliteration of bleeding eso­
phageal varices.15 While this may be 
effective in controlling massive bleeding 
and may reduce the need for emer­
gency surgery, recanalization of varices 
occurs16 and a definitive surgical opera­
tion may still be necessary.
Embolization techniques are still in 
their infancy. Undoubtedly they will 
be developed further, but at present 
they should be applied rarely. We still 
use the standard methods, along with 
vasopressin infusion or operation for 
most cases of upper gastrointestinal 
bleeding.
Lower Gastrointestinal Bleeding
Acute rectal bleeding is less fre­
quently encountered but is perhaps more 
of a diagnostic problem than upper 
gastrointestinal bleeding. Early angio­
graphy is the principal diagnostic tech­
nique in the investigation and treatment 
of this situation as summarized in 
Table V. Diverticular disease is the 
most frequent source but the diverticula
are often on the right side of the 
colon.17’18 In many cases the bleeding 
has been controlled by infusion of 
vasopressin.18"20 If bleeding persists or 
recurs, one may perform a less exten­
sive procedure than the subtotal colec­
tomy often advised for these patients. 
We have found angiography very 
useful in locating the source of bleed­
ing in cases of diverticular disease 
and arteriovenous malformations. Such 
sources as Crohn’s disease of the ileum 
and a fistula between a common iliac 
artery graft and the ileum have been 
precisely localized by angiography. We 
have been able to determine the origin 
of massive hemorrhage from the lower 
rectum by angiography in patients with 
leukemia and hepatic failure.21 Bleeding 
was so profuse that the site could not 
be discovered during sigmoidoscopy, 
but with angiographic evidence the 
bleeding site was readily identified so 
that ligatures could be placed. Arterial
Table V— Angiography for Lower G astroin­
testinal Bleeding
Diagnosis
All active bleeding (sigmoidoscopy is not 
diagnostic)
D iverticu lar disease, especially of right 
colon
Arteriovenous malformations 
Other: tumours, u lcerative co litis , etc. 
Therapy
Vasopressin infusion  
Especially for d iverticu lar disease 
Embolization
Only for extensive tumours 
High risk of bowel in farction
Table IV - Experience at U niversity Hospital, London, Ontario w ith Vascular Occlusion for Upper Gastrointestinal Bleeding, 1973 to 1977
Patient
no. Sex
Age
yr Source of bleeding Reason for vascular occlusion Method Result
i M 34 Lesser curve gastric stress 
ulcer
Shock, abdominal sepsis, mul­
tip le operations, total 
small-bowel resection
Le ft gastric artery occluded 
w ith  Gelfoam
Bleeding controlled. Survived  
4 years on home parentera l 
nutrition
2 M 58 Psuedoaneurysm, head of 
pancreas
Chronic pancreatitis, recur­
rent bleeding not controlled 
afte r 3 laparotomies
Electrocoagulation of feeding  
vessel
Bleeding controlled
3 M 25 Duodenal stress ulcer Quadriplegic Obstruction of gastroduodenal Bleeding controlled  
a rte ry  w ith  wedged cath­
e te r  fo r 48 h
4 M 40 Lesser curve gastric erosion 136 kg, alcoholic Branch of le ft gastric artery  
em bolized w ith Gelfoam
Bleeding controlled
5 M 67 Leiomyoma, 3rd part of 
duodenum
Previous gastrectomy, lapa­
rotomy while bleeding un­
successful
Feeding vessels embolized 
w ith  Gelfoam
Angiographic demonstration of 
controlled bleeding. Tum our 
resected a few hours la ter
6 M 63 Carcinoma, proximal stomach Shock, extensive malignant 
lesion obstructing eso­
phagus
L eft gastric artery occluded 
w ith  Gelfoam
Bleeding stopped tem porarily , 
emboli passed through ex­
tensive feeding vessels. Pa­
tien t died after resection of 
tumour
7 M 59 Esophageal varices Posthepatic cirrhosis, 
hepatoma of right lobe
T ran s ju g u lar catheterization  
of varices, Gelfoam em­
bolization
Reduced rate of bleeding. Pa­
tien t died 24 h la te r of 
hepatic fa ilu re
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embolization for control of bleeding 
from the small or large bowel is 
not recommended because of the 
danger of bowel infarction. However, 
this does not exclude its use to control 
rectal bleeding22 and bleeding from ab­
dominal tumours (including one of the 
large bowel).23 Recently, embolization of 
the right colic artery was used to check 
massive bleeding caused by diverticular 
disease of the ascending colon when 
vasopressin infusion was unsuccess­
ful;24 surprisingly, bowel infarction did 
not occur. In  spite of such instances, 
embolization of small- or large-bowel 
lesions should be reserved for very 
high-risk patients. A barium enema 
should still be given after control of 
lower gastrointestinal bleeding, but it 
must be remembered that the demon­
stration of diverticula does not neces­
sarily mean they are the source of 
bleeding. Occasionally administration 
of a barium  enema during acute hem­
orrhage may be therapeutic.25
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Trasytol
•  increases the chances 
of survival in acute 
pancreatitis
•  prevents the enzymatic 
release of toxic 
polypeptides and kinins
•  stops hyperfibrinolytic 
hemorrhage
Indications and Dosage 
Hyperfibrinolytic Hemorrhage 
These conditions occur in sur­
gery, including open heart sur­
gery, p ro s ta tic  su rge ry  and 
pathological obstetrical bleeding 
conditions, such as in abruptio 
placentae.
Initial dosage: 200,000 — 500,000 
K.I.U. of which 200,000 K.I.U. 
should be given by intravenous 
injection (at a rate not to exceed 
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Review of Function in Bilateral Lower Limb Amputees*
Gordon A. Hunter, mb, frcs, frcs[c] and Pam Holliday, b sc(pt ), MCPAf
A review of the results of bilateral 
lower limb amputation in 53 individuals 
indicates that the physician can now 
be more optimistic when considering 
the use of prostheses and the value 
of rehabilitation in patients with bi­
lateral amputation. Many patients 
continue to use a prosthesis after the 
second amputation, irrespective of 
the site of the first. Associated disease 
and lack of motivation delay successful 
rehabilitation. About half of the 
amputees used a wheelchair as a prin­
cipal aid to mobility. A number of 
patients found that amputation of the 
second limb necessitated a change of 
accommodation, reduced their degree 
of independence and decreased their 
social activities. Individuals with 
bilateral lower limb amputation prefer 
to retain the knee joint, even if they 
already have unilateral above-knee 
amputation.
line revue des resultats de I’amputation 
bilaterale des membres inferieurs 
chez 53 sujets, indique que le medecin 
peut maintenant etre plus optimiste 
lorsqu’il considere ('utilisation de 
protheses et la valeur de la readaptation 
chez les patients qui doivent subir 
une amputation bilaterale. Plusieurs 
patients poursuivent I'emploi d’une 
prothese apres la seconde amputation, 
independamment du niveau de la pre­
miere. Les maladies associees et le 
manque de motivation retardent la 
reussite de la readaptation. Environ la 
moitie des amputes utilise une chaise 
roulante comme principal moyen de 
locomotion. Un nombre de patients ont 
trouve que I'amputation du second
*From the Amputee Research Centre, 
Toronto, Ont.
Funded by the Ontario March of Dimes
t Amputee unit, University of Toronto, 
West Park Hospital, Toronto, Ont.
Reprint requests to: Dr. G.A. Hunter, 
Amputee Research Centre, West Park 
Hospital, 82 Buttonwood Ave., Toronto, 
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membre avait necessity un changement 
d'installation, avait reduit le degre 
de I’independance et diminue leurs 
activites sociales. Les amputes des 
deux membres inferieurs preferent 
conserver I'articulation du genou, 
meme si I’amputation du premier 
membre a ete faite au dessus du genou.
Peripheral vascular disease is the most 
common reason for amputation of a 
lower limb,1'3 and the loss of both limbs 
is not uncommon.4'6 The best site for 
amputation of the second limb is con­
troversial.
In the geriatric patient who has to 
undergo amputation of the second limb, 
preservation of the knee joint is im­
portant.3,7,8 Many authors9'14 support 
the view that length should be preserved 
in amputation of the second limb, re­
gardless of the level of the first amputa­
tion and the success of prosthetic re­
habilitation. However, Murdoch15 and 
others16’17 believe that if rehabilitation 
with a prosthesis is unsuccessful in a 
person with amputation of one limb, 
then amputation of the second limb at 
a lower level is a disservice to the pa­
tient. Clarke-Williams17 believes that it 
is easier for the patients to maintain 
balance on prostheses and to walk if 
both amputations are at the same level. 
The patient with above-knee amputa­
tions can be fitted with short nonarti- 
culated pylons, which can be gradually 
elongated. In the opinion of Vitali and 
Harris16 the asymmetrical rhythm pro­
duced by training at two different 
levels often results in failure of rehabili­
tation.
In view of this conflict of opinion, 
we decided to assess the functional re­
sults of bilateral amputations performed 
in the Toronto area.
Questionnaire
A comprehensive questionnaire was 
compiled to acquire information regard­
ing function in the area of accommoda­
tion, mobility, self-care, independence 
(ability to use stairs, public transporta­
tion and to go outside alone), occupa­
tion, hobbies and self-evaluation of 
disability (none, mild, moderate, severe) 
during each stage of the amputation 
process. Persons with one above-knee 
amputation and one below-knee am­
putation were asked to state the ad­
vantages or disadvantages in having 
two different leg lengths. The results 
were compared to determine function 
in the various combinations of amputa­
tion levels. The questionnaire was ad­
ministered by one interviewer. When 
the patient was out of town, contact 
was made by mail with a detailed cov­
ering letter.
Individuals with major amputation 
of both legs for any cause were con­
sidered for the study. If any person 
was unable to comprehend or answer 
the questionnaire, or if sufficient in­
formation was not available from files, 
family, or closely associated persons, 
the candidate was not included in the 
survey. Sufficient information was re­
ceived on, one deceased amputee to 
permit his inclusion in the study.
Clinical Material
Patients were drawn from amputa­
tion clinics in three Toronto hospitals. 
Sufficient information for their inclu­
sion in the study was obtained on 53 of 
them. The cause and level of the ampu­
tations are outlined in Table I. Of the 
53 patients, 46 (87%) were male. 
Twenty-three were diabetic. In patients 
with peripheral vascular disease the 
average age was 62 years at the time of 
the first amputation and 63 years at 
second amputation. The time between 
amputations varied from 0 to 85 
months. In patients undergoing simul­
taneous bilateral amputation for trauma, 
the average age at amputation was 42 
years. In three patients whose legs 
were amputated because of frostbite, 
the average age was 37 years.
Results
Follow-up ranged from 6 months to 
32 years. Prescription of prostheses and 
their use at follow-up in each bilateral 
group is outlined in Table II. Of the
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Table I— Level of Amputation and Etiology in 53 Patients
Cause A K /A K
Level of amputation 
A K /B K  B K/BK Mixed* Total
Arteriosclerosis (w ith  or w ithout diabetes),
including Buerger’s disease 9 13 17 3 42
Trauma 1 1 3 3 8
Frostbite — — 1 2 3
Total 10 14 21 3 53
*2 bilateral Syme’s amputation, 3 Syme’s/BK, 1 Syme’s/A K , 1 b ilateral through knee,
1 AK/through hip.
AK =  above knee; BK =  below knee.
Table I I— Prosthetic Use at Follow-up in 53 Patients with B ilateral Amputation
Level of amputation
A K /A K A K /B K B K/BK Mixed Total
(n =  10) (n =  14) (n =  21) (n =  8) (N  =  53)
Patients with unilatera l amputation who
used a prosthesis 2 11 13 1 27
Patients with b ilateral amputation fitted
with prostheses 5 12 19 6 42
Continued use of prostheses at follow-up 4 9 16 6 35
Table I l l - U s e  of Prostheses. Hamilton and Nichols' C lassification* Applied to 53 Patients w ith
Bilateral Amputation
Level of amputation
Use A K /A K A K /B K B K/BK Mixed Total
Nil — — 1 — 1
Wheelchair independence 6 5 4 2 17
Minimal usage 1 6 2 — 9
Reasonable usage 1 1 1 — 3
Good general use 2 2 13 6 23
Total 10 14 21 8 53
‘ Grading system: N il =  the patient is practically or to tally  dependent; wheelchair independence 
=  the patient uses w heelchair to perform self-care activities independently; minimal usage =  
patient wears appliance only part of day or only occasionally for assistance in walking o u td o o rs -  
prosthesis is not a substitute limb to increase total functional activities of patient; reasonable 
usage =  patient wears appliance in and around house either all day or part of most days; good 
general use =  patient is able to w alk more than 91 m (100 yd) and wears prosthesis all or most of 
day and regularly outdoors.
Table IV— Principal Mobility Aid for 53 Patients w ith B ilateral Amputation
Level of amputation
Principal aid A K /A K A K /B K B K/BK Mixed Total
No aids — — 1 4 5
1 or 2 canes 2 1 13 2 18
C rutches/w alkerette 1 2 — — 3
Wheelchair 7 11 7 2 27
Total 10 14 21 8 53
Table V— Independence by Level of Amputation in 53 B ilateral Cases a t Follow-up
Level of amputation
Degree A K /A K A K /B K BK/BK Mixed Total
of independence (n =  10) (n =  14) (n =  21) (n =  8) (N  =  53)
Unable to use public transportation 6 8 11 3 28
Unable to use stairs 7 7 6 2 22
Unable to go outside alone or w ith help 3 1 2 1 7
entire group 42 patients were fitted 
with either one or two prostheses, and 
a high percentage in each group con­
tinued to use the prosthesis at the time 
of follow-up.
We applied the classification system 
of Hamilton and Nichols to the am­
putees in this series (Table III). Our 
results show that 35 of 53 patients con­
tinued to make some use of their 
prostheses.
A change in the type of living accom­
modation was necessary for 12 of 53 
patients.
With respect to mobility (Table IV), 
27 patients used a wheelchair as the 
primary means.
The greatest decrease in self-care 
activities, which included dressing, 
feeding, washing, shaving, transfers, 
toilet use and bathing, occurred in sub­
jects with bilateral above-knee amputa­
tion.
With regard to the independence 
category, Table V shows the functional 
achievement at each level of amputa­
tion.
Occupational status was unchanged 
in 50% of patients with bilateral above­
knee amputation, in 20% of those with 
one above-knee and one below-knee 
amputation, in 52% with bilateral be- 
low-knee amputation and in 38% of 
the patients with “mixed” amputations.
All groups reported a decrease in 
participation in hobbies and pream­
putation social activities.
Five patients assessed themselves as 
having no disability; of these four had 
bilateral below-knee amputation. Six 
patients reported a mild degree of dis­
ability. Thirteen patients assessed them­
selves as having a moderate disability 
and 22 believed that they were severely 
disabled. Seven patients did not respond 
to this question.
Only four patients made negative 
comments about different lengths of 
amputation. One thought the below- 
knee amputation was a nuisance when 
the prosthesis was not worn and an­
other found it difficult to balance with 
uneven leg lengths. The other two 
negative comments were related to the 
fact that healing was delayed in the 
below-knee amputation and, as a result, 
the rehabilitation program was delayed.
The remaining 10 patients did not 
find the extra length a hindrance; all 
would have preferred bilateral below- 
knee amputations because of the ease 
in walking with a below-knee pros­
thesis.
Discussion
The ability to use one prosthesis be­
fore the second leg is amputated is 
considered by some5,9,18 to be crucial to 
successful prosthetic rehabilitation. In 
our series, two of the five patients with 
bilateral above-knee amputation were
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fitted with a prosthesis prior to the 
second amputation; at follow-up four of 
this group of five who were fitted with 
two prostheses were still using the ap­
pliances. In the other groups (Table II) 
the majority of patients with bilateral 
lower-limb amputation were fitted with 
prostheses, and a high percentage of 
these patients continued to use pros­
theses at follow-up.
Some authors6'9,12 are pessimistic 
about rehabilitation with prostheses in 
those with bilateral above-knee amputa­
tion. Our results showed that 4 of 10 
patients in this group were using their 
prostheses at follow-up.
Prior to this survey we, like McCol- 
lough,9 believed that successful rehabili­
tation with prostheses was more likely if 
the first amputation was above the knee 
and the patient learned to walk before 
losing the second leg. In our series, 8 
of 14 patients who had one above-knee 
and one below-knee amputation had 
the above-knee amputation before the 
below-knee procedure. Of these, seven 
used a prosthesis after the first opera­
tion and five were still using prostheses 
at follow-up. In five persons the below- 
knee preceded the above-knee proce­
dure. Four of these used a prosthesis 
after the first procedure and three of 
them were still using prostheses 
at the time of follow-up. These results 
indicate that there is little difference 
in prosthetic rehabilitation in these two 
groups.
Individuals with bilateral below-knee 
amputation and those with mixed levels 
of lower-extremity amputation have 
been given a favourable prognosis for 
successful rehabilitation using pros­
theses.9'12 These views are supported by 
our findings (Table II). We agree with 
Van de Ven19 that the terms “prosthetic 
use” and “prosthetic wear” require 
further definition. Evaluation scales for 
the degree of prosthetic rehabilitation 
have been outlined by several au­
thors,20-23 and we used the 1972 classi­
fication of Hamilton and Nichols.
Conclusion
The results of our study indicate that 
about half of the amputees use a wheel­
chair as the principal mobility aid. At 
follow-up two thirds of those with bila­
teral amputation who were fitted with 
prostheses continued to use the pros­
theses to some extent. The outcome of 
bilateral amputation does not seem to 
be influenced by the site of the initial 
amputation and, from the subjective in­
quiries, amputees prefer to retain their 
knee joint even if they have already 
had one above-knee amputation. Suit­
able accommodation and social support 
play an important part in the success 
or failure of prosthetic rehabilitation 
and the final degree of independence.19,24
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Aneurysmal Bone Cyst of the Vertebra 
with Paraplegia*
M ichael A. R osman , md, frcs[c]
Aneurysmal bone cyst, a benign lesion, 
is difficult to diagnose radiologicaily, 
particularly in the spine, but has a 
characteristic microscopic appearance. 
Treatment of spinal lesions consists of 
curettage, with or without bone grafting, 
together with irradiation at low doses 
(1000 to 2000 rads). The author reports 
a case of aneurysmal bone cyst of the 
neural arch associated with neurologic 
complication, which illustrates some 
typical features of such cysts of the 
spine. The condition should always 
be considered in patients with lytic 
lesions of the spine, and prompt 
surgical intervention is recommended.
La dysplasie fibreuse des os de la 
colonne vertebrale, une lesion benigne 
chez I’enfant, est difficile a diagnostiquer 
a la radiologie, mais elle presente un 
aspect microscopique caracteristique.
Le traitement tient dans le curettage, 
avec ou sans greffe osseuse, associe 
a une irradiation a faible dose (1000 a 
2000 rads). L'auteur decrit un cas de 
dysplasie fibreuse de I'os de I'arc neural, 
associee a des complications neuro- 
logiques, qui illustre les caracteristiques 
typiques de ces kystes de la colonne 
vertebrale. On devrait toujours 
considerer cette affection chez les 
patients souffrant de lesions lytiques 
de la colonne vertebrale, et une 
intervention chirurgicale rapide est 
recommandee.
Aneurysmal bone cyst, a benign lesion 
of young patients, was first described 
by Jaffe and Lichtenstein.1 It may occur 
in almost any part of the skeleton but 
is most frequently seen in long tubular 
bones. The second most common site 
is the vertebrae, where the lesion has a 
particular predilection for the neural 
arch,2-6 but it may occur in the vertebral 
body4,6,7 and involvement of an adjacent 
vertebra is not uncommon.5,8 The
*From the department of orthopedic 
surgery, Montreal Children’s Hospital, 
Montreal, PQ
Reprint requests to: Dr. Michael A. 
Rosman, department of orthopedic 
surgery, Montreal Children’s Hospital, 
2300 Tupper St., Montreal, PQ H3H 1P3
destructive lytic process destroys a ver­
tebral segment and there may be even­
tual intraspinal extension with extra­
dural compression of the cord. The pa­
tient may suffer from pain, muscle 
spasm, limitation of motion, radiculitis, 
paraparesis and paraplegia.4
The radiologic appearance of aneu­
rysmal bone cyst of the spine is fre­
quently not diagnostic5,7 and it may be 
difficult to demonstrate the bony shell 
that is so characteristic of eccentric cysts 
in long bones. The osteolytic process 
may be attributed initially to primary 
or metastatic tumour when a vertebral 
body is involved, since an aneurysmal 
cyst is expected to be found more fre­
quently in the neural arch or the trans­
verse process. When a spinous process 
is the site, it is often greatly expanded 
and ballooned; this finding is more 
typical of the lesion in the long bones. 
The diagnosis of aneurysmal bone cyst 
therefore must be considered in all pa­
tients with lytic lesions of the vertebral 
column.
The pathologic findings9 associated 
with aneurysmal cyst are characteristic. 
The bony expansion is surrounded by a 
thin shell of subperiosteal new bone and 
consists of a honeycombed mass whose 
spaces are filled with blood. Micro­
scopically there are blood-filled cavern­
ous spaces without an endothelial lin­
ing, elastic lamina or muscle layer. The 
walls consist of fibrous tissue and con­
tain osteoid and multinucleated giant 
cells. The latter have been responsible 
on occasion for the diagnosis of giant 
cell tumour. Giant cell tumours are rare 
in the vertebral column and are most 
frequently found in persons over 20 
years of age.
The case described below illustrates 
some of the typical clinical features of 
aneurysmal cyst of the spine. The neu­
rologic findings are of special interest.
Case Report
A 7-year-old girl complained of mid­
dorsal back pain of 2 months’ duration. 
Physical examination revealed no abnor­
mality. Roentgenograms of the spine 
showed a lytic defect in the T-6 vertebral 
arch. During biopsy of the lesion bleeding 
was so profuse that the orthopedic surgeon 
was obliged to close the wound without 
definitive treatment. However, a histologic
diagnosis of aneurysmal bone cyst was 
established.
The patient was transferred to the 
Montreal Children’s Hospital on the third 
postoperative day for further management. 
The physical findings on examination on 
her arrival were normal. Roentgenograms 
of the dorsal spine (Fig. 1) showed the 
presence of a lytic erosion of the lamina 
of T-6, some collapse of the vertebral 
body laterally and absence of the trans­
verse process and pedicle on the right 
side. Tomograms (Fig. 2) revealed similar 
findings as well as a soft-tissue swelling 
on the left. The patient’s condition was 
stable on bed rest and the attending sur­
geon decided to provide her with additional 
support by means of a Milwaukee brace 
and to delay further specific investigations 
and treatment.
On the 19th postoperative day, the pa­
tient became incontinent, progressive para­
paresis developed and she rapidly became 
completely paraplegic. Myelography (Fig. 
3) carried out as an emergency procedure 
disclosed a complete block at the T6-7 
interspace. Laminectomy was performed 
without delay. At operation destruction of
FIG. 1—Initial dorsal spine roentgeno­
gram showing lytic destruction of T-6 
lamina, collapse laterally and destruction 
of transverse processes and pedicles (ar­
rows).
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the posterior arch of T-6 and half that of 
T-5, as well as of the transverse pro­
cesses, was discovered. Tumour and granu­
lation tissue, reddish-purple in colour, was 
compressing the cord forward extradural- 
ly; this was removed. Lateral fusion was
FIG. 2— Anteroposterior projection to­
mogram showing pedicle destruction (large 
arrow) with soft-tissue swelling (small ar­
row).
FIG. 3— Myelogram shows complete 
block at T6-7 interspace. Needle is ex­
ternal marker over T-6.
performed with addition of a Harrington 
rod. The patient gradually recovered mus­
cular strength over the following 3 weeks. 
Only ankle dorsiflexion was not restored 
and this was treated with braces.
Two weeks postoperatively radiation 
therapy was commenced to a dose of up 
to 2000 rads. One month after opera­
tion she was placed in a body cast and 
kept flat in bed for an additional 2 
months. The cast was then changed and 
weight bearing begun. The patient was 
still unable to dorsiflex the ankles. A 
Milwaukee brace was applied 6 months 
after operation. The patient was examined
FIG. 4—One year after operation show­
ing rod in place. Assessment of fusion is 
not possible. Dye in canal passes freely 
by site of previous block.
FIG. 5—Two years after operation 
pedicles (arrows) have regenerated. There 
is no evidence of recurrence of tumour.
1 year after operation and roentgenograms 
were obtained (Fig. 4). Clinical assessment 
of the fusion was difficult and therefore 
16 months after the original surgery the 
operative site was re-explored. The fusion 
was found to be solid, so the Harrington 
rod was removed.
More than 2 years after the first ex­
amination the patient was found to be 
neurologically fully recovered. The most 
recent roentgenogram (Fig. 5) showed 
regeneration of the pedicle and transverse 
process. There was no evidence of recur­
rence of the tumour.
Discussion
The etiology of aneurysmal cyst is 
unknown but many explanations have 
been put forward. Jaffe and Lichten­
stein1 suggested that hemorrhage into a 
pre-existing lesion was the initiating 
factor. Lichtenstein9 believed that the 
cyst was the result of an abnormal vas­
cular disturbance associated with in­
creased venous pressure. Others have 
suggested that the condition results from 
organization within a subperiosteal 
hematoma,10 that it is a variant of a 
giant cell tumour,1' or an angiomatous 
malformation.9 Preoperatively and his­
tologically this tumour is most likely to 
be confused with eosinophilic granuloma 
or giant cell tumour.
The management of the aneurysmal 
bone cyst is simple curettage,2’4'5'12 with 
or without bone grafting. Recovery may 
occur spontaneously or after only par­
tial removal.2-3-12 Surgical treatment of 
cysts of the vertebral column can be 
more difficult particularly if the lesion 
is located in the body or transverse pro­
cess of a vertebra.4-5-7 In the case de­
scribed, the cyst was located in the 
lamina and pedicle of the vertebra so 
that it was accessible surgically; the 
presence of hemorrhage and proximity 
of neural tissue, however, limited the 
extent of the curettage. It was not pos­
sible to fill the cyst cavity with graft 
material and, after the laminectomy 
and excision of the visible cyst, only a 
lateral fusion was possible to achieve 
stability. The Harrington distraction 
rod was used to stabilize the spine 
further. It was not possible to use a 
compression system because the trans­
verse processes were involved by tu­
mour.
Radiation therapy as a modality of 
treatment was used long before the 
natural history of aneurysmal cysts had 
been clarified. Recurrence rates follow­
ing irradiation are low. When used in 
conjunction with partial surgical re­
moval, relatively low doses in the order 
of 1000 to 2000 rads are recom­
mended.5 These low doses appear to 
have a beneficial effect.
When an aneurysmal cyst involves 
the spine, prompt surgical intervention 
is advisable. As in this patient, com­
plete blockage of the spinal canal may
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occur suddenly and therefore when 
the cyst is first diagnosed urgent myelo- 
graphy and prompt decompression are 
indicated. In retrospect, this patient 
should have had an elective myelogram 
despite her normal neurologic status 
as soon as her physicians made the 
diagnosis and saw the extensive involve­
ment of the pedicle and lamina on the 
roentgenograms. The development of 
paraplegia, whether due to postbiopsy 
hemorrhage, spontaneous hemorrhage 
or further tumour growth, was pre­
dictable.
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Critique of Item 600 (SESAP II)
The cause o f Raynaud’s phenomenon is not clear. The entity is characterized by 
recurrent episodes o f vasospasm in the upper extremities precipitated by emo «™ 
stress or exposure to cold. It is often a secondary manifestation o f a m °re serious 
systemic or vascular disease, or o f both, which may not become apparent f "  “  
years. The phenomenon is usually secondary to one o f the following. 1) Buerge 
disease- 2) collagen diseases, especially scleroderma; 3) cervical rib associated with 
thoracic outlet obstruction, or 4) atherosclerosis. Therefore, all answers are correct.
Major attention should be given to the underlying disease. Since the 
tions of Raynaud’s phenomenon are thought to be secondary to sympathetic 
hyperactivity, sympathectomy may be useful.
Reference
418 /1 . Spencer FC, Imparato A M : Peripheral arterial disease, in Schwartz SI (ed): 
Principles^ o f Surgery, ed 2, New York, McGraw-Hill B ook Co. 1974, pp 901-903
DAVIS & GECK SURGICAL ESSAY AWARD FOR RESIDENTS
Davis & Geek annually awards $1000.00 to the surgical 
resident submitting the best paper on a surgical topic to the 
Canadian Journal of Surgery. This award is intended to pro­
mote scientific and literary excellence among Canadian sur­
geons in training.
The conditions of entry for the 1978 award are the fo l­
lowing:—
1. Candidates shall be currently engaged in a recognized 
surgical residency program leading to eligibility tor the 
Fellowship of the Royal College of Physicians and Sur­
geons o f Canada in one o f the surgical specialties (cardio­
vascular and thoracic surgery, general surgery, neuro­
surgery, obstetrics and gynecology, ophthalmology, oto­
laryngology, orthopedic surgery, plastic surgery and 
urology).
2. The material to be submitted shall be in the form o f  a 
manuscript relating to work in which a surgical resident 
is or has been the prime or major investigator. Prior 
oral presentation at a Royal College meeting or a surgical 
forum meeting will not be a disqualification, but prior 
publication as a formal paper in a journal will, lhe 
paper should relate to any field o f surgical interest. The 
manuscript must conform to the style requirements of 
the Journal and must not exceed 3000 words o f text
and six tables and/or six figures. Coauthors are permitted 
on the understanding that the candidate shall be the 
first author and that only the first author shall be eligible
3 Entries must be received in the office o f  the Journal no 
' later than June 30, 1978. Each entry must be submitted 
to the editorial office o f the Canadian Journal of Sur­
gery, PO Box 8650, Ottawa, Ont. K1G 0G8, with a letter 
stating that the paper is being submitted as an entry tor 
the Davis & Geek Surgical Essay Award.
4. All papers submitted shall be the property o f  the Cana­
dian Journal o f Surgery unless returned to the author 
without publication. . .
All papers submitted will be judged by an independent 
committee comprising at least one member o f foe editoria 
board of the Journal, one fellow o f the Royal College of 
Physicians and Surgeons o f Canada, and one representati 
o f The Canadian Medical Association, together with other 
fellows invited to serve at the discretion o f the three perma­
nent members o f  the committee. For the purpose o f  judging, 
the candidates will be anonymous. The judges decision shall
The name o f the successful candidate and the title o f the 
paper will be announced in the November 1978 issue of the 
Journal.
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Orthopedic Days 1978
A course entitled “Neck and Shoulder 
Pain” sponsored by the University of 
British Columbia’s division of continu­
ing education will be offered Apr. 27 
and 28, 1978 at the G.F. Strong Re­
habilitation Centre, 4255 Laurel St., 
Vancouver.
Guest faculty will be: R.L. Cruess, 
chairman, division of orthopedic sur­
gery, McGill University and orthopedic 
surgeon-in-charge, Royal Victoria Hos­
pital, Montreal; J.W. Fielding, clinical 
professor of orthopedic surgery, Colum­
bia University College of Physicians 
and Surgeons and director o>f ortho­
pedic surgery, St. Luke’s Hospital, New 
York; and R. Romano, clinical pro­
fessor of orthopedics, University of 
Washington, Seattle.
For further information contact the 
division of continuing education, In­
structional Resources Centre, The Uni­
versity of British Columbia, Vancou­
ver, BC V6T 1W5.
Gallstones
“Gallstones” is the title of the Fourth 
International Symposium of the Cana­
dian Foundation for Diseases of the 
Liver (formerly the Canadian Hepatic 
Foundation), to be held at the Ritz 
Carlton Hotel, Montreal, May 12 and 
13, 1978. Pre-registration is requested. 
Contact the Canadian Foundation for 
Diseases of the Liver, Ste. 510, 42 
Charles St. E, Toronto, Ont. M4Y 1T4.
Critical Care
The first biennial critical care 
symposium, entitled “Critical Care 
Medicine, 1978—A Pot Pourri”, will 
take place June 15 to 17, 1978 at the 
Banff Springs Hotel, Banff, Alberta.
It is sponsored by the American Col­
lege of Physicians, the Royal College 
of Physicians and Surgeons of Canada, 
the department, of medicine, division 
of continuing medical education, fa­
culty of medicine, University of Al­
berta, Council of the College of Physi­
cians & Surgeons of Alberta, Eli Lilly 
& Company (Canada) Limited and the 
Upjohn Company of Canada.
The symposium is intended to pro­
vide the physician, surgeon, anesthetist, 
pediatrician, or general practitioner 
actively involved in care of critically 
ill patients, with an up-to-date survey 
of acute care medicine.
The following limited attendance 
workshops will be held: (a) ventilators 
—basic mechanisms, utilization, wean­
ing; (b) hemodynamic monitoring; (c) 
newer antibiotics and their use in the
intensive care unit; (d) total parenteral 
nutrition—practical aspects; (e) arterial 
blood-gas analysis and acid-base prob­
lems in the critically ill; and (f) blood 
component therapy in the critically ill. 
Time will allow attendance at two of 
these workshops.
The guest faculty will be: K. Chat- 
terjee, professor of medicine, associate 
chief, cardiovascular division and di­
rector, CCU, University of California 
at San Francisco; M.B. Goldstein, as­
sociate professor, University of Toron­
to; A. Grenvik, professor of anesthe­
siology, director, critical care medicine, 
University of Pittsburgh; K.N. Jee- 
jeebhoy, professor, department of medi­
cine, University of Toronto and head, 
gastroenterology, Toronto General 
Hospital; Bryan W. Kirk, director, in­
tensive care unit, health sciences cen­
tre, and associate, professor of medi­
cine, University of Manitoba, Winnipeg; 
and Arthur Scott, professor and chair­
man, department of anesthesia, Uni­
versity of Toronto and director, in­
tensive care unit, Toronto General 
Hospital.
Codirectors of the symposium are 
E. Garner King, associate professor, 
University of Alberta and A. Aberman, 
associate professor of medicine, Uni­
versity of Toronto.
Registration for the symposium is 
limited; early application is advised. 
Fees are as follows: members and fel­
lows, American College of Physicians 
or Royal College of Physicians and Sur­
geons of Canada, $130; nonmembers, 
$195; residents and associates, $65.
Further information may be ob­
tained from the division of continuing 
medical education, 12-103 Clinical 
Sciences Building, University of Al­
berta, Edmonton, Alta. T6G 2G3.
BOOKS RECEIVED
continued from page 174
Das Typische Rontgenbild des Skeletts.
Standardbefunde und Varietaten vom 
Erwachsenen und Kind fur Arzte, Stu- 
denten und Radiologie-Assistenten. Ru­
dolf Birkner. 566 pp. Illust. Urban & 
Schwarzenberg, Munich, 1977. Price not 
stated. ISBN 3-541-07811-1.
Urinary System Malformations in Chil- 
dren. Proceedings of the International 
Pediatric Urological Seminar, Philadel­
phia, 1976. The National Foundation - 
March of Dimes. Birth Defects: Original 
Articles Series, Volume XIII, Number 
5, 1977. Edited by Daniel Bergsma and 
John W. Duckett. 481 pp. Illust. Alan 
R. Liss, Inc., New York, 1977. $50. 
ISBN 0-8451-1014-4.
La Vagotoinie Supra-Selective. L.F. Hol- 
lender et A. Marrie. 144 pp. Illust. Mas­
son S.A., Paris, 1977. Price not stated, 
paperbound. ISBN 2-225-46805-2.
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